SK12002003A3 - Novel tyrosine kinase inhibitors - Google Patents
Novel tyrosine kinase inhibitors Download PDFInfo
- Publication number
- SK12002003A3 SK12002003A3 SK12002003A SK12002003A SK12002003A3 SK 12002003 A3 SK12002003 A3 SK 12002003A3 SK 12002003 A SK12002003 A SK 12002003A SK 12002003 A SK12002003 A SK 12002003A SK 12002003 A3 SK12002003 A3 SK 12002003A3
- Authority
- SK
- Slovakia
- Prior art keywords
- methyl
- pyridin
- benzoimidazol
- group
- hydroxy
- Prior art date
Links
- 239000005483 tyrosine kinase inhibitor Substances 0.000 title description 8
- 229940121358 tyrosine kinase inhibitor Drugs 0.000 title description 7
- 150000001875 compounds Chemical class 0.000 claims abstract description 223
- 102000004022 Protein-Tyrosine Kinases Human genes 0.000 claims abstract description 23
- 108090000412 Protein-Tyrosine Kinases Proteins 0.000 claims abstract description 23
- 201000010099 disease Diseases 0.000 claims abstract description 16
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 16
- 150000003839 salts Chemical class 0.000 claims abstract description 14
- 239000002246 antineoplastic agent Substances 0.000 claims abstract description 10
- -1 sulfoxy, sulfonyl Chemical group 0.000 claims description 451
- 229910052739 hydrogen Inorganic materials 0.000 claims description 139
- 239000001257 hydrogen Substances 0.000 claims description 112
- 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 claims description 99
- 125000000217 alkyl group Chemical group 0.000 claims description 94
- 150000002431 hydrogen Chemical class 0.000 claims description 74
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 72
- 125000003118 aryl group Chemical group 0.000 claims description 56
- 229910052736 halogen Inorganic materials 0.000 claims description 55
- 125000001072 heteroaryl group Chemical group 0.000 claims description 55
- 150000002367 halogens Chemical class 0.000 claims description 54
- 125000003545 alkoxy group Chemical group 0.000 claims description 52
- 238000000034 method Methods 0.000 claims description 52
- 239000000203 mixture Substances 0.000 claims description 51
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 48
- 125000003342 alkenyl group Chemical group 0.000 claims description 42
- 229910052757 nitrogen Inorganic materials 0.000 claims description 39
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 37
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 36
- 125000005309 thioalkoxy group Chemical group 0.000 claims description 36
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims description 35
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 claims description 33
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 31
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims description 30
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 24
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims description 24
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 24
- 229910052731 fluorine Inorganic materials 0.000 claims description 21
- 206010028980 Neoplasm Diseases 0.000 claims description 20
- 125000000304 alkynyl group Chemical group 0.000 claims description 20
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 claims description 18
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 18
- 125000001424 substituent group Chemical group 0.000 claims description 17
- 102000004190 Enzymes Human genes 0.000 claims description 16
- 108090000790 Enzymes Proteins 0.000 claims description 16
- 229910052760 oxygen Inorganic materials 0.000 claims description 16
- 125000004194 piperazin-1-yl group Chemical group [H]N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 claims description 16
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims description 15
- 229910052799 carbon Inorganic materials 0.000 claims description 14
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 14
- 239000003112 inhibitor Substances 0.000 claims description 14
- 229910052717 sulfur Inorganic materials 0.000 claims description 14
- 125000006275 3-bromophenyl group Chemical group [H]C1=C([H])C(Br)=C([H])C(*)=C1[H] 0.000 claims description 13
- 201000011510 cancer Diseases 0.000 claims description 13
- 125000000623 heterocyclic group Chemical group 0.000 claims description 13
- 125000003282 alkyl amino group Chemical group 0.000 claims description 12
- 125000004663 dialkyl amino group Chemical group 0.000 claims description 12
- 229910052794 bromium Inorganic materials 0.000 claims description 10
- 229910052801 chlorine Inorganic materials 0.000 claims description 10
- 150000002780 morpholines Chemical class 0.000 claims description 10
- 125000000547 substituted alkyl group Chemical group 0.000 claims description 10
- ZNGWEEUXTBNKFR-UHFFFAOYSA-N 1,4-oxazepane Chemical compound C1CNCCOC1 ZNGWEEUXTBNKFR-UHFFFAOYSA-N 0.000 claims description 9
- 241000124008 Mammalia Species 0.000 claims description 9
- 239000008194 pharmaceutical composition Substances 0.000 claims description 9
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 9
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 claims description 8
- NKANXQFJJICGDU-QPLCGJKRSA-N Tamoxifen Chemical compound C=1C=CC=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=CC=C1 NKANXQFJJICGDU-QPLCGJKRSA-N 0.000 claims description 8
- 108010053099 Vascular Endothelial Growth Factor Receptor-2 Proteins 0.000 claims description 8
- 229910002091 carbon monoxide Inorganic materials 0.000 claims description 8
- RFIOZSIHFNEKFF-UHFFFAOYSA-N piperazine-1-carboxylic acid Chemical compound OC(=O)N1CCNCC1 RFIOZSIHFNEKFF-UHFFFAOYSA-N 0.000 claims description 8
- 125000003277 amino group Chemical group 0.000 claims description 7
- KXDHJXZQYSOELW-UHFFFAOYSA-N carbonic acid monoamide Natural products NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 claims description 7
- 229940002612 prodrug Drugs 0.000 claims description 7
- 239000000651 prodrug Substances 0.000 claims description 7
- BRNULMACUQOKMR-UHFFFAOYSA-N thiomorpholine Chemical compound C1CSCCN1 BRNULMACUQOKMR-UHFFFAOYSA-N 0.000 claims description 7
- KJAMZCVTJDTESW-UHFFFAOYSA-N tiracizine Chemical compound C1CC2=CC=CC=C2N(C(=O)CN(C)C)C2=CC(NC(=O)OCC)=CC=C21 KJAMZCVTJDTESW-UHFFFAOYSA-N 0.000 claims description 7
- 101100123850 Caenorhabditis elegans her-1 gene Proteins 0.000 claims description 6
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims description 6
- FQUYSHZXSKYCSY-UHFFFAOYSA-N 1,4-diazepane Chemical compound C1CNCCNC1 FQUYSHZXSKYCSY-UHFFFAOYSA-N 0.000 claims description 5
- UIUYQDFIVJOTTH-UHFFFAOYSA-N 4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-3-(4-methyl-6-piperazin-1-yl-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound N=1C=2C(C)=CC(N3CCNCC3)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(Cl)=C1 UIUYQDFIVJOTTH-UHFFFAOYSA-N 0.000 claims description 5
- 101150029707 ERBB2 gene Proteins 0.000 claims description 5
- 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 claims description 5
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 claims description 5
- 125000001246 bromo group Chemical group Br* 0.000 claims description 5
- 229940022353 herceptin Drugs 0.000 claims description 5
- XPTAUSRPHWOZPN-UHFFFAOYSA-N morpholin-4-yl hydrogen sulfate Chemical compound OS(=O)(=O)ON1CCOCC1 XPTAUSRPHWOZPN-UHFFFAOYSA-N 0.000 claims description 5
- 230000002062 proliferating effect Effects 0.000 claims description 5
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 5
- OTPDWCMLUKMQNO-UHFFFAOYSA-N 1,2,3,4-tetrahydropyrimidine Chemical compound C1NCC=CN1 OTPDWCMLUKMQNO-UHFFFAOYSA-N 0.000 claims description 4
- WOXFMYVTSLAQMO-UHFFFAOYSA-N 2-Pyridinemethanamine Chemical compound NCC1=CC=CC=N1 WOXFMYVTSLAQMO-UHFFFAOYSA-N 0.000 claims description 4
- QEDRKDBUNJAFMZ-UHFFFAOYSA-N 2-[4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-2-oxo-1H-pyridin-3-yl]-7-methyl-3H-benzimidazole-5-carbonitrile Chemical compound N=1C=2C(C)=CC(C#N)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(Cl)=C1 QEDRKDBUNJAFMZ-UHFFFAOYSA-N 0.000 claims description 4
- OTOIUCLFSQHFOX-UHFFFAOYSA-N 3-sulfonylmorpholine Chemical compound O=S(=O)=C1COCCN1 OTOIUCLFSQHFOX-UHFFFAOYSA-N 0.000 claims description 4
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 claims description 4
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 claims description 4
- 239000005411 L01XE02 - Gefitinib Substances 0.000 claims description 4
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 claims description 4
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 claims description 4
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 claims description 4
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 4
- RJURFGZVJUQBHK-UHFFFAOYSA-N actinomycin D Natural products CC1OC(=O)C(C(C)C)N(C)C(=O)CN(C)C(=O)C2CCCN2C(=O)C(C(C)C)NC(=O)C1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)NC4C(=O)NC(C(N5CCCC5C(=O)N(C)CC(=O)N(C)C(C(C)C)C(=O)OC4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-UHFFFAOYSA-N 0.000 claims description 4
- 239000004037 angiogenesis inhibitor Substances 0.000 claims description 4
- 229940121369 angiogenesis inhibitor Drugs 0.000 claims description 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 4
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 claims description 4
- 229960004316 cisplatin Drugs 0.000 claims description 4
- 229940043378 cyclin-dependent kinase inhibitor Drugs 0.000 claims description 4
- 229960004679 doxorubicin Drugs 0.000 claims description 4
- 239000003937 drug carrier Substances 0.000 claims description 4
- 229930013356 epothilone Natural products 0.000 claims description 4
- 229960001433 erlotinib Drugs 0.000 claims description 4
- AAKJLRGGTJKAMG-UHFFFAOYSA-N erlotinib Chemical compound C=12C=C(OCCOC)C(OCCOC)=CC2=NC=NC=1NC1=CC=CC(C#C)=C1 AAKJLRGGTJKAMG-UHFFFAOYSA-N 0.000 claims description 4
- VJJPUSNTGOMMGY-MRVIYFEKSA-N etoposide Chemical compound COC1=C(O)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@@H](O[C@H]3[C@@H]([C@@H](O)[C@@H]4O[C@H](C)OC[C@H]4O3)O)[C@@H]3[C@@H]2C(OC3)=O)=C1 VJJPUSNTGOMMGY-MRVIYFEKSA-N 0.000 claims description 4
- 229960005420 etoposide Drugs 0.000 claims description 4
- 229960002949 fluorouracil Drugs 0.000 claims description 4
- XGALLCVXEZPNRQ-UHFFFAOYSA-N gefitinib Chemical compound C=12C=C(OCCCN3CCOCC3)C(OC)=CC2=NC=NC=1NC1=CC=C(F)C(Cl)=C1 XGALLCVXEZPNRQ-UHFFFAOYSA-N 0.000 claims description 4
- 125000001188 haloalkyl group Chemical group 0.000 claims description 4
- 125000004446 heteroarylalkyl group Chemical group 0.000 claims description 4
- 150000004677 hydrates Chemical class 0.000 claims description 4
- 229940084651 iressa Drugs 0.000 claims description 4
- UWKQSNNFCGGAFS-XIFFEERXSA-N irinotecan Chemical compound C1=C2C(CC)=C3CN(C(C4=C([C@@](C(=O)OC4)(O)CC)C=4)=O)C=4C3=NC2=CC=C1OC(=O)N(CC1)CCC1N1CCCCC1 UWKQSNNFCGGAFS-XIFFEERXSA-N 0.000 claims description 4
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 4
- 229960000485 methotrexate Drugs 0.000 claims description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 4
- 239000012453 solvate Substances 0.000 claims description 4
- 229960001603 tamoxifen Drugs 0.000 claims description 4
- 229960000303 topotecan Drugs 0.000 claims description 4
- UCFGDBYHRUNTLO-QHCPKHFHSA-N topotecan Chemical compound C1=C(O)C(CN(C)C)=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 UCFGDBYHRUNTLO-QHCPKHFHSA-N 0.000 claims description 4
- 239000002525 vasculotropin inhibitor Substances 0.000 claims description 4
- WDELNBOQCPAGPI-KRWDZBQOSA-N (2s)-2-[[6-chloro-5-(6-imidazol-1-yl-4-methyl-1h-benzimidazol-2-yl)pyrimidin-4-yl]amino]-3-phenylpropan-1-ol Chemical compound C([C@@H](CO)NC1=NC=NC(Cl)=C1C=1NC=2C=C(C=C(C=2N=1)C)N1C=NC=C1)C1=CC=CC=C1 WDELNBOQCPAGPI-KRWDZBQOSA-N 0.000 claims description 3
- LKJPYSCBVHEWIU-KRWDZBQOSA-N (R)-bicalutamide Chemical compound C([C@@](O)(C)C(=O)NC=1C=C(C(C#N)=CC=1)C(F)(F)F)S(=O)(=O)C1=CC=C(F)C=C1 LKJPYSCBVHEWIU-KRWDZBQOSA-N 0.000 claims description 3
- VDFVNEFVBPFDSB-UHFFFAOYSA-N 1,3-dioxane Chemical compound C1COCOC1 VDFVNEFVBPFDSB-UHFFFAOYSA-N 0.000 claims description 3
- WNXJIVFYUVYPPR-UHFFFAOYSA-N 1,3-dioxolane Chemical compound C1COCO1 WNXJIVFYUVYPPR-UHFFFAOYSA-N 0.000 claims description 3
- HHGVGFMWJQKOFG-KRWDZBQOSA-N 2-[4-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-2-oxo-1H-pyridin-3-yl]-7-methyl-3H-benzimidazole-5-carbonitrile Chemical compound C([C@@H](CO)NC1=C(C(NC=C1)=O)C=1NC=2C=C(C=C(C=2N=1)C)C#N)C1=CC=CC=C1 HHGVGFMWJQKOFG-KRWDZBQOSA-N 0.000 claims description 3
- ZYTNMZZEEKVKAX-OAQYLSRUSA-N 4-[2-[4-[[(2S)-2-(3-bromo-4-methoxyphenyl)-2-hydroxyethyl]amino]-2-oxo-1H-pyridin-3-yl]-7-methyl-3H-benzimidazol-5-yl]piperazine-1-carboxylic acid Chemical compound BrC=1C=C(C=CC=1OC)[C@@H](CNC1=C(C(NC=C1)=O)C=1NC2=C(N=1)C(=CC(=C2)N1CCN(CC1)C(=O)O)C)O ZYTNMZZEEKVKAX-OAQYLSRUSA-N 0.000 claims description 3
- WGKQPIGFIPWZNV-KRWDZBQOSA-N 4-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-5-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-1H-pyrimidin-6-one Chemical compound C([C@@H](CO)NC1=C(C(NC=N1)=O)C=1NC=2C=C(C=C(C=2N=1)C)N1C=NC=C1)C1=CC=CC=C1 WGKQPIGFIPWZNV-KRWDZBQOSA-N 0.000 claims description 3
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims description 3
- 108010069236 Goserelin Proteins 0.000 claims description 3
- 229930012538 Paclitaxel Natural products 0.000 claims description 3
- 102000016549 Vascular Endothelial Growth Factor Receptor-2 Human genes 0.000 claims description 3
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims description 3
- 229960000997 bicalutamide Drugs 0.000 claims description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 3
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims description 3
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 claims description 3
- OTXBWGUYZNKPMG-UHFFFAOYSA-N isofulminic acid Chemical compound O[N+]#[C-] OTXBWGUYZNKPMG-UHFFFAOYSA-N 0.000 claims description 3
- 229960001592 paclitaxel Drugs 0.000 claims description 3
- 125000004193 piperazinyl group Chemical group 0.000 claims description 3
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 3
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 claims description 3
- IFNWESYYDINUHV-UHFFFAOYSA-N 2,6-dimethylpiperazine Chemical compound CC1CNCC(C)N1 IFNWESYYDINUHV-UHFFFAOYSA-N 0.000 claims description 2
- BXPWYRZCEDJCQW-GOSISDBHSA-N 2-[4-[[(2S)-2-hydroxy-2-phenylethyl]amino]-2-oxo-1H-pyridin-3-yl]-7-methyl-3H-benzimidazole-5-carbonitrile Chemical compound C1([C@H](O)CNC2=C(C(NC=C2)=O)C=2NC=3C=C(C=C(C=3N=2)C)C#N)=CC=CC=C1 BXPWYRZCEDJCQW-GOSISDBHSA-N 0.000 claims description 2
- LQEBRSGCLFNPHN-UHFFFAOYSA-N 2-[4-[[2-(3-bromo-4-methoxyphenyl)-2-hydroxyethyl]amino]-2-oxo-1H-pyridin-3-yl]-7-methyl-3H-benzimidazole-5-carbonitrile Chemical compound C1=C(Br)C(OC)=CC=C1C(O)CNC1=C(C=2NC3=CC(=CC(C)=C3N=2)C#N)C(=O)NC=C1 LQEBRSGCLFNPHN-UHFFFAOYSA-N 0.000 claims description 2
- YETIHONGYJNLSF-UHFFFAOYSA-N 2-[4-[[2-(3-bromophenyl)-2-hydroxyethyl]amino]-2-oxo-1H-pyridin-3-yl]-7-methyl-3H-benzimidazole-5-carbonitrile Chemical compound N=1C=2C(C)=CC(C#N)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(Br)=C1 YETIHONGYJNLSF-UHFFFAOYSA-N 0.000 claims description 2
- BKOVQGMNMPRQPP-UHFFFAOYSA-N 2-[4-[[2-(3-fluorophenyl)-2-hydroxyethyl]amino]-2-oxo-1H-pyridin-3-yl]-7-methyl-3H-benzimidazole-5-carbonitrile Chemical compound N=1C=2C(C)=CC(C#N)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(F)=C1 BKOVQGMNMPRQPP-UHFFFAOYSA-N 0.000 claims description 2
- 125000003006 2-dimethylaminoethyl group Chemical group [H]C([H])([H])N(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 claims description 2
- JOMNTHCQHJPVAZ-UHFFFAOYSA-N 2-methylpiperazine Chemical compound CC1CNCCN1 JOMNTHCQHJPVAZ-UHFFFAOYSA-N 0.000 claims description 2
- COZVWKMJBNLADG-HNNXBMFYSA-N 3-(1H-benzimidazol-2-yl)-4-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-1H-pyridin-2-one Chemical compound C([C@@H](CO)NC1=C(C(=O)NC=C1)C=1NC2=CC=CC=C2N=1)C1=CC=CC=C1 COZVWKMJBNLADG-HNNXBMFYSA-N 0.000 claims description 2
- CMYZQDNEXKMVAP-UHFFFAOYSA-N 3-(1H-benzimidazol-2-yl)-4-[[2-(3-bromophenyl)-2-hydroxyethyl]amino]-1H-pyridin-2-one Chemical compound C1=CNC(=O)C(C=2NC3=CC=CC=C3N=2)=C1NCC(O)C1=CC=CC(Br)=C1 CMYZQDNEXKMVAP-UHFFFAOYSA-N 0.000 claims description 2
- OBHSRNCZUIOTPY-OAQYLSRUSA-N 3-[4-bromo-6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-4-[[(2S)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]-1H-pyridin-2-one Chemical compound C([C@@H](O)C=1C=C(Cl)C=CC=1)NC=1C=CNC(=O)C=1C(NC1=C2)=NC1=C(Br)C=C2CN1CCOCC1 OBHSRNCZUIOTPY-OAQYLSRUSA-N 0.000 claims description 2
- AOJJSUZBOXZQNB-VTZDEGQISA-N 4'-epidoxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-VTZDEGQISA-N 0.000 claims description 2
- CLWRLQRRLJJWJG-JOCHJYFZSA-N 4-[2-[4-[[(2S)-2-(3-bromo-4-methoxyphenyl)-2-hydroxyethyl]amino]-2-oxo-1H-pyridin-3-yl]-7-methyl-3H-benzimidazol-5-yl]piperazine-1-carbaldehyde Chemical compound C1=C(Br)C(OC)=CC=C1[C@H](O)CNC1=C(C=2NC3=CC(=CC(C)=C3N=2)N2CCN(CC2)C=O)C(=O)NC=C1 CLWRLQRRLJJWJG-JOCHJYFZSA-N 0.000 claims description 2
- UOEYQBMDBOFQKW-JOCHJYFZSA-N 4-[2-[4-[[(2S)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]-2-oxo-1H-pyridin-3-yl]-7-methyl-3H-benzimidazol-5-yl]piperazine-1-carbaldehyde Chemical compound C1([C@H](O)CNC2=C(C(NC=C2)=O)C=2NC=3C=C(C=C(C=3N=2)C)N2CCN(CC2)C=O)=CC=CC(Cl)=C1 UOEYQBMDBOFQKW-JOCHJYFZSA-N 0.000 claims description 2
- AMJILRTVLRYXLQ-HXUWFJFHSA-N 4-[[(1S)-2-hydroxy-1-phenylethyl]amino]-3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound C1([C@@H](CO)NC2=C(C(NC=C2)=O)C=2NC=3C=C(C=C(C=3N=2)C)N2C=NC=C2)=CC=CC=C1 AMJILRTVLRYXLQ-HXUWFJFHSA-N 0.000 claims description 2
- QSATVYVNCXNSPW-QFIPXVFZSA-N 4-[[(2S)-1-hydroxy-3-naphthalen-2-ylpropan-2-yl]amino]-3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound C=1C=2NC(C=3C(NC=CC=3N[C@H](CO)CC=3C=C4C=CC=CC4=CC=3)=O)=NC=2C(C)=CC=1N1C=CN=C1 QSATVYVNCXNSPW-QFIPXVFZSA-N 0.000 claims description 2
- VULKTEGKCCHBBY-IBGZPJMESA-N 4-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-3-(4-methyl-6-morpholin-4-yl-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound C([C@@H](CO)NC1=C(C(NC=C1)=O)C=1NC=2C=C(C=C(C=2N=1)C)N1CCOCC1)C1=CC=CC=C1 VULKTEGKCCHBBY-IBGZPJMESA-N 0.000 claims description 2
- RHIFVNRZXJLERW-QFIPXVFZSA-N 4-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-3-[4-methyl-6-(4-propan-2-ylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound C1CN(C(C)C)CCN1C1=CC(C)=C(N=C(N2)C=3C(NC=CC=3N[C@H](CO)CC=3C=CC=CC=3)=O)C2=C1 RHIFVNRZXJLERW-QFIPXVFZSA-N 0.000 claims description 2
- XSHAQUDGMYHMSJ-JOCHJYFZSA-N 4-[[(2S)-2-(3-bromo-4-methoxyphenyl)-2-hydroxyethyl]amino]-3-[4-methyl-6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound C1=C(Br)C(OC)=CC=C1[C@H](O)CNC1=C(C=2NC3=CC(=CC(C)=C3N=2)N2CCN(C)CC2)C(=O)NC=C1 XSHAQUDGMYHMSJ-JOCHJYFZSA-N 0.000 claims description 2
- DNTQJDXWGFMNLI-OPAMFIHVSA-N 4-[[(2S)-2-(3-bromo-4-methoxyphenyl)-2-hydroxyethyl]amino]-3-[4-methyl-6-[(2R)-2-methylmorpholin-4-yl]-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound C1=C(Br)C(OC)=CC=C1[C@H](O)CNC1=C(C=2NC3=CC(=CC(C)=C3N=2)N2C[C@@H](C)OCC2)C(=O)NC=C1 DNTQJDXWGFMNLI-OPAMFIHVSA-N 0.000 claims description 2
- XTGIVFQBEPPGGX-PGRDOPGGSA-N 4-[[(2S)-2-(3-bromo-4-methoxyphenyl)-2-hydroxyethyl]amino]-3-[6-[(2R)-2-(fluoromethyl)morpholin-4-yl]-4-methyl-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound C1=C(Br)C(OC)=CC=C1[C@H](O)CNC1=C(C=2NC3=CC(=CC(C)=C3N=2)N2C[C@H](CF)OCC2)C(=O)NC=C1 XTGIVFQBEPPGGX-PGRDOPGGSA-N 0.000 claims description 2
- LUSNIDFBBMXWAZ-XMSQKQJNSA-N 4-[[(2S)-2-(3-bromo-4-methoxyphenyl)-2-hydroxyethyl]amino]-3-[6-[(2R)-2-(hydroxymethyl)morpholin-4-yl]-4-methyl-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound C1=C(Br)C(OC)=CC=C1[C@H](O)CNC1=C(C=2NC3=CC(=CC(C)=C3N=2)N2C[C@H](CO)OCC2)C(=O)NC=C1 LUSNIDFBBMXWAZ-XMSQKQJNSA-N 0.000 claims description 2
- ODUJFBNSLMAOSE-AUSIDOKSSA-N 4-[[(2S)-2-(3-bromo-4-methoxyphenyl)-2-hydroxyethyl]amino]-3-[6-[(2R)-2-(methoxymethyl)morpholin-4-yl]-4-methyl-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound C1CO[C@@H](COC)CN1C1=CC(C)=C(N=C(N2)C=3C(NC=CC=3NC[C@@H](O)C=3C=C(Br)C(OC)=CC=3)=O)C2=C1 ODUJFBNSLMAOSE-AUSIDOKSSA-N 0.000 claims description 2
- LUSNIDFBBMXWAZ-PGRDOPGGSA-N 4-[[(2S)-2-(3-bromo-4-methoxyphenyl)-2-hydroxyethyl]amino]-3-[6-[(2S)-2-(hydroxymethyl)morpholin-4-yl]-4-methyl-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound COc1ccc(cc1Br)[C@H](O)CNc1cc[nH]c(=O)c1-c1nc2c(C)cc(cc2[nH]1)N1CCO[C@H](CO)C1 LUSNIDFBBMXWAZ-PGRDOPGGSA-N 0.000 claims description 2
- ODUJFBNSLMAOSE-WMZHIEFXSA-N 4-[[(2S)-2-(3-bromo-4-methoxyphenyl)-2-hydroxyethyl]amino]-3-[6-[(2S)-2-(methoxymethyl)morpholin-4-yl]-4-methyl-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound C1CO[C@H](COC)CN1C1=CC(C)=C(N=C(N2)C=3C(NC=CC=3NC[C@@H](O)C=3C=C(Br)C(OC)=CC=3)=O)C2=C1 ODUJFBNSLMAOSE-WMZHIEFXSA-N 0.000 claims description 2
- ONIBKFKEUOBONC-OPAMFIHVSA-N 4-[[(2S)-2-(3-chloro-4-methoxyphenyl)-2-hydroxyethyl]amino]-3-[4-methyl-6-[(2R)-2-methylmorpholin-4-yl]-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound C1=C(Cl)C(OC)=CC=C1[C@H](O)CNC1=C(C=2NC3=CC(=CC(C)=C3N=2)N2C[C@@H](C)OCC2)C(=O)NC=C1 ONIBKFKEUOBONC-OPAMFIHVSA-N 0.000 claims description 2
- ONIBKFKEUOBONC-KSFYIVLOSA-N 4-[[(2S)-2-(3-chloro-4-methoxyphenyl)-2-hydroxyethyl]amino]-3-[4-methyl-6-[(2S)-2-methylmorpholin-4-yl]-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound C1=C(Cl)C(OC)=CC=C1[C@H](O)CNC1=C(C=2NC3=CC(=CC(C)=C3N=2)N2C[C@H](C)OCC2)C(=O)NC=C1 ONIBKFKEUOBONC-KSFYIVLOSA-N 0.000 claims description 2
- PKNHVWJAADMUFX-WMZHIEFXSA-N 4-[[(2S)-2-(3-chloro-4-methoxyphenyl)-2-hydroxyethyl]amino]-3-[6-[(2S)-2-(methoxymethyl)morpholin-4-yl]-4-methyl-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound C1CO[C@H](COC)CN1C1=CC(C)=C(N=C(N2)C=3C(NC=CC=3NC[C@@H](O)C=3C=C(Cl)C(OC)=CC=3)=O)C2=C1 PKNHVWJAADMUFX-WMZHIEFXSA-N 0.000 claims description 2
- IIJGLRWTELJRPH-KSFYIVLOSA-N 4-[[(2S)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]-3-[4-methyl-6-[(2S)-2-methylmorpholin-4-yl]-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound C1CO[C@@H](C)CN1C1=CC(C)=C(N=C(N2)C=3C(NC=CC=3NC[C@@H](O)C=3C=C(Cl)C=CC=3)=O)C2=C1 IIJGLRWTELJRPH-KSFYIVLOSA-N 0.000 claims description 2
- DACIYZDSXDZZSX-HSZRJFAPSA-N 4-[[(2S)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]-3-[4-methyl-6-[(4-methylpiperazin-1-yl)methyl]-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound C1CN(C)CCN1CC1=CC(C)=C(N=C(N2)C=3C(NC=CC=3NC[C@@H](O)C=3C=C(Cl)C=CC=3)=O)C2=C1 DACIYZDSXDZZSX-HSZRJFAPSA-N 0.000 claims description 2
- KPFSRAAWPJUHQV-OAQYLSRUSA-N 4-[[(2S)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]-3-[6-(5,6-dihydro-4H-pyrimidin-1-yl)-4-methyl-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound C1([C@H](O)CNC2=C(C(NC=C2)=O)C=2NC=3C=C(C=C(C=3N=2)C)N2C=NCCC2)=CC=CC(Cl)=C1 KPFSRAAWPJUHQV-OAQYLSRUSA-N 0.000 claims description 2
- HHGSXZXKYKUWGJ-DENIHFKCSA-N 4-[[(2S)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]-3-[6-[(2R)-2-(hydroxymethyl)morpholin-4-yl]-4-methyl-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound C1([C@H](O)CNC2=C(C(NC=C2)=O)C=2NC=3C=C(C=C(C=3N=2)C)N2C[C@H](CO)OCC2)=CC=CC(Cl)=C1 HHGSXZXKYKUWGJ-DENIHFKCSA-N 0.000 claims description 2
- UHOVHYKNOIFMRB-NZQKXSOJSA-N 4-[[(2S)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]-3-[6-[(2S)-2-(methoxymethyl)morpholin-4-yl]-4-methyl-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound COC[C@@H]1CN(CCO1)c1cc(C)c2nc([nH]c2c1)-c1c(NC[C@@H](O)c2cccc(Cl)c2)cc[nH]c1=O UHOVHYKNOIFMRB-NZQKXSOJSA-N 0.000 claims description 2
- LQRBWXDBMNHGCK-HXUWFJFHSA-N 4-[[(2S)-2-hydroxy-2-phenylethyl]amino]-3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound C1([C@H](O)CNC2=C(C(NC=C2)=O)C=2NC=3C=C(C=C(C=3N=2)C)N2C=NC=C2)=CC=CC=C1 LQRBWXDBMNHGCK-HXUWFJFHSA-N 0.000 claims description 2
- GCHQRFUKBLZIMY-IBGZPJMESA-N 4-[[(2S)-2-hydroxy-2-pyridin-2-ylethyl]amino]-3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound C1([C@@H](O)CNC2=C(C(NC=C2)=O)C=2NC=3C=C(C=C(C=3N=2)C)N2C=NC=C2)=CC=CC=N1 GCHQRFUKBLZIMY-IBGZPJMESA-N 0.000 claims description 2
- FOYPTSVQLMKMNX-UHFFFAOYSA-N 4-[[2-(3-bromophenyl)-2-fluoroethyl]amino]-3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound N=1C=2C(C)=CC(N3C=NC=C3)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(F)C1=CC=CC(Br)=C1 FOYPTSVQLMKMNX-UHFFFAOYSA-N 0.000 claims description 2
- WNILFJVHQPMAFY-UHFFFAOYSA-N 4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-3-[6-(2-hydroxypropan-2-yl)-4-methyl-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound N=1C=2C(C)=CC(C(C)(C)O)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(Cl)=C1 WNILFJVHQPMAFY-UHFFFAOYSA-N 0.000 claims description 2
- IHQMLJBDDJVMHI-UHFFFAOYSA-N 4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-3-[6-[4-(2-hydroxyethyl)piperazin-1-yl]-4-methyl-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound N=1C=2C(C)=CC(N3CCN(CCO)CC3)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(Cl)=C1 IHQMLJBDDJVMHI-UHFFFAOYSA-N 0.000 claims description 2
- GHIBXMDVXCYMIY-UHFFFAOYSA-N 4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-5-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-1H-pyrimidin-6-one Chemical compound N=1C=2C(C)=CC(N3C=NC=C3)=CC=2NC=1C(C(NC=N1)=O)=C1NCC(O)C1=CC=CC(Cl)=C1 GHIBXMDVXCYMIY-UHFFFAOYSA-N 0.000 claims description 2
- XFRUTERHWUMUIX-UHFFFAOYSA-N 4-[[2-hydroxy-2-(3-iodophenyl)ethyl]amino]-3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound N=1C=2C(C)=CC(N3C=NC=C3)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(I)=C1 XFRUTERHWUMUIX-UHFFFAOYSA-N 0.000 claims description 2
- BFYIZQONLCFLEV-DAELLWKTSA-N Aromasine Chemical compound O=C1C=C[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC(=C)C2=C1 BFYIZQONLCFLEV-DAELLWKTSA-N 0.000 claims description 2
- UHDGCWIWMRVCDJ-CCXZUQQUSA-N Cytarabine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O1 UHDGCWIWMRVCDJ-CCXZUQQUSA-N 0.000 claims description 2
- 108010092160 Dactinomycin Proteins 0.000 claims description 2
- ZQZFYGIXNQKOAV-OCEACIFDSA-N Droloxifene Chemical compound C=1C=CC=CC=1C(/CC)=C(C=1C=C(O)C=CC=1)\C1=CC=C(OCCN(C)C)C=C1 ZQZFYGIXNQKOAV-OCEACIFDSA-N 0.000 claims description 2
- HTIJFSOGRVMCQR-UHFFFAOYSA-N Epirubicin Natural products COc1cccc2C(=O)c3c(O)c4CC(O)(CC(OC5CC(N)C(=O)C(C)O5)c4c(O)c3C(=O)c12)C(=O)CO HTIJFSOGRVMCQR-UHFFFAOYSA-N 0.000 claims description 2
- XDXDZDZNSLXDNA-TZNDIEGXSA-N Idarubicin Chemical compound C1[C@H](N)[C@H](O)[C@H](C)O[C@H]1O[C@@H]1C2=C(O)C(C(=O)C3=CC=CC=C3C3=O)=C3C(O)=C2C[C@@](O)(C(C)=O)C1 XDXDZDZNSLXDNA-TZNDIEGXSA-N 0.000 claims description 2
- XDXDZDZNSLXDNA-UHFFFAOYSA-N Idarubicin Natural products C1C(N)C(O)C(C)OC1OC1C2=C(O)C(C(=O)C3=CC=CC=C3C3=O)=C3C(O)=C2CC(O)(C(C)=O)C1 XDXDZDZNSLXDNA-UHFFFAOYSA-N 0.000 claims description 2
- OWADAENBHRXWNV-UHFFFAOYSA-N N-[1-[2-[4-[[2-(3-bromophenyl)-2-hydroxyethyl]amino]-2-oxo-1H-pyridin-3-yl]-7-methyl-3H-benzimidazol-5-yl]piperidin-4-yl]-2-hydroxyacetamide Chemical compound N=1C=2C(C)=CC(N3CCC(CC3)NC(=O)CO)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(Br)=C1 OWADAENBHRXWNV-UHFFFAOYSA-N 0.000 claims description 2
- HZQLLKQPXMHIMZ-UHFFFAOYSA-N N-[1-[2-[4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-2-oxo-1H-pyridin-3-yl]-7-methyl-3H-benzimidazol-5-yl]piperidin-4-yl]-2-fluoroacetamide Chemical compound N=1C=2C(C)=CC(N3CCC(CC3)NC(=O)CF)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(Cl)=C1 HZQLLKQPXMHIMZ-UHFFFAOYSA-N 0.000 claims description 2
- RJURFGZVJUQBHK-IIXSONLDSA-N actinomycin D Chemical compound C[C@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)[C@@H](C(C)C)NC(=O)[C@H]1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)N[C@@H]4C(=O)N[C@@H](C(N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-IIXSONLDSA-N 0.000 claims description 2
- XCPGHVQEEXUHNC-UHFFFAOYSA-N amsacrine Chemical compound COC1=CC(NS(C)(=O)=O)=CC=C1NC1=C(C=CC=C2)C2=NC2=CC=CC=C12 XCPGHVQEEXUHNC-UHFFFAOYSA-N 0.000 claims description 2
- 229960001220 amsacrine Drugs 0.000 claims description 2
- 229960002932 anastrozole Drugs 0.000 claims description 2
- YBBLVLTVTVSKRW-UHFFFAOYSA-N anastrozole Chemical compound N#CC(C)(C)C1=CC(C(C)(C#N)C)=CC(CN2N=CN=C2)=C1 YBBLVLTVTVSKRW-UHFFFAOYSA-N 0.000 claims description 2
- 125000004391 aryl sulfonyl group Chemical group 0.000 claims description 2
- 125000006367 bivalent amino carbonyl group Chemical group [H]N([*:1])C([*:2])=O 0.000 claims description 2
- BGECDVWSWDRFSP-UHFFFAOYSA-N borazine Chemical compound B1NBNBN1 BGECDVWSWDRFSP-UHFFFAOYSA-N 0.000 claims description 2
- 150000003857 carboxamides Chemical class 0.000 claims description 2
- WASNZPFVELUKFM-UHFFFAOYSA-N chembl231306 Chemical compound N=1C=2C(C)=CC(N3C=NC=C3)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(Cl)=C1 WASNZPFVELUKFM-UHFFFAOYSA-N 0.000 claims description 2
- SQNXDJMPLAKIID-UHFFFAOYSA-N chembl231307 Chemical compound N=1C=2C(C)=CC(N3C=NC=C3)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(Br)=C1 SQNXDJMPLAKIID-UHFFFAOYSA-N 0.000 claims description 2
- SVOBCURLIYHUOI-KRWDZBQOSA-N chembl245369 Chemical compound C([C@@H](CO)NC1=C(C(NC=C1)=O)C=1NC=2C=C(C=C(C=2N=1)C)N1C=NC=C1)C1=CC=CC=C1Br SVOBCURLIYHUOI-KRWDZBQOSA-N 0.000 claims description 2
- QXPRTJGNGUKZMP-SFHVURJKSA-N chembl391157 Chemical compound C([C@@H](CO)NC1=C(C(NC=C1)=O)C=1NC=2C=C(C=C(C=2N=1)C)N1C=NC=C1)C1=CC=CC(Br)=C1 QXPRTJGNGUKZMP-SFHVURJKSA-N 0.000 claims description 2
- ZWVZORIKUNOTCS-OAQYLSRUSA-N chembl401930 Chemical compound C1([C@H](O)CNC2=C(C(NC=C2)=O)C=2NC=3C=C(C=C(C=3N=2)C)N2CCOCC2)=CC=CC(Cl)=C1 ZWVZORIKUNOTCS-OAQYLSRUSA-N 0.000 claims description 2
- IXRUDPNBDKEDFQ-UHFFFAOYSA-N chembl428222 Chemical compound N=1C=2C(C)=CC(N3C=NC=C3)=CC=2NC=1C(C(NC=C1)=O)=C1OCC1=CC=CC=N1 IXRUDPNBDKEDFQ-UHFFFAOYSA-N 0.000 claims description 2
- 125000004966 cyanoalkyl group Chemical group 0.000 claims description 2
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims description 2
- 229960000640 dactinomycin Drugs 0.000 claims description 2
- 229950004203 droloxifene Drugs 0.000 claims description 2
- 229960001904 epirubicin Drugs 0.000 claims description 2
- 150000003883 epothilone derivatives Chemical class 0.000 claims description 2
- 150000002148 esters Chemical class 0.000 claims description 2
- 229960000255 exemestane Drugs 0.000 claims description 2
- 229960002074 flutamide Drugs 0.000 claims description 2
- MKXKFYHWDHIYRV-UHFFFAOYSA-N flutamide Chemical compound CC(C)C(=O)NC1=CC=C([N+]([O-])=O)C(C(F)(F)F)=C1 MKXKFYHWDHIYRV-UHFFFAOYSA-N 0.000 claims description 2
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 claims description 2
- 229960000908 idarubicin Drugs 0.000 claims description 2
- 229960004768 irinotecan Drugs 0.000 claims description 2
- 229960003881 letrozole Drugs 0.000 claims description 2
- HPJKCIUCZWXJDR-UHFFFAOYSA-N letrozole Chemical compound C1=CC(C#N)=CC=C1C(N1N=CN=C1)C1=CC=C(C#N)C=C1 HPJKCIUCZWXJDR-UHFFFAOYSA-N 0.000 claims description 2
- RQZAXGRLVPAYTJ-GQFGMJRRSA-N megestrol acetate Chemical compound C1=C(C)C2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 RQZAXGRLVPAYTJ-GQFGMJRRSA-N 0.000 claims description 2
- 229960004296 megestrol acetate Drugs 0.000 claims description 2
- SGDBTWWWUNNDEQ-LBPRGKRZSA-N melphalan Chemical compound OC(=O)[C@@H](N)CC1=CC=C(N(CCCl)CCCl)C=C1 SGDBTWWWUNNDEQ-LBPRGKRZSA-N 0.000 claims description 2
- 229960001924 melphalan Drugs 0.000 claims description 2
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 claims description 2
- CFCUWKMKBJTWLW-BKHRDMLASA-N mithramycin Chemical compound O([C@@H]1C[C@@H](O[C@H](C)[C@H]1O)OC=1C=C2C=C3C[C@H]([C@@H](C(=O)C3=C(O)C2=C(O)C=1C)O[C@@H]1O[C@H](C)[C@@H](O)[C@H](O[C@@H]2O[C@H](C)[C@H](O)[C@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@@](C)(O)C3)C2)C1)[C@H](OC)C(=O)[C@@H](O)[C@@H](C)O)[C@H]1C[C@@H](O)[C@H](O)[C@@H](C)O1 CFCUWKMKBJTWLW-BKHRDMLASA-N 0.000 claims description 2
- 229960004857 mitomycin Drugs 0.000 claims description 2
- XWXYUMMDTVBTOU-UHFFFAOYSA-N nilutamide Chemical compound O=C1C(C)(C)NC(=O)N1C1=CC=C([N+]([O-])=O)C(C(F)(F)F)=C1 XWXYUMMDTVBTOU-UHFFFAOYSA-N 0.000 claims description 2
- 229960002653 nilutamide Drugs 0.000 claims description 2
- 229960003171 plicamycin Drugs 0.000 claims description 2
- JHHZLHWJQPUNKB-UHFFFAOYSA-N pyrrolidin-3-ol Chemical compound OC1CCNC1 JHHZLHWJQPUNKB-UHFFFAOYSA-N 0.000 claims description 2
- 229960004622 raloxifene Drugs 0.000 claims description 2
- GZUITABIAKMVPG-UHFFFAOYSA-N raloxifene Chemical compound C1=CC(O)=CC=C1C1=C(C(=O)C=2C=CC(OCCN3CCCCC3)=CC=2)C2=CC=C(O)C=C2S1 GZUITABIAKMVPG-UHFFFAOYSA-N 0.000 claims description 2
- NRUKOCRGYNPUPR-QBPJDGROSA-N teniposide Chemical compound COC1=C(O)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@@H](O[C@H]3[C@@H]([C@@H](O)[C@@H]4O[C@@H](OC[C@H]4O3)C=3SC=CC=3)O)[C@@H]3[C@@H]2C(OC3)=O)=C1 NRUKOCRGYNPUPR-QBPJDGROSA-N 0.000 claims description 2
- 229960001278 teniposide Drugs 0.000 claims description 2
- XFCLJVABOIYOMF-QPLCGJKRSA-N toremifene Chemical compound C1=CC(OCCN(C)C)=CC=C1C(\C=1C=CC=CC=1)=C(\CCCl)C1=CC=CC=C1 XFCLJVABOIYOMF-QPLCGJKRSA-N 0.000 claims description 2
- 229960005026 toremifene Drugs 0.000 claims description 2
- 150000003573 thiols Chemical class 0.000 claims 15
- HNEGJTWNOOWEMH-UHFFFAOYSA-N 1-fluoropropane Chemical group [CH2]CCF HNEGJTWNOOWEMH-UHFFFAOYSA-N 0.000 claims 3
- 125000001309 chloro group Chemical group Cl* 0.000 claims 3
- 125000001153 fluoro group Chemical group F* 0.000 claims 3
- SLYJOQJAIBXMFF-FQEVSTJZSA-N 4-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-3-(4-methyl-6-piperidin-1-yl-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound C([C@@H](CO)NC1=C(C(NC=C1)=O)C=1NC=2C=C(C=C(C=2N=1)C)N1CCCCC1)C1=CC=CC=C1 SLYJOQJAIBXMFF-FQEVSTJZSA-N 0.000 claims 2
- GGNQGVSKUWHOKX-UHFFFAOYSA-N 4-[[2-(3-bromophenyl)-2-hydroxyethyl]amino]-3-(4-methyl-6-piperazin-1-yl-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound N=1C=2C(C)=CC(N3CCNCC3)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(Br)=C1 GGNQGVSKUWHOKX-UHFFFAOYSA-N 0.000 claims 2
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 claims 2
- ZLEMMUBHALJEGB-UHFFFAOYSA-N 1-[2-[4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-2-oxo-1H-pyridin-3-yl]-7-methyl-3H-benzimidazol-5-yl]-N-(2-methoxyethoxy)piperidine-4-carboxamide Chemical compound C1CC(C(=O)NOCCOC)CCN1C1=CC(C)=C(N=C(N2)C=3C(NC=CC=3NCC(O)C=3C=C(Cl)C=CC=3)=O)C2=C1 ZLEMMUBHALJEGB-UHFFFAOYSA-N 0.000 claims 1
- WKJBSMLANQKUCC-UHFFFAOYSA-N 1-[2-[4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-2-oxo-1H-pyridin-3-yl]-7-methyl-3H-benzimidazol-5-yl]-N-methoxypiperidine-4-carboxamide Chemical compound C1CC(C(=O)NOC)CCN1C1=CC(C)=C(N=C(N2)C=3C(NC=CC=3NCC(O)C=3C=C(Cl)C=CC=3)=O)C2=C1 WKJBSMLANQKUCC-UHFFFAOYSA-N 0.000 claims 1
- BKRADANXACAJKT-UHFFFAOYSA-N 2-[4-[2-[4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-2-oxo-1H-pyridin-3-yl]-7-methyl-3H-benzimidazol-5-yl]piperazin-1-yl]acetonitrile Chemical compound N=1C=2C(C)=CC(N3CCN(CC#N)CC3)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(Cl)=C1 BKRADANXACAJKT-UHFFFAOYSA-N 0.000 claims 1
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 claims 1
- 125000001731 2-cyanoethyl group Chemical group [H]C([H])(*)C([H])([H])C#N 0.000 claims 1
- 125000004777 2-fluoroethyl group Chemical group [H]C([H])(F)C([H])([H])* 0.000 claims 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 claims 1
- VVIPLSCLYCWUQT-UHFFFAOYSA-N 3-[4-[2-[4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-2-oxo-1H-pyridin-3-yl]-7-methyl-3H-benzimidazol-5-yl]piperazin-1-yl]propanenitrile Chemical compound N=1C=2C(C)=CC(N3CCN(CCC#N)CC3)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(Cl)=C1 VVIPLSCLYCWUQT-UHFFFAOYSA-N 0.000 claims 1
- MUZVVLKDYCWGDU-VWLOTQADSA-N 3-[6-(4-benzoylpiperazin-1-yl)-4-methyl-1H-benzimidazol-2-yl]-4-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-1H-pyridin-2-one Chemical compound C([C@@H](CO)NC1=C(C(NC=C1)=O)C=1NC=2C=C(C=C(C=2N=1)C)N1CCN(CC1)C(=O)C=1C=CC=CC=1)C1=CC=CC=C1 MUZVVLKDYCWGDU-VWLOTQADSA-N 0.000 claims 1
- HGDHHEZBLVABGA-UHFFFAOYSA-N 3-[6-[4-(2-chloroacetyl)piperazin-1-yl]-4-methyl-1H-benzimidazol-2-yl]-4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-1H-pyridin-2-one Chemical compound N=1C=2C(C)=CC(N3CCN(CC3)C(=O)CCl)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(Cl)=C1 HGDHHEZBLVABGA-UHFFFAOYSA-N 0.000 claims 1
- XXVGYZJJJDYLCD-IBGZPJMESA-N 4-[2-[4-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-2-oxo-1H-pyridin-3-yl]-7-methyl-3H-benzimidazol-5-yl]piperazine-1-carboxamide Chemical compound C([C@@H](CO)NC1=C(C(NC=C1)=O)C=1NC=2C=C(C=C(C=2N=1)C)N1CCN(CC1)C(N)=O)C1=CC=CC=C1 XXVGYZJJJDYLCD-IBGZPJMESA-N 0.000 claims 1
- LQRBWXDBMNHGCK-FQEVSTJZSA-N 4-[[(2R)-2-hydroxy-2-phenylethyl]amino]-3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound C1([C@@H](O)CNC2=C(C(NC=C2)=O)C=2NC=3C=C(C=C(C=3N=2)C)N2C=NC=C2)=CC=CC=C1 LQRBWXDBMNHGCK-FQEVSTJZSA-N 0.000 claims 1
- XBNXAXRVKFHSSL-QFIPXVFZSA-N 4-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-3-[4-methyl-6-(2-morpholin-4-ylethylamino)-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound C=1C=2NC(C=3C(NC=CC=3N[C@H](CO)CC=3C=CC=CC=3)=O)=NC=2C(C)=CC=1NCCN1CCOCC1 XBNXAXRVKFHSSL-QFIPXVFZSA-N 0.000 claims 1
- MZHLCADPMKFBDN-KRWDZBQOSA-N 4-[[(2S)-1-hydroxy-3-pyridin-4-ylpropan-2-yl]amino]-3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound C([C@@H](CO)NC1=C(C(NC=C1)=O)C=1NC=2C=C(C=C(C=2N=1)C)N1C=NC=C1)C1=CC=NC=C1 MZHLCADPMKFBDN-KRWDZBQOSA-N 0.000 claims 1
- XTGIVFQBEPPGGX-XMSQKQJNSA-N 4-[[(2S)-2-(3-bromo-4-methoxyphenyl)-2-hydroxyethyl]amino]-3-[6-[(2S)-2-(fluoromethyl)morpholin-4-yl]-4-methyl-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound C1=C(Br)C(OC)=CC=C1[C@H](O)CNC1=C(C=2NC3=CC(=CC(C)=C3N=2)N2C[C@@H](CF)OCC2)C(=O)NC=C1 XTGIVFQBEPPGGX-XMSQKQJNSA-N 0.000 claims 1
- SQNXDJMPLAKIID-HXUWFJFHSA-N 4-[[(2S)-2-(3-bromophenyl)-2-hydroxyethyl]amino]-3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound C1([C@H](O)CNC2=C(C(NC=C2)=O)C=2NC=3C=C(C=C(C=3N=2)C)N2C=NC=C2)=CC=CC(Br)=C1 SQNXDJMPLAKIID-HXUWFJFHSA-N 0.000 claims 1
- XNQQOBWDWJLPKE-PGRDOPGGSA-N 4-[[(2S)-2-(3-chloro-4-methoxyphenyl)-2-hydroxyethyl]amino]-3-[6-[(2R)-2-(fluoromethyl)morpholin-4-yl]-4-methyl-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound C1=C(Cl)C(OC)=CC=C1[C@H](O)CNC1=C(C=2NC3=CC(=CC(C)=C3N=2)N2C[C@H](CF)OCC2)C(=O)NC=C1 XNQQOBWDWJLPKE-PGRDOPGGSA-N 0.000 claims 1
- XNQQOBWDWJLPKE-XMSQKQJNSA-N 4-[[(2S)-2-(3-chloro-4-methoxyphenyl)-2-hydroxyethyl]amino]-3-[6-[(2S)-2-(fluoromethyl)morpholin-4-yl]-4-methyl-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound C1=C(Cl)C(OC)=CC=C1[C@H](O)CNC1=C(C=2NC3=CC(=CC(C)=C3N=2)N2C[C@@H](CF)OCC2)C(=O)NC=C1 XNQQOBWDWJLPKE-XMSQKQJNSA-N 0.000 claims 1
- RJOLTVNZKRBSOZ-PGRDOPGGSA-N 4-[[(2S)-2-(3-chloro-4-methoxyphenyl)-2-hydroxyethyl]amino]-3-[6-[(2S)-2-(hydroxymethyl)morpholin-4-yl]-4-methyl-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound COc1ccc(cc1Cl)[C@H](O)CNc1cc[nH]c(=O)c1-c1nc2c(C)cc(cc2[nH]1)N1CCO[C@H](CO)C1 RJOLTVNZKRBSOZ-PGRDOPGGSA-N 0.000 claims 1
- GAUMNPIAVGVDBX-HSZRJFAPSA-N 4-[[(2S)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]-3-[4-methyl-6-(2-morpholin-4-ylethoxy)-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound C=1C=2NC(C=3C(NC=CC=3NC[C@@H](O)C=3C=C(Cl)C=CC=3)=O)=NC=2C(C)=CC=1OCCN1CCOCC1 GAUMNPIAVGVDBX-HSZRJFAPSA-N 0.000 claims 1
- IIJGLRWTELJRPH-OPAMFIHVSA-N 4-[[(2S)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]-3-[4-methyl-6-[(2R)-2-methylmorpholin-4-yl]-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound C1CO[C@H](C)CN1C1=CC(C)=C(N=C(N2)C=3C(NC=CC=3NC[C@@H](O)C=3C=C(Cl)C=CC=3)=O)C2=C1 IIJGLRWTELJRPH-OPAMFIHVSA-N 0.000 claims 1
- CJCXXSGEMIIROV-HXUWFJFHSA-N 4-[[(2S)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]-3-[6-(2-methoxyethoxy)-4-methyl-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound C1([C@H](O)CNC2=C(C(NC=C2)=O)C2=NC3=C(C)C=C(C=C3N2)OCCOC)=CC=CC(Cl)=C1 CJCXXSGEMIIROV-HXUWFJFHSA-N 0.000 claims 1
- WHJWUUJEQQJCLJ-SIKLNZKXSA-N 4-[[(2S)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]-3-[6-[(2R)-2-(fluoromethyl)morpholin-4-yl]-4-methyl-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound C1([C@H](O)CNC2=C(C(NC=C2)=O)C=2NC=3C=C(C=C(C=3N=2)C)N2C[C@H](CF)OCC2)=CC=CC(Cl)=C1 WHJWUUJEQQJCLJ-SIKLNZKXSA-N 0.000 claims 1
- HHGSXZXKYKUWGJ-SIKLNZKXSA-N 4-[[(2S)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]-3-[6-[(2S)-2-(hydroxymethyl)morpholin-4-yl]-4-methyl-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound Cc1cc(cc2[nH]c(nc12)-c1c(NC[C@@H](O)c2cccc(Cl)c2)cc[nH]c1=O)N1CCO[C@H](CO)C1 HHGSXZXKYKUWGJ-SIKLNZKXSA-N 0.000 claims 1
- MDBNOVPXWFLVKY-UHFFFAOYSA-N 4-[[2-(3-bromo-4-methoxyphenyl)-2-hydroxyethyl]amino]-3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound C1=C(Br)C(OC)=CC=C1C(O)CNC1=C(C=2NC3=CC(=CC(C)=C3N=2)N2C=NC=C2)C(=O)NC=C1 MDBNOVPXWFLVKY-UHFFFAOYSA-N 0.000 claims 1
- PZSACZRLMBGKSF-VEXWJQHLSA-N 4-[[2-(3-bromo-4-methoxyphenyl)-2-hydroxyethyl]amino]-3-[4-methyl-6-[(2S)-2-morpholin-4-ylpropoxy]-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound BrC=1C=C(C=CC1OC)C(CNC1=C(C(NC=C1)=O)C1=NC2=C(N1)C=C(C=C2C)OC[C@H](C)N2CCOCC2)O PZSACZRLMBGKSF-VEXWJQHLSA-N 0.000 claims 1
- MQPZCABORBJAFW-UHFFFAOYSA-N 4-[[2-(3-chloro-4-fluorophenyl)-2-hydroxyethyl]amino]-3-(4-methyl-6-morpholin-4-yl-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound N=1C=2C(C)=CC(N3CCOCC3)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(O)C1=CC=C(F)C(Cl)=C1 MQPZCABORBJAFW-UHFFFAOYSA-N 0.000 claims 1
- MQKSVRLGJFYTRI-UHFFFAOYSA-N 4-[[2-(3-chloro-4-fluorophenyl)-2-hydroxyethyl]amino]-3-(4-methyl-6-piperazin-1-yl-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound N=1C=2C(C)=CC(N3CCNCC3)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(O)C1=CC=C(F)C(Cl)=C1 MQKSVRLGJFYTRI-UHFFFAOYSA-N 0.000 claims 1
- MZFRECTUVDMWLE-UHFFFAOYSA-N 4-[[2-(3-chloro-4-methylsulfanylphenyl)-2-hydroxyethyl]amino]-3-(4-methyl-6-piperazin-1-yl-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound C1=C(Cl)C(SC)=CC=C1C(O)CNC1=C(C=2NC3=CC(=CC(C)=C3N=2)N2CCNCC2)C(=O)NC=C1 MZFRECTUVDMWLE-UHFFFAOYSA-N 0.000 claims 1
- ZEBVMFXVTKXQJX-VEXWJQHLSA-N 4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-3-[4-methyl-6-[(2S)-2-morpholin-4-ylpropoxy]-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound ClC=1C=C(C=CC1)C(CNC1=C(C(NC=C1)=O)C1=NC2=C(N1)C=C(C=C2C)OC[C@H](C)N2CCOCC2)O ZEBVMFXVTKXQJX-VEXWJQHLSA-N 0.000 claims 1
- BPAKRUQJYIEQNO-UHFFFAOYSA-N 4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-3-[4-methyl-6-[4-(2-methylsulfanylacetyl)piperazin-1-yl]-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound C1CN(C(=O)CSC)CCN1C1=CC(C)=C(N=C(N2)C=3C(NC=CC=3NCC(O)C=3C=C(Cl)C=CC=3)=O)C2=C1 BPAKRUQJYIEQNO-UHFFFAOYSA-N 0.000 claims 1
- INGPCXNUMNHUML-UHFFFAOYSA-N 4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-3-[4-methyl-6-[4-(2-methylsulfinylacetyl)piperazin-1-yl]-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound N=1C=2C(C)=CC(N3CCN(CC3)C(=O)CS(C)=O)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(Cl)=C1 INGPCXNUMNHUML-UHFFFAOYSA-N 0.000 claims 1
- ODKOFIIUMZVPOY-UHFFFAOYSA-N 4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-3-[4-methyl-6-[4-(2-methylsulfonylacetyl)piperazin-1-yl]-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound N=1C=2C(C)=CC(N3CCN(CC3)C(=O)CS(C)(=O)=O)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(Cl)=C1 ODKOFIIUMZVPOY-UHFFFAOYSA-N 0.000 claims 1
- IAOSNXWODOEZQA-UHFFFAOYSA-N 4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-3-[4-methyl-6-[4-(2-methylsulfonylethyl)piperazin-1-yl]-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound N=1C=2C(C)=CC(N3CCN(CCS(C)(=O)=O)CC3)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(Cl)=C1 IAOSNXWODOEZQA-UHFFFAOYSA-N 0.000 claims 1
- QLBZNPSNLVNWIT-UHFFFAOYSA-N 4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-3-[4-methyl-6-[4-(3,3,3-trifluoropropyl)piperazin-1-yl]-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound N=1C=2C(C)=CC(N3CCN(CCC(F)(F)F)CC3)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(Cl)=C1 QLBZNPSNLVNWIT-UHFFFAOYSA-N 0.000 claims 1
- VQPODECQMREPQU-UHFFFAOYSA-N 4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-3-[6-[4-(2,2-difluoroacetyl)piperazin-1-yl]-4-methyl-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound N=1C=2C(C)=CC(N3CCN(CC3)C(=O)C(F)F)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(Cl)=C1 VQPODECQMREPQU-UHFFFAOYSA-N 0.000 claims 1
- ZAKBVBOEYCRZJE-UHFFFAOYSA-N 4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-3-[6-[4-(2-fluoroethyl)piperazin-1-yl]-4-methyl-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound N=1C=2C(C)=CC(N3CCN(CCF)CC3)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(Cl)=C1 ZAKBVBOEYCRZJE-UHFFFAOYSA-N 0.000 claims 1
- ODZVOOVRXLCZEN-UHFFFAOYSA-N 4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-3-[6-[4-(2-hydroxy-2-methylpropyl)piperazin-1-yl]-4-methyl-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound N=1C=2C(C)=CC(N3CCN(CC(C)(C)O)CC3)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(Cl)=C1 ODZVOOVRXLCZEN-UHFFFAOYSA-N 0.000 claims 1
- UXGODHMBZZMTNL-UHFFFAOYSA-N 4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-3-[6-[4-(2-methoxyacetyl)piperazin-1-yl]-4-methyl-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound C1CN(C(=O)COC)CCN1C1=CC(C)=C(N=C(N2)C=3C(NC=CC=3NCC(O)C=3C=C(Cl)C=CC=3)=O)C2=C1 UXGODHMBZZMTNL-UHFFFAOYSA-N 0.000 claims 1
- VUVAXIBXIAPBBM-UHFFFAOYSA-N 4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-3-[6-[4-(3-fluoropropyl)piperazin-1-yl]-4-methyl-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound N=1C=2C(C)=CC(N3CCN(CCCF)CC3)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(Cl)=C1 VUVAXIBXIAPBBM-UHFFFAOYSA-N 0.000 claims 1
- SJEQKFKYXGQTRS-UHFFFAOYSA-N 4-[[2-(7-bromo-2,3-dihydro-1-benzofuran-5-yl)-2-hydroxyethyl]amino]-3-(4-methyl-6-morpholin-4-yl-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound C=1C=2NC(C=3C(NC=CC=3NCC(O)C=3C=C(Br)C=4OCCC=4C=3)=O)=NC=2C(C)=CC=1N1CCOCC1 SJEQKFKYXGQTRS-UHFFFAOYSA-N 0.000 claims 1
- 125000004195 4-methylpiperazin-1-yl group Chemical group [H]C([H])([H])N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 claims 1
- QAPZNKPZJJBBJP-UHFFFAOYSA-N N-[1-[2-[4-[[2-(3-bromo-4-methoxyphenyl)-2-hydroxyethyl]amino]-2-oxo-1H-pyridin-3-yl]-7-methyl-3H-benzimidazol-5-yl]piperidin-4-yl]acetamide Chemical compound C1=C(Br)C(OC)=CC=C1C(O)CNC1=C(C=2NC3=CC(=CC(C)=C3N=2)N2CCC(CC2)NC(C)=O)C(=O)NC=C1 QAPZNKPZJJBBJP-UHFFFAOYSA-N 0.000 claims 1
- QMPSWERXKSJDER-UHFFFAOYSA-N N-[1-[2-[4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-2-oxo-1H-pyridin-3-yl]-7-methyl-3H-benzimidazol-5-yl]piperidin-4-yl]-2-hydroxyacetamide Chemical compound N=1C=2C(C)=CC(N3CCC(CC3)NC(=O)CO)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(Cl)=C1 QMPSWERXKSJDER-UHFFFAOYSA-N 0.000 claims 1
- 125000005122 aminoalkylamino group Chemical group 0.000 claims 1
- ZWVZORIKUNOTCS-UHFFFAOYSA-N chembl2005886 Chemical compound N=1C=2C(C)=CC(N3CCOCC3)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(Cl)=C1 ZWVZORIKUNOTCS-UHFFFAOYSA-N 0.000 claims 1
- DJEARTUSVWKEAS-UHFFFAOYSA-N chembl231212 Chemical compound N=1C=2C(C)=CC(N3C=NC=C3)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(O)C1=CC=C(F)C(Cl)=C1 DJEARTUSVWKEAS-UHFFFAOYSA-N 0.000 claims 1
- XMRDJZYWIDOPTO-UHFFFAOYSA-N chembl231305 Chemical compound N=1C=2C(C)=CC(N3C=NC=C3)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(F)=C1 XMRDJZYWIDOPTO-UHFFFAOYSA-N 0.000 claims 1
- QZBMIUISTXROQE-SFHVURJKSA-N chembl245366 Chemical compound C([C@@H](CO)NC1=C(C(NC=C1)=O)C=1NC=2C=C(C=C(C=2N=1)C)N1C=NC=C1)C1=CC=CC(Cl)=C1 QZBMIUISTXROQE-SFHVURJKSA-N 0.000 claims 1
- NVXUNXUNXWQVAY-UHFFFAOYSA-N chembl387610 Chemical compound N=1C=2C(C)=CC(N3C=NC=C3)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(O)=C1 NVXUNXUNXWQVAY-UHFFFAOYSA-N 0.000 claims 1
- ITOBIOBRLRLTTQ-UHFFFAOYSA-N chembl388206 Chemical compound N=1C=2C(C)=CC(N3C=NC=C3)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(NS(C)(=O)=O)=C1 ITOBIOBRLRLTTQ-UHFFFAOYSA-N 0.000 claims 1
- WASNZPFVELUKFM-HXUWFJFHSA-N chembl389605 Chemical compound C1([C@H](O)CNC2=C(C(NC=C2)=O)C=2NC=3C=C(C=C(C=3N=2)C)N2C=NC=C2)=CC=CC(Cl)=C1 WASNZPFVELUKFM-HXUWFJFHSA-N 0.000 claims 1
- ZFWLXTPDKRBCNN-UHFFFAOYSA-N chembl390198 Chemical compound C1=C(Cl)C(OC)=CC=C1C(O)CNC1=C(C=2NC3=CC(=CC(C)=C3N=2)N2C=NC=C2)C(=O)NC=C1 ZFWLXTPDKRBCNN-UHFFFAOYSA-N 0.000 claims 1
- IKELJUFKSAJTLQ-SFHVURJKSA-N chembl391158 Chemical compound C([C@@H](CO)NC1=C(C(NC=C1)=O)C=1NC=2C=C(C=C(C=2N=1)C)N1C=NC=C1)C1=CC=CC(F)=C1 IKELJUFKSAJTLQ-SFHVURJKSA-N 0.000 claims 1
- 125000000068 chlorophenyl group Chemical group 0.000 claims 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims 1
- 125000005448 ethoxyethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])C([H])([H])* 0.000 claims 1
- 229960004039 finasteride Drugs 0.000 claims 1
- DBEPLOCGEIEOCV-WSBQPABSSA-N finasteride Chemical compound N([C@@H]1CC2)C(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](C(=O)NC(C)(C)C)[C@@]2(C)CC1 DBEPLOCGEIEOCV-WSBQPABSSA-N 0.000 claims 1
- 229960003690 goserelin acetate Drugs 0.000 claims 1
- 125000005191 hydroxyalkylamino group Chemical group 0.000 claims 1
- BLCLNMBMMGCOAS-UHFFFAOYSA-N n-[1-[[1-[[1-[[1-[[1-[[1-[[1-[2-[(carbamoylamino)carbamoyl]pyrrolidin-1-yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-[(2-methylpropan-2-yl)oxy]-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amin Chemical compound C1CCC(C(=O)NNC(N)=O)N1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(COC(C)(C)C)NC(=O)C(NC(=O)C(CO)NC(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C(CC=1NC=NC=1)NC(=O)C1NC(=O)CC1)CC1=CC=C(O)C=C1 BLCLNMBMMGCOAS-UHFFFAOYSA-N 0.000 claims 1
- 238000006467 substitution reaction Methods 0.000 claims 1
- OGWKCGZFUXNPDA-XQKSVPLYSA-N vincristine Chemical compound C([N@]1C[C@@H](C[C@]2(C(=O)OC)C=3C(=CC4=C([C@]56[C@H]([C@@]([C@H](OC(C)=O)[C@]7(CC)C=CCN([C@H]67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)C[C@@](C1)(O)CC)CC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-XQKSVPLYSA-N 0.000 claims 1
- 229960004528 vincristine Drugs 0.000 claims 1
- OGWKCGZFUXNPDA-UHFFFAOYSA-N vincristine Natural products C1C(CC)(O)CC(CC2(C(=O)OC)C=3C(=CC4=C(C56C(C(C(OC(C)=O)C7(CC)C=CCN(C67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)CN1CCC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-UHFFFAOYSA-N 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 abstract description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 327
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 216
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 167
- 239000000243 solution Substances 0.000 description 167
- 239000011541 reaction mixture Substances 0.000 description 115
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 80
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 64
- 235000019439 ethyl acetate Nutrition 0.000 description 62
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 60
- 238000000746 purification Methods 0.000 description 51
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 47
- 238000002360 preparation method Methods 0.000 description 38
- 239000000460 chlorine Substances 0.000 description 36
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 35
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 35
- 230000002829 reductive effect Effects 0.000 description 35
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 33
- 239000011734 sodium Substances 0.000 description 33
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 31
- 239000012267 brine Substances 0.000 description 30
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 30
- 238000002953 preparative HPLC Methods 0.000 description 29
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 27
- 239000007787 solid Substances 0.000 description 27
- WYURNTSHIVDZCO-UHFFFAOYSA-N tetrahydrofuran Substances C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 27
- 108091000080 Phosphotransferase Proteins 0.000 description 25
- 102000020233 phosphotransferase Human genes 0.000 description 25
- 239000000725 suspension Substances 0.000 description 25
- 230000000694 effects Effects 0.000 description 24
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 24
- 238000003818 flash chromatography Methods 0.000 description 23
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 23
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 21
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 20
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 20
- 238000010828 elution Methods 0.000 description 19
- 239000012043 crude product Substances 0.000 description 18
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 17
- 239000012044 organic layer Substances 0.000 description 17
- 239000002904 solvent Substances 0.000 description 17
- 125000003396 thiol group Chemical class [H]S* 0.000 description 17
- DTQVDTLACAAQTR-UHFFFAOYSA-N trifluoroacetic acid Substances OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 17
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 16
- 229910021529 ammonia Inorganic materials 0.000 description 16
- 125000004432 carbon atom Chemical group C* 0.000 description 16
- 239000000047 product Substances 0.000 description 15
- UBQKCCHYAOITMY-UHFFFAOYSA-N pyridin-2-ol Chemical class OC1=CC=CC=N1 UBQKCCHYAOITMY-UHFFFAOYSA-N 0.000 description 15
- 239000002253 acid Substances 0.000 description 14
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 13
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 13
- 125000000899 L-alpha-glutamyl group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C([H])([H])C([H])([H])C(O[H])=O 0.000 description 13
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 13
- 238000006243 chemical reaction Methods 0.000 description 13
- 239000000706 filtrate Substances 0.000 description 13
- 238000010992 reflux Methods 0.000 description 13
- 229920006395 saturated elastomer Polymers 0.000 description 13
- GNBKAOHTTIVAMT-UHFFFAOYSA-N 4-iodo-2-methoxypyridine-3-carbaldehyde Chemical compound COC1=NC=CC(I)=C1C=O GNBKAOHTTIVAMT-UHFFFAOYSA-N 0.000 description 12
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical class C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 11
- BCIIMDOZSUCSEN-UHFFFAOYSA-N piperidin-4-amine Chemical compound NC1CCNCC1 BCIIMDOZSUCSEN-UHFFFAOYSA-N 0.000 description 11
- 239000002244 precipitate Substances 0.000 description 11
- 238000003556 assay Methods 0.000 description 10
- CEIPQQODRKXDSB-UHFFFAOYSA-N ethyl 3-(6-hydroxynaphthalen-2-yl)-1H-indazole-5-carboximidate dihydrochloride Chemical compound Cl.Cl.C1=C(O)C=CC2=CC(C3=NNC4=CC=C(C=C43)C(=N)OCC)=CC=C21 CEIPQQODRKXDSB-UHFFFAOYSA-N 0.000 description 10
- 125000000031 ethylamino group Chemical group [H]C([H])([H])C([H])([H])N([H])[*] 0.000 description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 9
- 238000001704 evaporation Methods 0.000 description 9
- 230000008020 evaporation Effects 0.000 description 9
- 238000004128 high performance liquid chromatography Methods 0.000 description 9
- 229910019142 PO4 Inorganic materials 0.000 description 8
- 150000001408 amides Chemical class 0.000 description 8
- 150000001412 amines Chemical class 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 8
- 238000000021 kinase assay Methods 0.000 description 8
- 238000012417 linear regression Methods 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 239000012071 phase Substances 0.000 description 8
- 239000010452 phosphate Substances 0.000 description 8
- 239000000741 silica gel Substances 0.000 description 8
- 229910002027 silica gel Inorganic materials 0.000 description 8
- 239000000758 substrate Substances 0.000 description 8
- 239000000872 buffer Substances 0.000 description 7
- 150000004985 diamines Chemical class 0.000 description 7
- 229910052740 iodine Inorganic materials 0.000 description 7
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 239000002002 slurry Substances 0.000 description 7
- GRVCMTABBYJKTD-UHFFFAOYSA-N 5-fluoro-3-methyl-2-nitroaniline Chemical compound CC1=CC(F)=CC(N)=C1[N+]([O-])=O GRVCMTABBYJKTD-UHFFFAOYSA-N 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 6
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 6
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical class ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- VHVGFEDTMPYCSX-UHFFFAOYSA-N [1-[[2,2-dimethyl-3-[[4-(oxoazaniumylmethylidene)pyridin-1-yl]methoxy]propoxy]methyl]pyridin-4-ylidene]methyl-oxoazanium;dichloride Chemical compound [Cl-].[Cl-].C1=CC(=C[NH+]=O)C=CN1COCC(C)(C)COCN1C=CC(=C[NH+]=O)C=C1 VHVGFEDTMPYCSX-UHFFFAOYSA-N 0.000 description 6
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- XENVCRGQTABGKY-ZHACJKMWSA-N chlorohydrin Chemical compound CC#CC#CC#CC#C\C=C\C(Cl)CO XENVCRGQTABGKY-ZHACJKMWSA-N 0.000 description 6
- 125000005842 heteroatom Chemical group 0.000 description 6
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 6
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 5
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 5
- VGCXGMAHQTYDJK-UHFFFAOYSA-N Chloroacetyl chloride Chemical compound ClCC(Cl)=O VGCXGMAHQTYDJK-UHFFFAOYSA-N 0.000 description 5
- 150000001409 amidines Chemical class 0.000 description 5
- 239000012298 atmosphere Substances 0.000 description 5
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 5
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 5
- RWTQXCQZLXMHMX-UHFFFAOYSA-N chembl230412 Chemical compound N=1C=2C(C)=CC(C(N)=O)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(Cl)=C1 RWTQXCQZLXMHMX-UHFFFAOYSA-N 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 238000001816 cooling Methods 0.000 description 5
- 239000002254 cytotoxic agent Substances 0.000 description 5
- 231100000673 dose–response relationship Toxicity 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 239000012458 free base Substances 0.000 description 5
- 230000008570 general process Effects 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- 239000011630 iodine Substances 0.000 description 5
- 125000004433 nitrogen atom Chemical group N* 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 150000004885 piperazines Chemical class 0.000 description 5
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 5
- 230000002441 reversible effect Effects 0.000 description 5
- 125000004306 triazinyl group Chemical group 0.000 description 5
- VMKAFJQFKBASMU-KRWDZBQOSA-N (3as)-1-methyl-3,3-diphenyl-3a,4,5,6-tetrahydropyrrolo[1,2-c][1,3,2]oxazaborole Chemical compound C([C@H]12)CCN1B(C)OC2(C=1C=CC=CC=1)C1=CC=CC=C1 VMKAFJQFKBASMU-KRWDZBQOSA-N 0.000 description 4
- JADBQNNRRQRIFM-UHFFFAOYSA-N 1-aminopyridin-2-one Chemical compound NN1C=CC=CC1=O JADBQNNRRQRIFM-UHFFFAOYSA-N 0.000 description 4
- XPTGLFPSVLWIAH-UHFFFAOYSA-N 3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-4-iodo-1H-pyridin-2-one Chemical compound N=1C=2C(C)=CC(N3C=NC=C3)=CC=2NC=1C1=C(I)C=CNC1=O XPTGLFPSVLWIAH-UHFFFAOYSA-N 0.000 description 4
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 4
- 125000004180 3-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(F)=C1[H] 0.000 description 4
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 239000007983 Tris buffer Substances 0.000 description 4
- 102100033177 Vascular endothelial growth factor receptor 2 Human genes 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- 150000001299 aldehydes Chemical class 0.000 description 4
- 206010003246 arthritis Diseases 0.000 description 4
- 125000002619 bicyclic group Chemical group 0.000 description 4
- UWTDFICHZKXYAC-UHFFFAOYSA-N boron;oxolane Chemical compound [B].C1CCOC1 UWTDFICHZKXYAC-UHFFFAOYSA-N 0.000 description 4
- 238000002425 crystallisation Methods 0.000 description 4
- 230000008025 crystallization Effects 0.000 description 4
- 229940127089 cytotoxic agent Drugs 0.000 description 4
- 231100000599 cytotoxic agent Toxicity 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 239000012065 filter cake Substances 0.000 description 4
- 239000006260 foam Substances 0.000 description 4
- 125000000524 functional group Chemical group 0.000 description 4
- 150000002462 imidazolines Chemical class 0.000 description 4
- HNQIVZYLYMDVSB-UHFFFAOYSA-N methanesulfonimidic acid Chemical compound CS(N)(=O)=O HNQIVZYLYMDVSB-UHFFFAOYSA-N 0.000 description 4
- 208000015122 neurodegenerative disease Diseases 0.000 description 4
- 239000012299 nitrogen atmosphere Substances 0.000 description 4
- 229910052763 palladium Inorganic materials 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- 125000006514 pyridin-2-ylmethyl group Chemical group [H]C1=C([H])C([H])=C([H])C(=N1)C([H])([H])* 0.000 description 4
- 238000006722 reduction reaction Methods 0.000 description 4
- 238000005055 short column chromatography Methods 0.000 description 4
- MFRIHAYPQRLWNB-UHFFFAOYSA-N sodium tert-butoxide Chemical compound [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 description 4
- 229940066771 systemic antihistamines piperazine derivative Drugs 0.000 description 4
- 210000004881 tumor cell Anatomy 0.000 description 4
- ABCHDVQSASAULL-UHFFFAOYSA-N 2-(4,6-dichloropyrimidin-5-yl)-6-imidazol-1-yl-4-methyl-1h-benzimidazole Chemical compound N=1C=2C(C)=CC(N3C=NC=C3)=CC=2NC=1C1=C(Cl)N=CN=C1Cl ABCHDVQSASAULL-UHFFFAOYSA-N 0.000 description 3
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 3
- 125000004204 2-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C(OC([H])([H])[H])C([H])=C1[H] 0.000 description 3
- VMCYKRLUYHGDDI-UMSFTDKQSA-N 3-(6-bromo-4-methyl-1H-benzimidazol-2-yl)-4-[[(2S)-1-phenyl-3-trityloxypropan-2-yl]amino]-1H-pyridin-2-one Chemical compound C([C@@H](NC1=C(C(NC=C1)=O)C=1NC=2C=C(Br)C=C(C=2N=1)C)CC=1C=CC=CC=1)OC(C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 VMCYKRLUYHGDDI-UMSFTDKQSA-N 0.000 description 3
- NKYNLLWVSLFYOZ-UHFFFAOYSA-N 3-[6-(4-acetylpiperazin-1-yl)-4-methyl-1H-benzimidazol-2-yl]-4-chloro-1H-pyridin-2-one Chemical compound C1CN(C(=O)C)CCN1C1=CC(C)=C(N=C(N2)C=3C(NC=CC=3Cl)=O)C2=C1 NKYNLLWVSLFYOZ-UHFFFAOYSA-N 0.000 description 3
- UHGFPMUGEQINGV-UHFFFAOYSA-N 3h-benzimidazole-5-carboximidamide Chemical compound NC(=N)C1=CC=C2N=CNC2=C1 UHGFPMUGEQINGV-UHFFFAOYSA-N 0.000 description 3
- ZXFVKFUXKFPUQJ-UHFFFAOYSA-N 4-bromo-2-methyl-6-nitroaniline Chemical compound CC1=CC(Br)=CC([N+]([O-])=O)=C1N ZXFVKFUXKFPUQJ-UHFFFAOYSA-N 0.000 description 3
- JRHAXYKFTBEDMV-UHFFFAOYSA-N 5-imidazol-1-yl-3-methylbenzene-1,2-diamine Chemical compound NC1=C(N)C(C)=CC(N2C=NC=C2)=C1 JRHAXYKFTBEDMV-UHFFFAOYSA-N 0.000 description 3
- 208000023275 Autoimmune disease Diseases 0.000 description 3
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 3
- 108010009202 Growth Factor Receptors Proteins 0.000 description 3
- 102000009465 Growth Factor Receptors Human genes 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
- STVVMTBJNDTZBF-VIFPVBQESA-N L-phenylalaninol Chemical compound OC[C@@H](N)CC1=CC=CC=C1 STVVMTBJNDTZBF-VIFPVBQESA-N 0.000 description 3
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 3
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Substances CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 3
- 201000004681 Psoriasis Diseases 0.000 description 3
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 3
- 125000004390 alkyl sulfonyl group Chemical group 0.000 description 3
- 125000005332 alkyl sulfoxy group Chemical group 0.000 description 3
- 230000029936 alkylation Effects 0.000 description 3
- 238000005804 alkylation reaction Methods 0.000 description 3
- 125000003368 amide group Chemical group 0.000 description 3
- 229910052786 argon Inorganic materials 0.000 description 3
- 125000004429 atom Chemical group 0.000 description 3
- 150000001556 benzimidazoles Chemical class 0.000 description 3
- 229940098773 bovine serum albumin Drugs 0.000 description 3
- 230000004663 cell proliferation Effects 0.000 description 3
- 239000012230 colorless oil Substances 0.000 description 3
- 238000009833 condensation Methods 0.000 description 3
- 230000005494 condensation Effects 0.000 description 3
- 239000000824 cytostatic agent Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 229940082789 erbitux Drugs 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- RWTNPBWLLIMQHL-UHFFFAOYSA-N fexofenadine Chemical compound C1=CC(C(C)(C(O)=O)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 RWTNPBWLLIMQHL-UHFFFAOYSA-N 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000011737 fluorine Substances 0.000 description 3
- 238000007429 general method Methods 0.000 description 3
- 150000002430 hydrocarbons Chemical class 0.000 description 3
- 238000010348 incorporation Methods 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 125000002950 monocyclic group Chemical group 0.000 description 3
- 230000000269 nucleophilic effect Effects 0.000 description 3
- 125000004095 oxindolyl group Chemical group N1(C(CC2=CC=CC=C12)=O)* 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000010791 quenching Methods 0.000 description 3
- 230000000171 quenching effect Effects 0.000 description 3
- 230000002285 radioactive effect Effects 0.000 description 3
- 102000027426 receptor tyrosine kinases Human genes 0.000 description 3
- 108091008598 receptor tyrosine kinases Proteins 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 238000006268 reductive amination reaction Methods 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 230000011664 signaling Effects 0.000 description 3
- 239000000377 silicon dioxide Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 125000004434 sulfur atom Chemical group 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- WMQKEUSSEXKFIK-UHFFFAOYSA-N tert-butyl 4-[2-(4-chloro-2-oxo-1H-pyridin-3-yl)-7-methyl-3H-benzimidazol-5-yl]piperazine-1-carboxylate Chemical compound N=1C=2C(C)=CC(N3CCN(CC3)C(=O)OC(C)(C)C)=CC=2NC=1C1=C(Cl)C=CNC1=O WMQKEUSSEXKFIK-UHFFFAOYSA-N 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 125000004001 thioalkyl group Chemical group 0.000 description 3
- FWPIDFUJEMBDLS-UHFFFAOYSA-L tin(II) chloride dihydrate Chemical compound O.O.Cl[Sn]Cl FWPIDFUJEMBDLS-UHFFFAOYSA-L 0.000 description 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 3
- CSRZQMIRAZTJOY-UHFFFAOYSA-N trimethylsilyl iodide Substances C[Si](C)(C)I CSRZQMIRAZTJOY-UHFFFAOYSA-N 0.000 description 3
- 239000003039 volatile agent Substances 0.000 description 3
- 239000003643 water by type Substances 0.000 description 3
- MNEMOYMUJXAGNE-DDWIOCJRSA-N (1s)-2-amino-1-(3-chloro-4-methoxyphenyl)ethanol;hydrochloride Chemical compound Cl.COC1=CC=C([C@H](O)CN)C=C1Cl MNEMOYMUJXAGNE-DDWIOCJRSA-N 0.000 description 2
- RVDCGHYILQGONA-SNVBAGLBSA-N (1s)-2-chloro-1-(7-chloro-1-methyl-2,3-dihydroindol-5-yl)ethanol Chemical compound ClC[C@@H](O)C1=CC(Cl)=C2N(C)CCC2=C1 RVDCGHYILQGONA-SNVBAGLBSA-N 0.000 description 2
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Substances CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 2
- IOUSTGPAKJVUGJ-UHFFFAOYSA-N 1-[4-(4-amino-3-methyl-5-nitrophenyl)piperazin-1-yl]ethanone Chemical compound C1CN(C(=O)C)CCN1C1=CC(C)=C(N)C([N+]([O-])=O)=C1 IOUSTGPAKJVUGJ-UHFFFAOYSA-N 0.000 description 2
- 125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 2
- YIWUPBWWJCQSMU-UHFFFAOYSA-N 2-(3-amino-5-fluoro-2-nitrophenyl)acetic acid Chemical compound NC1=CC(F)=CC(CC(O)=O)=C1[N+]([O-])=O YIWUPBWWJCQSMU-UHFFFAOYSA-N 0.000 description 2
- JGEUKMABSQAXHO-UHFFFAOYSA-N 2-(4-chloro-2-oxo-1H-pyridin-3-yl)-7-methyl-3H-benzimidazole-5-carbonitrile Chemical compound N=1C=2C(C)=CC(C#N)=CC=2NC=1C1=C(Cl)C=CNC1=O JGEUKMABSQAXHO-UHFFFAOYSA-N 0.000 description 2
- AMFABIDXRCKLRE-UHFFFAOYSA-N 2-(4-iodo-2-methoxypyridin-3-yl)-7-methyl-3h-benzimidazole-5-carbonitrile Chemical compound COC1=NC=CC(I)=C1C1=NC2=C(C)C=C(C#N)C=C2N1 AMFABIDXRCKLRE-UHFFFAOYSA-N 0.000 description 2
- FPOYQLJSDCOZDH-UHFFFAOYSA-N 2-[4-[[2-(3-chloro-4-methoxyphenyl)-2-methoxyethyl]amino]-2-oxo-1H-pyridin-3-yl]-N',7-dimethyl-3H-benzimidazole-5-carboximidamide Chemical compound N1C2=CC(C(=N)NC)=CC(C)=C2N=C1C(C(NC=C1)=O)=C1NCC(OC)C1=CC=C(OC)C(Cl)=C1 FPOYQLJSDCOZDH-UHFFFAOYSA-N 0.000 description 2
- QIOFFVKZRKYQPF-UHFFFAOYSA-N 2-[4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-2-oxo-1H-pyridin-3-yl]-7-methyl-3H-benzimidazole-5-carboxylic acid Chemical compound N=1C=2C(C)=CC(C(O)=O)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(Cl)=C1 QIOFFVKZRKYQPF-UHFFFAOYSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- ASSKVPFEZFQQNQ-UHFFFAOYSA-N 2-benzoxazolinone Chemical group C1=CC=C2OC(O)=NC2=C1 ASSKVPFEZFQQNQ-UHFFFAOYSA-N 0.000 description 2
- KXZXJEVYBOPMLC-UHFFFAOYSA-N 2-chloro-1-(4-chloro-2-methyl-1,3-benzoxazol-6-yl)ethanone Chemical compound C1=C(C(=O)CCl)C=C2OC(C)=NC2=C1Cl KXZXJEVYBOPMLC-UHFFFAOYSA-N 0.000 description 2
- SCZJVSVJAILREE-UHFFFAOYSA-N 2-chloro-1-(7-chloro-1-methyl-2,3-dihydroindol-5-yl)ethanone Chemical compound ClCC(=O)C1=CC(Cl)=C2N(C)CCC2=C1 SCZJVSVJAILREE-UHFFFAOYSA-N 0.000 description 2
- 125000004182 2-chlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(*)C([H])=C1[H] 0.000 description 2
- BQZOMWPTJWWTMQ-UHFFFAOYSA-N 2-methyl-4-morpholin-4-yl-6-nitroaniline Chemical compound [O-][N+](=O)C1=C(N)C(C)=CC(N2CCOCC2)=C1 BQZOMWPTJWWTMQ-UHFFFAOYSA-N 0.000 description 2
- RENQQMGYOXDBQA-UHFFFAOYSA-N 3,4-diamino-5-methylbenzonitrile Chemical compound CC1=CC(C#N)=CC(N)=C1N RENQQMGYOXDBQA-UHFFFAOYSA-N 0.000 description 2
- 125000004189 3,4-dichlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(Cl)C([H])=C1* 0.000 description 2
- DMOQUVLZRZWARC-UHFFFAOYSA-N 3-(6-bromo-4-methyl-1H-benzimidazol-2-yl)-4-chloro-1H-pyridin-2-one Chemical compound N=1C=2C(C)=CC(Br)=CC=2NC=1C1=C(Cl)C=CNC1=O DMOQUVLZRZWARC-UHFFFAOYSA-N 0.000 description 2
- ZJMVWQJIUMSZOS-UHFFFAOYSA-N 3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-4-(pyridin-4-ylamino)-1H-pyridin-2-one Chemical compound N=1C=2C(C)=CC(N3C=NC=C3)=CC=2NC=1C(C(NC=C1)=O)=C1NC1=CC=NC=C1 ZJMVWQJIUMSZOS-UHFFFAOYSA-N 0.000 description 2
- NXPFAMCFTFRWLY-NRFANRHFSA-N 3-[6-(4-acetylpiperazin-1-yl)-4-methyl-1H-benzimidazol-2-yl]-4-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-1H-pyridin-2-one Chemical compound C1CN(C(=O)C)CCN1C1=CC(C)=C(N=C(N2)C=3C(NC=CC=3N[C@H](CO)CC=3C=CC=CC=3)=O)C2=C1 NXPFAMCFTFRWLY-NRFANRHFSA-N 0.000 description 2
- FPGCLBKOTXGRNQ-UHFFFAOYSA-N 3-[6-(4-aminopiperidin-1-yl)-4-methyl-1H-benzimidazol-2-yl]-4-iodo-1H-pyridin-2-one Chemical compound N=1C=2C(C)=CC(N3CCC(N)CC3)=CC=2NC=1C1=C(I)C=CNC1=O FPGCLBKOTXGRNQ-UHFFFAOYSA-N 0.000 description 2
- DGQFUGZAZIEOTL-SANMLTNESA-N 3-[6-(4-benzylpiperazin-1-yl)-4-methyl-1H-benzimidazol-2-yl]-4-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-1H-pyridin-2-one Chemical compound C([C@@H](CO)NC1=C(C(NC=C1)=O)C=1NC=2C=C(C=C(C=2N=1)C)N1CCN(CC=2C=CC=CC=2)CC1)C1=CC=CC=C1 DGQFUGZAZIEOTL-SANMLTNESA-N 0.000 description 2
- XMIIGOLPHOKFCH-UHFFFAOYSA-N 3-phenylpropionic acid Chemical compound OC(=O)CCC1=CC=CC=C1 XMIIGOLPHOKFCH-UHFFFAOYSA-N 0.000 description 2
- XQSJHQXYQAUDFC-UHFFFAOYSA-N 4,6-dichloropyrimidine-5-carbaldehyde Chemical compound ClC1=NC=NC(Cl)=C1C=O XQSJHQXYQAUDFC-UHFFFAOYSA-N 0.000 description 2
- NTYDYGKBAGRVOE-UHFFFAOYSA-N 4-[2-(4-iodo-2-methoxypyridin-3-yl)-7-methyl-3h-benzimidazol-5-yl]morpholine Chemical compound COC1=NC=CC(I)=C1C1=NC2=C(C)C=C(N3CCOCC3)C=C2N1 NTYDYGKBAGRVOE-UHFFFAOYSA-N 0.000 description 2
- YMJSKHUSIRTYRR-UHFFFAOYSA-N 4-[2-(4-iodo-2-oxo-1H-pyridin-3-yl)-7-methyl-3H-benzimidazol-5-yl]piperazine-1-carboxylic acid Chemical compound IC1=C(C(NC=C1)=O)C=1NC2=C(N1)C(=CC(=C2)N2CCN(CC2)C(=O)O)C YMJSKHUSIRTYRR-UHFFFAOYSA-N 0.000 description 2
- ZVNYXNHAMHULPF-OAQYLSRUSA-N 4-[2-[4-[[(2S)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]-2-oxo-1H-pyridin-3-yl]-7-methyl-3H-benzimidazol-5-yl]piperazine-1-carboxylic acid Chemical compound ClC=1C=C(C=CC=1)[C@@H](CNC1=C(C(NC=C1)=O)C=1NC2=C(N=1)C(=CC(=C2)N1CCN(CC1)C(=O)O)C)O ZVNYXNHAMHULPF-OAQYLSRUSA-N 0.000 description 2
- VMNUNODKDDCZKW-UHFFFAOYSA-N 4-amino-3-methyl-5-nitrobenzonitrile Chemical compound CC1=CC(C#N)=CC([N+]([O-])=O)=C1N VMNUNODKDDCZKW-UHFFFAOYSA-N 0.000 description 2
- MBZDCUMFFPWLTJ-UHFFFAOYSA-N 4-amino-3-methylbenzonitrile Chemical compound CC1=CC(C#N)=CC=C1N MBZDCUMFFPWLTJ-UHFFFAOYSA-N 0.000 description 2
- OZUXGFRLSKQVMI-UHFFFAOYSA-N 4-chloro-1h-pyridin-2-one Chemical compound OC1=CC(Cl)=CC=N1 OZUXGFRLSKQVMI-UHFFFAOYSA-N 0.000 description 2
- UBFFFAXMQZYDAN-UHFFFAOYSA-N 4-chloro-2-methyl-1,3-benzoxazole Chemical compound C1=CC=C2OC(C)=NC2=C1Cl UBFFFAXMQZYDAN-UHFFFAOYSA-N 0.000 description 2
- LWAADTSEEZOBDN-UHFFFAOYSA-N 4-chloro-3-(4-methyl-6-morpholin-4-yl-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound N=1C=2C(C)=CC(N3CCOCC3)=CC=2NC=1C1=C(Cl)C=CNC1=O LWAADTSEEZOBDN-UHFFFAOYSA-N 0.000 description 2
- CIKGNTMCJKDTAN-UHFFFAOYSA-N 4-chloro-3h-1,3-benzoxazol-2-one Chemical compound ClC1=CC=CC2=C1NC(=O)O2 CIKGNTMCJKDTAN-UHFFFAOYSA-N 0.000 description 2
- HNQLDOGYHSKNTN-UHFFFAOYSA-N 4-chloro-6-(2-chloroacetyl)-3h-1,3-benzoxazol-2-one Chemical compound ClCC(=O)C1=CC(Cl)=C2NC(=O)OC2=C1 HNQLDOGYHSKNTN-UHFFFAOYSA-N 0.000 description 2
- FCOXEQRRWIJVOZ-UHFFFAOYSA-N 4-imidazol-1-yl-2-methyl-6-nitroaniline Chemical compound [O-][N+](=O)C1=C(N)C(C)=CC(N2C=NC=C2)=C1 FCOXEQRRWIJVOZ-UHFFFAOYSA-N 0.000 description 2
- OWJYLMYMJROSAM-UHFFFAOYSA-N 4-iodo-3-(4-methyl-6-piperazin-1-yl-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound N=1C=2C(C)=CC(N3CCNCC3)=CC=2NC=1C1=C(I)C=CNC1=O OWJYLMYMJROSAM-UHFFFAOYSA-N 0.000 description 2
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 2
- MFCFIGKITSBBJL-UHFFFAOYSA-N 6-imidazol-1-yl-2-(4-iodo-2-methoxypyridin-3-yl)-4-methyl-1h-benzimidazole Chemical compound COC1=NC=CC(I)=C1C1=NC2=C(C)C=C(N3C=NC=C3)C=C2N1 MFCFIGKITSBBJL-UHFFFAOYSA-N 0.000 description 2
- WMYQAKANKREQLM-UHFFFAOYSA-N 7-chloro-1h-indole Chemical compound ClC1=CC=CC2=C1NC=C2 WMYQAKANKREQLM-UHFFFAOYSA-N 0.000 description 2
- PDBXHPORMXSXKO-UHFFFAOYSA-N 8-benzyl-7-[2-[ethyl(2-hydroxyethyl)amino]ethyl]-1,3-dimethylpurine-2,6-dione;hydron;chloride Chemical class Cl.N=1C=2N(C)C(=O)N(C)C(=O)C=2N(CCN(CCO)CC)C=1CC1=CC=CC=C1 PDBXHPORMXSXKO-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- 208000024893 Acute lymphoblastic leukemia Diseases 0.000 description 2
- 208000014697 Acute lymphocytic leukaemia Diseases 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- 208000032467 Aplastic anaemia Diseases 0.000 description 2
- 101710178035 Chorismate synthase 2 Proteins 0.000 description 2
- 102000003909 Cyclin E Human genes 0.000 description 2
- 108090000257 Cyclin E Proteins 0.000 description 2
- 101710152694 Cysteine synthase 2 Proteins 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- 229940123780 DNA topoisomerase I inhibitor Drugs 0.000 description 2
- 229940124087 DNA topoisomerase II inhibitor Drugs 0.000 description 2
- 206010018364 Glomerulonephritis Diseases 0.000 description 2
- 241000701044 Human gammaherpesvirus 4 Species 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 2
- 208000031422 Lymphocytic Chronic B-Cell Leukemia Diseases 0.000 description 2
- 206010052178 Lymphocytic lymphoma Diseases 0.000 description 2
- 206010025323 Lymphomas Diseases 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
- ZDZOTLJHXYCWBA-VCVYQWHSSA-N N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C=4C=CC=CC=4)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 ZDZOTLJHXYCWBA-VCVYQWHSSA-N 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 description 2
- 239000007868 Raney catalyst Substances 0.000 description 2
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 2
- 229910000564 Raney nickel Inorganic materials 0.000 description 2
- 241000710960 Sindbis virus Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000000365 Topoisomerase I Inhibitor Substances 0.000 description 2
- 239000000317 Topoisomerase II Inhibitor Substances 0.000 description 2
- 102000004243 Tubulin Human genes 0.000 description 2
- 108090000704 Tubulin Proteins 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 208000036142 Viral infection Diseases 0.000 description 2
- KSBZFAQREVCNIH-UHFFFAOYSA-N [1-(3-chlorophenyl)-2-nitroethoxy]-triethylsilane Chemical compound CC[Si](CC)(CC)OC(C[N+]([O-])=O)C1=CC=CC(Cl)=C1 KSBZFAQREVCNIH-UHFFFAOYSA-N 0.000 description 2
- 229940022663 acetate Drugs 0.000 description 2
- 230000010933 acylation Effects 0.000 description 2
- 238000005917 acylation reaction Methods 0.000 description 2
- 125000004414 alkyl thio group Chemical group 0.000 description 2
- 239000000908 ammonium hydroxide Substances 0.000 description 2
- 230000000340 anti-metabolite Effects 0.000 description 2
- 229940100197 antimetabolite Drugs 0.000 description 2
- 239000002256 antimetabolite Substances 0.000 description 2
- 230000006907 apoptotic process Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- XJHCXCQVJFPJIK-UHFFFAOYSA-M caesium fluoride Chemical compound [F-].[Cs+] XJHCXCQVJFPJIK-UHFFFAOYSA-M 0.000 description 2
- 230000021235 carbamoylation Effects 0.000 description 2
- 150000001721 carbon Chemical group 0.000 description 2
- LOYHRPQPVDZCBA-UHFFFAOYSA-N chembl230309 Chemical compound N=1C=2C(C)=CC=CC=2NC=1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(Cl)=C1 LOYHRPQPVDZCBA-UHFFFAOYSA-N 0.000 description 2
- HHYOQRDAWFAMAJ-INIZCTEOSA-N chembl397667 Chemical compound C([C@@H](CO)NC1=C(C(NC=C1)=O)C=1NC=2C=C(Br)C=C(C=2N=1)C)C1=CC=CC=C1 HHYOQRDAWFAMAJ-INIZCTEOSA-N 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000002113 chemopreventative effect Effects 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 239000013256 coordination polymer Substances 0.000 description 2
- 230000001085 cytostatic effect Effects 0.000 description 2
- 231100000433 cytotoxic Toxicity 0.000 description 2
- 230000001472 cytotoxic effect Effects 0.000 description 2
- 230000003013 cytotoxicity Effects 0.000 description 2
- 231100000135 cytotoxicity Toxicity 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 229960003668 docetaxel Drugs 0.000 description 2
- HESCAJZNRMSMJG-KKQRBIROSA-N epothilone A Chemical class C/C([C@@H]1C[C@@H]2O[C@@H]2CCC[C@@H]([C@@H]([C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)O1)O)C)=C\C1=CSC(C)=N1 HESCAJZNRMSMJG-KKQRBIROSA-N 0.000 description 2
- CCXMGXOCXHRQQX-UHFFFAOYSA-N ethyl 2-[4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-2-oxo-1H-pyridin-3-yl]-7-methyl-3H-benzimidazole-5-carboximidate Chemical compound N1C2=CC(C(=N)OCC)=CC(C)=C2N=C1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(Cl)=C1 CCXMGXOCXHRQQX-UHFFFAOYSA-N 0.000 description 2
- GTHGCQHCBQGFPK-UHFFFAOYSA-N ethyl 2-[4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-2-oxo-1H-pyridin-3-yl]-7-methyl-3H-benzimidazole-5-carboxylate Chemical compound N1C2=CC(C(=O)OCC)=CC(C)=C2N=C1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(Cl)=C1 GTHGCQHCBQGFPK-UHFFFAOYSA-N 0.000 description 2
- 125000004494 ethyl ester group Chemical group 0.000 description 2
- 238000005755 formation reaction Methods 0.000 description 2
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- 208000024200 hematopoietic and lymphoid system neoplasm Diseases 0.000 description 2
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 238000002868 homogeneous time resolved fluorescence Methods 0.000 description 2
- 229940125697 hormonal agent Drugs 0.000 description 2
- 150000002460 imidazoles Chemical class 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 125000003387 indolinyl group Chemical group N1(CCC2=CC=CC=C12)* 0.000 description 2
- 125000001041 indolyl group Chemical group 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 108010042209 insulin receptor tyrosine kinase Proteins 0.000 description 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 2
- 238000005304 joining Methods 0.000 description 2
- GEGPEDZKUUFDDR-UHFFFAOYSA-N n-(4-cyano-2-methyl-6-nitrophenyl)-2,2,2-trifluoroacetamide Chemical compound CC1=CC(C#N)=CC([N+]([O-])=O)=C1NC(=O)C(F)(F)F GEGPEDZKUUFDDR-UHFFFAOYSA-N 0.000 description 2
- IFTQXEXFRSTUGM-UHFFFAOYSA-N n-(4-imidazol-1-yl-2-methyl-6-nitrophenyl)acetamide Chemical compound C1=C([N+]([O-])=O)C(NC(=O)C)=C(C)C=C1N1C=NC=C1 IFTQXEXFRSTUGM-UHFFFAOYSA-N 0.000 description 2
- 230000004770 neurodegeneration Effects 0.000 description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 229940127084 other anti-cancer agent Drugs 0.000 description 2
- 230000002018 overexpression Effects 0.000 description 2
- 150000002918 oxazolines Chemical class 0.000 description 2
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 2
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 2
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 2
- 150000003053 piperidines Chemical class 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 125000006308 propyl amino group Chemical group 0.000 description 2
- 125000006239 protecting group Chemical group 0.000 description 2
- 150000003235 pyrrolidines Chemical class 0.000 description 2
- 238000001959 radiotherapy Methods 0.000 description 2
- 208000037803 restenosis Diseases 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 125000005346 substituted cycloalkyl group Chemical group 0.000 description 2
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 2
- LCZVKKUAUWQDPX-UHFFFAOYSA-N tert-butyl 2-[(2-acetyloxyphenyl)methyl-[2-[(2-acetyloxyphenyl)methyl-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]amino]ethyl]amino]acetate Chemical compound CC(=O)OC1=CC=CC=C1CN(CC(=O)OC(C)(C)C)CCN(CC(=O)OC(C)(C)C)CC1=CC=CC=C1OC(C)=O LCZVKKUAUWQDPX-UHFFFAOYSA-N 0.000 description 2
- XVPJHGJOHVZFMO-UHFFFAOYSA-N tert-butyl 4-(3,4-diamino-5-methylphenyl)piperazine-1-carboxylate Chemical compound NC1=C(N)C(C)=CC(N2CCN(CC2)C(=O)OC(C)(C)C)=C1 XVPJHGJOHVZFMO-UHFFFAOYSA-N 0.000 description 2
- LCQMAJWPZLRBGM-UHFFFAOYSA-N tert-butyl 4-(3-amino-5-methyl-4-nitrophenyl)piperazine-1-carboxylate Chemical compound NC1=C([N+]([O-])=O)C(C)=CC(N2CCN(CC2)C(=O)OC(C)(C)C)=C1 LCQMAJWPZLRBGM-UHFFFAOYSA-N 0.000 description 2
- RFFFWJIOZJLAHV-UHFFFAOYSA-N tert-butyl 4-[2-(4-iodo-2-methoxypyridin-3-yl)-7-methyl-3h-benzimidazol-5-yl]piperazine-1-carboxylate Chemical compound COC1=NC=CC(I)=C1C1=NC2=C(C)C=C(N3CCN(CC3)C(=O)OC(C)(C)C)C=C2N1 RFFFWJIOZJLAHV-UHFFFAOYSA-N 0.000 description 2
- BHCIXRPUHVBMRO-LBPRGKRZSA-N tert-butyl n-[(2s)-1-(3-bromophenyl)-3-hydroxypropan-2-yl]carbamate Chemical compound CC(C)(C)OC(=O)N[C@H](CO)CC1=CC=CC(Br)=C1 BHCIXRPUHVBMRO-LBPRGKRZSA-N 0.000 description 2
- RZJACUGLMVIFQO-UHFFFAOYSA-N tert-butyl n-[1-(3-amino-5-methyl-4-nitrophenyl)piperidin-4-yl]carbamate Chemical compound NC1=C([N+]([O-])=O)C(C)=CC(N2CCC(CC2)NC(=O)OC(C)(C)C)=C1 RZJACUGLMVIFQO-UHFFFAOYSA-N 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 description 2
- 150000003549 thiazolines Chemical class 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 125000006168 tricyclic group Chemical group 0.000 description 2
- QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 description 2
- 241000701161 unidentified adenovirus Species 0.000 description 2
- 241001529453 unidentified herpesvirus Species 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- 230000009385 viral infection Effects 0.000 description 2
- KOSUZOTZIAPVKN-QMMMGPOBSA-N (1S)-2,2-diamino-1-(7-bromo-2,3-dihydro-1-benzofuran-5-yl)ethanol Chemical compound BrC1=CC([C@H](O)C(N)N)=CC2=C1OCC2 KOSUZOTZIAPVKN-QMMMGPOBSA-N 0.000 description 1
- CYPYTURSJDMMMP-WVCUSYJESA-N (1e,4e)-1,5-diphenylpenta-1,4-dien-3-one;palladium Chemical compound [Pd].[Pd].C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1 CYPYTURSJDMMMP-WVCUSYJESA-N 0.000 description 1
- ITDCEEMCJJUSBB-DDWIOCJRSA-N (1s)-2-amino-1-(3-bromophenyl)ethanol;hydrochloride Chemical compound Cl.NC[C@@H](O)C1=CC=CC(Br)=C1 ITDCEEMCJJUSBB-DDWIOCJRSA-N 0.000 description 1
- OETLFANFFALIGI-DDWIOCJRSA-N (1s)-2-amino-1-(3-chloro-4-fluorophenyl)ethanol;hydrochloride Chemical compound Cl.NC[C@@H](O)C1=CC=C(F)C(Cl)=C1 OETLFANFFALIGI-DDWIOCJRSA-N 0.000 description 1
- HDXPPVNAHRADDH-DDWIOCJRSA-N (1s)-2-amino-1-(3-chloro-4-methylsulfanylphenyl)ethanol;hydrochloride Chemical compound Cl.CSC1=CC=C([C@H](O)CN)C=C1Cl HDXPPVNAHRADDH-DDWIOCJRSA-N 0.000 description 1
- KEYKAIIHCHCFEO-DDWIOCJRSA-N (1s)-2-amino-1-(3-chlorophenyl)ethanol;hydrochloride Chemical compound Cl.NC[C@@H](O)C1=CC=CC(Cl)=C1 KEYKAIIHCHCFEO-DDWIOCJRSA-N 0.000 description 1
- UPJMEEMDJVVXRP-DDWIOCJRSA-N (1s)-2-amino-1-(4-chloro-2-methyl-1,3-benzoxazol-6-yl)ethanol;hydrochloride Chemical compound Cl.C1=C([C@H](O)CN)C=C2OC(C)=NC2=C1Cl UPJMEEMDJVVXRP-DDWIOCJRSA-N 0.000 description 1
- QXNGSOXIIWEFAO-HNCPQSOCSA-N (1s)-2-amino-1-(7-chloro-1-methyl-2,3-dihydroindol-5-yl)ethanol;hydrochloride Chemical compound Cl.NC[C@@H](O)C1=CC(Cl)=C2N(C)CCC2=C1 QXNGSOXIIWEFAO-HNCPQSOCSA-N 0.000 description 1
- ULSIYEODSMZIPX-MRVPVSSYSA-N (1s)-2-amino-1-phenylethanol Chemical compound NC[C@@H](O)C1=CC=CC=C1 ULSIYEODSMZIPX-MRVPVSSYSA-N 0.000 description 1
- QOSKETZIPGIXHN-MRVPVSSYSA-N (1s)-2-chloro-1-(4-chloro-2-methyl-1,3-benzoxazol-6-yl)ethanol Chemical compound C1=C([C@H](O)CCl)C=C2OC(C)=NC2=C1Cl QOSKETZIPGIXHN-MRVPVSSYSA-N 0.000 description 1
- UVLODALMANQJQZ-SNVBAGLBSA-N (1s)-2-chloro-1-(7-chloro-1-methylindol-5-yl)ethanol Chemical compound ClC[C@@H](O)C1=CC(Cl)=C2N(C)C=CC2=C1 UVLODALMANQJQZ-SNVBAGLBSA-N 0.000 description 1
- SJMQQGPIJHSATB-FQEVSTJZSA-N (2S)-2-[[3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-2-oxo-1H-pyridin-4-yl]amino]-3-phenylpropanoic acid Chemical compound C([C@H](NC1=C(C(NC=C1)=O)C=1NC=2C=C(C=C(C=2N=1)C)N1C=NC=C1)C(O)=O)C1=CC=CC=C1 SJMQQGPIJHSATB-FQEVSTJZSA-N 0.000 description 1
- BOMIUROCBUEZOM-DEOSSOPVSA-N (2S)-3-hydroxy-2-[[3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-2-oxo-1H-pyridin-4-yl]amino]-N-naphthalen-1-ylpropanamide Chemical compound C=1C=2NC(C=3C(NC=CC=3N[C@@H](CO)C(=O)NC=3C4=CC=CC=C4C=CC=3)=O)=NC=2C(C)=CC=1N1C=CN=C1 BOMIUROCBUEZOM-DEOSSOPVSA-N 0.000 description 1
- RRMCWFHKHSBXJH-VIFPVBQESA-N (2s)-2-amino-3-(3-bromophenyl)propan-1-ol Chemical compound OC[C@@H](N)CC1=CC=CC(Br)=C1 RRMCWFHKHSBXJH-VIFPVBQESA-N 0.000 description 1
- FBUDYESOPLBQIR-NSHDSACASA-N (2s)-3-(3-bromophenyl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid Chemical compound CC(C)(C)OC(=O)N[C@H](C(O)=O)CC1=CC=CC(Br)=C1 FBUDYESOPLBQIR-NSHDSACASA-N 0.000 description 1
- VEEGZPWAAPPXRB-BJMVGYQFSA-N (3e)-3-(1h-imidazol-5-ylmethylidene)-1h-indol-2-one Chemical compound O=C1NC2=CC=CC=C2\C1=C/C1=CN=CN1 VEEGZPWAAPPXRB-BJMVGYQFSA-N 0.000 description 1
- HGRWHBQLRXWSLV-DEOSSOPVSA-N (4s)-3'-(3,6-dihydro-2h-pyran-5-yl)-1'-fluoro-7'-(3-fluoropyridin-2-yl)spiro[5h-1,3-oxazole-4,5'-chromeno[2,3-c]pyridine]-2-amine Chemical compound C1OC(N)=N[C@]21C1=CC(C=3COCCC=3)=NC(F)=C1OC1=CC=C(C=3C(=CC=CN=3)F)C=C12 HGRWHBQLRXWSLV-DEOSSOPVSA-N 0.000 description 1
- 125000006727 (C1-C6) alkenyl group Chemical group 0.000 description 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 1
- 125000003161 (C1-C6) alkylene group Chemical group 0.000 description 1
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
- PWRFDGYYJWQIAB-UHFFFAOYSA-N 1,3,5-trifluoro-2-nitrobenzene Chemical compound [O-][N+](=O)C1=C(F)C=C(F)C=C1F PWRFDGYYJWQIAB-UHFFFAOYSA-N 0.000 description 1
- VBXZSFNZVNDOPB-UHFFFAOYSA-N 1,4,5,6-tetrahydropyrimidine Chemical compound C1CNC=NC1 VBXZSFNZVNDOPB-UHFFFAOYSA-N 0.000 description 1
- NDOVLWQBFFJETK-UHFFFAOYSA-N 1,4-thiazinane 1,1-dioxide Chemical compound O=S1(=O)CCNCC1 NDOVLWQBFFJETK-UHFFFAOYSA-N 0.000 description 1
- HJHMYJMYRHZPEF-UHFFFAOYSA-N 1-(3-chlorophenyl)-2-nitroethanol Chemical compound [O-][N+](=O)CC(O)C1=CC=CC(Cl)=C1 HJHMYJMYRHZPEF-UHFFFAOYSA-N 0.000 description 1
- HYTUDPOPONCSCM-UHFFFAOYSA-N 1-(3-methyl-4-nitrophenyl)imidazole Chemical compound C1=C([N+]([O-])=O)C(C)=CC(N2C=NC=C2)=C1 HYTUDPOPONCSCM-UHFFFAOYSA-N 0.000 description 1
- GMVBFXQOAXJZDF-UHFFFAOYSA-N 1-[2-[4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-2-oxo-1H-pyridin-3-yl]-7-methyl-3H-benzimidazol-5-yl]-3-ethylurea Chemical compound N1C2=CC(NC(=O)NCC)=CC(C)=C2N=C1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(Cl)=C1 GMVBFXQOAXJZDF-UHFFFAOYSA-N 0.000 description 1
- ZATMIVLEUNUJPE-UHFFFAOYSA-N 1-[2-[4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-2-oxo-1H-pyridin-3-yl]-7-methyl-3H-benzimidazol-5-yl]-3-propan-2-ylurea Chemical compound N1C2=CC(NC(=O)NC(C)C)=CC(C)=C2N=C1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(Cl)=C1 ZATMIVLEUNUJPE-UHFFFAOYSA-N 0.000 description 1
- LWELCYJSAYQTOX-UHFFFAOYSA-N 1-[2-[4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-2-oxo-1H-pyridin-3-yl]-7-methyl-3H-benzimidazol-5-yl]-N-(2-fluoroethoxy)piperidine-4-carboxamide Chemical compound N=1C=2C(C)=CC(N3CCC(CC3)C(=O)NOCCF)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(Cl)=C1 LWELCYJSAYQTOX-UHFFFAOYSA-N 0.000 description 1
- SLPKYXHBHLTLCD-UHFFFAOYSA-N 1-[4-(3,4-diamino-5-methylphenyl)piperazin-1-yl]ethanone Chemical compound C1CN(C(=O)C)CCN1C1=CC(C)=C(N)C(N)=C1 SLPKYXHBHLTLCD-UHFFFAOYSA-N 0.000 description 1
- ZXTKCOJENNWDTP-UHFFFAOYSA-N 1-[4-[2-(4-iodo-2-methoxypyridin-3-yl)-7-methyl-3h-benzimidazol-5-yl]piperazin-1-yl]ethanone Chemical compound COC1=NC=CC(I)=C1C1=NC2=C(C)C=C(N3CCN(CC3)C(C)=O)C=C2N1 ZXTKCOJENNWDTP-UHFFFAOYSA-N 0.000 description 1
- BJHCYTJNPVGSBZ-YXSASFKJSA-N 1-[4-[6-amino-5-[(Z)-methoxyiminomethyl]pyrimidin-4-yl]oxy-2-chlorophenyl]-3-ethylurea Chemical compound CCNC(=O)Nc1ccc(Oc2ncnc(N)c2\C=N/OC)cc1Cl BJHCYTJNPVGSBZ-YXSASFKJSA-N 0.000 description 1
- HTDQSWDEWGSAMN-UHFFFAOYSA-N 1-bromo-2-methoxybenzene Chemical compound COC1=CC=CC=C1Br HTDQSWDEWGSAMN-UHFFFAOYSA-N 0.000 description 1
- PJUPKRYGDFTMTM-UHFFFAOYSA-N 1-hydroxybenzotriazole;hydrate Chemical compound O.C1=CC=C2N(O)N=NC2=C1 PJUPKRYGDFTMTM-UHFFFAOYSA-N 0.000 description 1
- 125000004484 1-methylpiperidin-4-yl group Chemical group CN1CCC(CC1)* 0.000 description 1
- PKDPUENCROCRCH-UHFFFAOYSA-N 1-piperazin-1-ylethanone Chemical compound CC(=O)N1CCNCC1 PKDPUENCROCRCH-UHFFFAOYSA-N 0.000 description 1
- FPYJSJDOHRDAMT-KQWNVCNZSA-N 1h-indole-5-sulfonamide, n-(3-chlorophenyl)-3-[[3,5-dimethyl-4-[(4-methyl-1-piperazinyl)carbonyl]-1h-pyrrol-2-yl]methylene]-2,3-dihydro-n-methyl-2-oxo-, (3z)- Chemical compound C=1C=C2NC(=O)\C(=C/C3=C(C(C(=O)N4CCN(C)CC4)=C(C)N3)C)C2=CC=1S(=O)(=O)N(C)C1=CC=CC(Cl)=C1 FPYJSJDOHRDAMT-KQWNVCNZSA-N 0.000 description 1
- 125000004206 2,2,2-trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 description 1
- MEKOFIRRDATTAG-UHFFFAOYSA-N 2,2,5,8-tetramethyl-3,4-dihydrochromen-6-ol Chemical compound C1CC(C)(C)OC2=C1C(C)=C(O)C=C2C MEKOFIRRDATTAG-UHFFFAOYSA-N 0.000 description 1
- HJKLEAOXCZIMPI-UHFFFAOYSA-N 2,2-diethoxyethanamine Chemical compound CCOC(CN)OCC HJKLEAOXCZIMPI-UHFFFAOYSA-N 0.000 description 1
- VEPOHXYIFQMVHW-XOZOLZJESA-N 2,3-dihydroxybutanedioic acid (2S,3S)-3,4-dimethyl-2-phenylmorpholine Chemical compound OC(C(O)C(O)=O)C(O)=O.C[C@H]1[C@@H](OCCN1C)c1ccccc1 VEPOHXYIFQMVHW-XOZOLZJESA-N 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- KKFDCBRMNNSAAW-UHFFFAOYSA-N 2-(morpholin-4-yl)ethanol Chemical compound OCCN1CCOCC1 KKFDCBRMNNSAAW-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- KGISRUBEXABIRL-UHFFFAOYSA-N 2-[4-[2-(3-chlorophenyl)ethylamino]-2-oxo-1H-pyridin-3-yl]-N',7-dimethyl-3H-benzimidazole-5-carboximidamide Chemical compound N1C2=CC(C(=N)NC)=CC(C)=C2N=C1C(C(NC=C1)=O)=C1NCCC1=CC=CC(Cl)=C1 KGISRUBEXABIRL-UHFFFAOYSA-N 0.000 description 1
- PZDOUVSJFQKFHB-KRWDZBQOSA-N 2-[4-[[(2S)-1-(1-benzothiophen-3-yl)-3-hydroxypropan-2-yl]amino]-2-oxo-1H-pyridin-3-yl]-7-methyl-3H-benzimidazole-5-carbonitrile Chemical compound C1=CC=C2C(C[C@@H](CO)NC3=C(C(NC=C3)=O)C=3NC=4C=C(C=C(C=4N=3)C)C#N)=CSC2=C1 PZDOUVSJFQKFHB-KRWDZBQOSA-N 0.000 description 1
- LSNAFSUSECPLOD-KRWDZBQOSA-N 2-[4-[[(2S)-1-(1-benzothiophen-3-yl)-3-hydroxypropan-2-yl]amino]-2-oxo-1H-pyridin-3-yl]-N',7-dimethyl-3H-benzimidazole-5-carboximidamide Chemical compound C1=CC=C2C(C[C@@H](CO)NC3=C(C(NC=C3)=O)C3=NC4=C(C)C=C(C=C4N3)C(=N)NC)=CSC2=C1 LSNAFSUSECPLOD-KRWDZBQOSA-N 0.000 description 1
- WUBKSJXCBPMEJM-INIZCTEOSA-N 2-[4-[[(2S)-1-(2-chlorophenyl)-3-hydroxypropan-2-yl]amino]-2-oxo-1H-pyridin-3-yl]-N',7-dimethyl-3H-benzimidazole-5-carboximidamide Chemical compound C([C@@H](CO)NC1=C(C(NC=C1)=O)C1=NC2=C(C)C=C(C=C2N1)C(=N)NC)C1=CC=CC=C1Cl WUBKSJXCBPMEJM-INIZCTEOSA-N 0.000 description 1
- ITBQRJLMIYQCJD-KRWDZBQOSA-N 2-[4-[[(2S)-1-(3-chlorophenyl)-3-hydroxypropan-2-yl]amino]-2-oxo-1H-pyridin-3-yl]-N',7-dimethyl-3H-benzimidazole-5-carboximidamide Chemical compound C([C@@H](CO)NC1=C(C(NC=C1)=O)C1=NC2=C(C)C=C(C=C2N1)C(=N)NC)C1=CC=CC(Cl)=C1 ITBQRJLMIYQCJD-KRWDZBQOSA-N 0.000 description 1
- DSKMYGKEJHZGTO-QFIPXVFZSA-N 2-[4-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-2-oxo-1H-pyridin-3-yl]-7-methyl-N'-(2-morpholin-4-ylethyl)-3H-benzimidazole-5-carboximidamide Chemical compound C([C@@H](CO)NC1=C(C(NC=C1)=O)C=1NC=2C=C(C=C(C=2N=1)C)C(=N)NCCN1CCOCC1)C1=CC=CC=C1 DSKMYGKEJHZGTO-QFIPXVFZSA-N 0.000 description 1
- XHTVVKJKWSQMMQ-QHCPKHFHSA-N 2-[4-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-2-oxo-1H-pyridin-3-yl]-7-methyl-N'-(2-pyridin-2-ylethyl)-3H-benzimidazole-5-carboximidamide Chemical compound C([C@@H](CO)NC1=C(C(NC=C1)=O)C=1NC=2C=C(C=C(C=2N=1)C)C(=N)NCCC=1N=CC=CC=1)C1=CC=CC=C1 XHTVVKJKWSQMMQ-QHCPKHFHSA-N 0.000 description 1
- ZBRPMRXIVCPKDC-QHCPKHFHSA-N 2-[4-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-2-oxo-1H-pyridin-3-yl]-7-methyl-N'-(2-pyridin-3-ylethyl)-3H-benzimidazole-5-carboximidamide Chemical compound C([C@@H](CO)NC1=C(C(NC=C1)=O)C=1NC=2C=C(C=C(C=2N=1)C)C(=N)NCCC=1C=NC=CC=1)C1=CC=CC=C1 ZBRPMRXIVCPKDC-QHCPKHFHSA-N 0.000 description 1
- UYGQZEPZSRBNNE-QHCPKHFHSA-N 2-[4-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-2-oxo-1H-pyridin-3-yl]-7-methyl-N'-(2-pyridin-4-ylethyl)-3H-benzimidazole-5-carboximidamide Chemical compound C([C@@H](CO)NC1=C(C(NC=C1)=O)C=1NC=2C=C(C=C(C=2N=1)C)C(=N)NCCC=1C=CN=CC=1)C1=CC=CC=C1 UYGQZEPZSRBNNE-QHCPKHFHSA-N 0.000 description 1
- KCDAINLTMKZOOG-NRFANRHFSA-N 2-[4-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-2-oxo-1H-pyridin-3-yl]-7-methyl-N'-(2-thiophen-2-ylethyl)-3H-benzimidazole-5-carboximidamide Chemical compound C([C@@H](CO)NC1=C(C(NC=C1)=O)C=1NC=2C=C(C=C(C=2N=1)C)C(=N)NCCC=1SC=CC=1)C1=CC=CC=C1 KCDAINLTMKZOOG-NRFANRHFSA-N 0.000 description 1
- GGEVTNFPOHXMHC-KRWDZBQOSA-N 2-[4-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-2-oxo-1H-pyridin-3-yl]-N',7-dimethyl-3H-benzimidazole-5-carboximidamide Chemical compound C([C@@H](CO)NC1=C(C(NC=C1)=O)C1=NC2=C(C)C=C(C=C2N1)C(=N)NC)C1=CC=CC=C1 GGEVTNFPOHXMHC-KRWDZBQOSA-N 0.000 description 1
- NTDPLYMZBPXYAD-INIZCTEOSA-N 2-[4-[[(2S)-1-hydroxy-3-pyridin-3-ylpropan-2-yl]amino]-2-oxo-1H-pyridin-3-yl]-7-methyl-3H-benzimidazole-5-carbonitrile Chemical compound C([C@@H](CO)NC1=C(C(NC=C1)=O)C=1NC=2C=C(C=C(C=2N=1)C)C#N)C1=CC=CN=C1 NTDPLYMZBPXYAD-INIZCTEOSA-N 0.000 description 1
- ZAWBTFBCKJARNK-INIZCTEOSA-N 2-[4-[[(2S)-1-hydroxy-3-pyridin-3-ylpropan-2-yl]amino]-2-oxo-1H-pyridin-3-yl]-N',7-dimethyl-3H-benzimidazole-5-carboximidamide Chemical compound C([C@@H](CO)NC1=C(C(NC=C1)=O)C1=NC2=C(C)C=C(C=C2N1)C(=N)NC)C1=CC=CN=C1 ZAWBTFBCKJARNK-INIZCTEOSA-N 0.000 description 1
- SXUYUOORQJDACD-INIZCTEOSA-N 2-[4-[[(2S)-1-hydroxy-3-pyridin-4-ylpropan-2-yl]amino]-2-oxo-1H-pyridin-3-yl]-N',7-dimethyl-3H-benzimidazole-5-carboximidamide Chemical compound C([C@@H](CO)NC1=C(C(NC=C1)=O)C1=NC2=C(C)C=C(C=C2N1)C(=N)NC)C1=CC=NC=C1 SXUYUOORQJDACD-INIZCTEOSA-N 0.000 description 1
- UXBZLMCXWBXAEF-AWEZNQCLSA-N 2-[4-[[(2S)-1-hydroxy-3-thiophen-2-ylpropan-2-yl]amino]-2-oxo-1H-pyridin-3-yl]-7-methyl-3H-benzimidazole-5-carbonitrile Chemical compound C([C@@H](CO)NC1=C(C(NC=C1)=O)C=1NC=2C=C(C=C(C=2N=1)C)C#N)C1=CC=CS1 UXBZLMCXWBXAEF-AWEZNQCLSA-N 0.000 description 1
- QGFFRGJYLGIOFC-UHFFFAOYSA-N 2-[4-[[2-(3-bromo-4-methoxyphenyl)-2-hydroxyethyl]amino]-2-oxo-1H-pyridin-3-yl]-7-chloro-3H-benzimidazole-5-carbonitrile Chemical compound C1=C(Br)C(OC)=CC=C1C(O)CNC1=C(C=2NC3=CC(=CC(Cl)=C3N=2)C#N)C(=O)NC=C1 QGFFRGJYLGIOFC-UHFFFAOYSA-N 0.000 description 1
- YRCKQWRMZCUVOR-UHFFFAOYSA-N 2-[4-[[2-(3-bromo-4-methoxyphenyl)-2-hydroxyethyl]amino]-2-oxo-1H-pyridin-3-yl]-7-ethyl-3H-benzimidazole-5-carbonitrile Chemical compound N=1C=2C(CC)=CC(C#N)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(O)C1=CC=C(OC)C(Br)=C1 YRCKQWRMZCUVOR-UHFFFAOYSA-N 0.000 description 1
- AOCACAFJPATEKZ-UHFFFAOYSA-N 2-[4-[[2-(3-bromo-4-methoxyphenyl)-2-hydroxyethyl]amino]-2-oxo-1H-pyridin-3-yl]-N',7-dimethyl-3H-benzimidazole-5-carboximidamide Chemical compound N1C2=CC(C(=N)NC)=CC(C)=C2N=C1C(C(NC=C1)=O)=C1NCC(O)C1=CC=C(OC)C(Br)=C1 AOCACAFJPATEKZ-UHFFFAOYSA-N 0.000 description 1
- FXUCFRPHRXAPQJ-UHFFFAOYSA-N 2-[4-[[2-(3-bromophenyl)-2-hydroxyethyl]amino]-2-oxo-1H-pyridin-3-yl]-7-ethyl-3H-benzimidazole-5-carbonitrile Chemical compound N=1C=2C(CC)=CC(C#N)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(Br)=C1 FXUCFRPHRXAPQJ-UHFFFAOYSA-N 0.000 description 1
- RHTQMMRIBLMVQL-UHFFFAOYSA-N 2-[4-[[2-(3-chloro-4-methoxyphenyl)-2-hydroxyethyl]amino]-2-oxo-1H-pyridin-3-yl]-N',7-dimethyl-3H-benzimidazole-5-carboximidamide Chemical compound N1C2=CC(C(=N)NC)=CC(C)=C2N=C1C(C(NC=C1)=O)=C1NCC(O)C1=CC=C(OC)C(Cl)=C1 RHTQMMRIBLMVQL-UHFFFAOYSA-N 0.000 description 1
- FGNVSXXCQVYOSK-UHFFFAOYSA-N 2-[4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-2-oxo-1H-pyridin-3-yl]-7-ethyl-3H-benzimidazole-5-carbonitrile Chemical compound N=1C=2C(CC)=CC(C#N)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(Cl)=C1 FGNVSXXCQVYOSK-UHFFFAOYSA-N 0.000 description 1
- WSWOUQFTRJBYTM-UHFFFAOYSA-N 2-[4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-2-oxo-1H-pyridin-3-yl]-7-ethyl-N'-methyl-3H-benzimidazole-5-carboximidamide Chemical compound N=1C=2C(CC)=CC(C(=N)NC)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(Cl)=C1 WSWOUQFTRJBYTM-UHFFFAOYSA-N 0.000 description 1
- MKGNFQQMNWMSQL-UHFFFAOYSA-N 2-[4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-2-oxo-1H-pyridin-3-yl]-7-methyl-3H-benzimidazole-5-carbaldehyde Chemical compound N=1C=2C(C)=CC(C=O)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(Cl)=C1 MKGNFQQMNWMSQL-UHFFFAOYSA-N 0.000 description 1
- BTLLFYWUNGEHQZ-UHFFFAOYSA-N 2-[4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-2-oxo-1H-pyridin-3-yl]-7-methyl-3H-benzimidazole-5-carboximidamide Chemical compound N=1C=2C(C)=CC(C(N)=N)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(Cl)=C1 BTLLFYWUNGEHQZ-UHFFFAOYSA-N 0.000 description 1
- NFOWTMFUFBEGCT-UHFFFAOYSA-N 2-[4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-2-oxo-1H-pyridin-3-yl]-7-methyl-N'-(2-morpholin-4-ylethyl)-3H-benzimidazole-5-carboximidamide Chemical compound N=1C=2C(C)=CC(C(=N)NCCN3CCOCC3)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(Cl)=C1 NFOWTMFUFBEGCT-UHFFFAOYSA-N 0.000 description 1
- PYIVHSNDRCHFFA-UHFFFAOYSA-N 2-[4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-2-oxo-1H-pyridin-3-yl]-7-methyl-N,N'-dipropyl-3H-benzimidazole-5-carboximidamide Chemical compound CCCN\C(=N/CCC)C1=CC(C)=C2N=C(NC2=C1)C1=C(NCC(O)C2=CC=CC(Cl)=C2)C=CNC1=O PYIVHSNDRCHFFA-UHFFFAOYSA-N 0.000 description 1
- LYRUKKPSRMFNGG-UHFFFAOYSA-N 2-[4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-2-oxo-1H-pyridin-3-yl]-N'-ethyl-7-methyl-3H-benzimidazole-5-carboximidamide Chemical compound N1C2=CC(C(=N)NCC)=CC(C)=C2N=C1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(Cl)=C1 LYRUKKPSRMFNGG-UHFFFAOYSA-N 0.000 description 1
- IXMFCQVDDSYKKH-UHFFFAOYSA-N 2-[4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-2-oxo-1H-pyridin-3-yl]-N,N',7-trimethyl-3H-benzimidazole-5-carboximidamide Chemical compound N1C2=CC(C(=NC)NC)=CC(C)=C2N=C1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(Cl)=C1 IXMFCQVDDSYKKH-UHFFFAOYSA-N 0.000 description 1
- MMILMVJAAQDAKJ-UHFFFAOYSA-N 2-[4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-2-oxo-1H-pyridin-3-yl]-N,N,7-trimethyl-3H-benzimidazole-5-carboximidamide Chemical compound CN(C)C(=N)c1cc(C)c2nc([nH]c2c1)-c1c(NCC(O)c2cccc(Cl)c2)cc[nH]c1=O MMILMVJAAQDAKJ-UHFFFAOYSA-N 0.000 description 1
- HSFVICKXNNZWGQ-UHFFFAOYSA-N 2-[4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-2-oxo-1H-pyridin-3-yl]-N-hydroxy-N,7-dimethyl-3H-benzimidazole-5-carboximidamide Chemical compound N1C2=CC(C(=N)N(O)C)=CC(C)=C2N=C1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(Cl)=C1 HSFVICKXNNZWGQ-UHFFFAOYSA-N 0.000 description 1
- HHKWQXXZSVSJMF-UHFFFAOYSA-N 2-[4-[[2-(3-fluorophenyl)-2-hydroxyethyl]amino]-2-oxo-1H-pyridin-3-yl]-N',7-dimethyl-3H-benzimidazole-5-carboximidamide Chemical compound N1C2=CC(C(=N)NC)=CC(C)=C2N=C1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(F)=C1 HHKWQXXZSVSJMF-UHFFFAOYSA-N 0.000 description 1
- 125000006276 2-bromophenyl group Chemical group [H]C1=C([H])C(Br)=C(*)C([H])=C1[H] 0.000 description 1
- 125000001340 2-chloroethyl group Chemical group [H]C([H])(Cl)C([H])([H])* 0.000 description 1
- MAYUMUDTQDNZBD-UHFFFAOYSA-N 2-chloroethylsilane Chemical compound [SiH3]CCCl MAYUMUDTQDNZBD-UHFFFAOYSA-N 0.000 description 1
- 125000004847 2-fluorobenzyl group Chemical group [H]C1=C([H])C(F)=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- FOHSVPIFZASOED-UHFFFAOYSA-N 2-fluoroethyl carbonochloridate Chemical compound FCCOC(Cl)=O FOHSVPIFZASOED-UHFFFAOYSA-N 0.000 description 1
- 125000004198 2-fluorophenyl group Chemical group [H]C1=C([H])C(F)=C(*)C([H])=C1[H] 0.000 description 1
- 125000006304 2-iodophenyl group Chemical group [H]C1=C([H])C(I)=C(*)C([H])=C1[H] 0.000 description 1
- GSLTVFIVJMCNBH-UHFFFAOYSA-N 2-isocyanatopropane Chemical compound CC(C)N=C=O GSLTVFIVJMCNBH-UHFFFAOYSA-N 0.000 description 1
- IWTFOFMTUOBLHG-UHFFFAOYSA-N 2-methoxypyridine Chemical compound COC1=CC=CC=N1 IWTFOFMTUOBLHG-UHFFFAOYSA-N 0.000 description 1
- VRGCYEIGVVTZCC-UHFFFAOYSA-N 3,4,5,6-tetrachlorocyclohexa-3,5-diene-1,2-dione Chemical compound ClC1=C(Cl)C(=O)C(=O)C(Cl)=C1Cl VRGCYEIGVVTZCC-UHFFFAOYSA-N 0.000 description 1
- 125000005809 3,4,5-trimethoxyphenyl group Chemical group [H]C1=C(OC([H])([H])[H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1* 0.000 description 1
- LFCAYPXQGPUYPM-UHFFFAOYSA-N 3-(1H-benzimidazol-2-yl)-4-(pyridin-2-ylmethylamino)-1H-pyridin-2-one Chemical compound N=1C2=CC=CC=C2NC=1C=1C(=O)NC=CC=1NCC1=CC=CC=N1 LFCAYPXQGPUYPM-UHFFFAOYSA-N 0.000 description 1
- XVTGMPIWLFRYCU-UHFFFAOYSA-N 3-(1H-benzimidazol-2-yl)-4-[[2-(3-bromo-4-methoxyphenyl)-2-hydroxyethyl]amino]-1H-pyridin-2-one Chemical compound C1=C(Br)C(OC)=CC=C1C(O)CNC1=C(C=2NC3=CC=CC=C3N=2)C(=O)NC=C1 XVTGMPIWLFRYCU-UHFFFAOYSA-N 0.000 description 1
- IDTCIUBBSXRUKF-UHFFFAOYSA-N 3-(4,6-dibromo-1H-benzimidazol-2-yl)-4-(pyridin-2-ylmethylamino)-1H-pyridin-2-one Chemical compound N1C2=CC(Br)=CC(Br)=C2N=C1C(C(NC=C1)=O)=C1NCC1=CC=CC=N1 IDTCIUBBSXRUKF-UHFFFAOYSA-N 0.000 description 1
- MIXOKQBXPOBLSJ-AWEZNQCLSA-N 3-(4,6-dibromo-1H-benzimidazol-2-yl)-4-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-1H-pyridin-2-one Chemical compound C([C@@H](CO)NC1=C(C(=O)NC=C1)C=1NC2=CC(Br)=CC(Br)=C2N=1)C1=CC=CC=C1 MIXOKQBXPOBLSJ-AWEZNQCLSA-N 0.000 description 1
- NVZDJHAMFXZKRQ-ZDUSSCGKSA-N 3-(5,6-dichloro-1H-benzimidazol-2-yl)-4-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-1H-pyridin-2-one Chemical compound C([C@@H](CO)NC1=C(C(=O)NC=C1)C=1NC2=CC(Cl)=C(Cl)C=C2N=1)C1=CC=CC=C1 NVZDJHAMFXZKRQ-ZDUSSCGKSA-N 0.000 description 1
- TYVTWJYNDRDSMV-UHFFFAOYSA-N 3-(5,6-difluoro-1H-benzimidazol-2-yl)-4-(pyridin-2-ylmethylamino)-1H-pyridin-2-one Chemical compound N1C=2C=C(F)C(F)=CC=2N=C1C(C(NC=C1)=O)=C1NCC1=CC=CC=N1 TYVTWJYNDRDSMV-UHFFFAOYSA-N 0.000 description 1
- FFDRZHINRVZINY-UHFFFAOYSA-N 3-(5-amino-6-methyl-1H-benzimidazol-2-yl)-4-[[2-(3-bromophenyl)-2-hydroxyethyl]amino]-1H-pyridin-2-one Chemical compound N1C=2C=C(N)C(C)=CC=2N=C1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(Br)=C1 FFDRZHINRVZINY-UHFFFAOYSA-N 0.000 description 1
- CBCJVUGZXNTQBR-UHFFFAOYSA-N 3-(6-amino-4-methyl-1H-benzimidazol-2-yl)-4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-1H-pyridin-2-one Chemical compound N=1C=2C(C)=CC(N)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(Cl)=C1 CBCJVUGZXNTQBR-UHFFFAOYSA-N 0.000 description 1
- XZOVJHKBKPRZQE-UHFFFAOYSA-N 3-(6-bromo-4-methyl-1H-benzimidazol-2-yl)-4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-1H-pyridin-2-one Chemical compound N=1C=2C(C)=CC(Br)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(Cl)=C1 XZOVJHKBKPRZQE-UHFFFAOYSA-N 0.000 description 1
- MIGIDUNPFFJEEK-UHFFFAOYSA-N 3-(6-fluoro-5-imidazol-1-yl-1H-benzimidazol-2-yl)-4-(pyridin-2-ylmethylamino)-1H-pyridin-2-one Chemical compound FC1=CC=2N=C(C=3C(NC=CC=3NCC=3N=CC=CC=3)=O)NC=2C=C1N1C=CN=C1 MIGIDUNPFFJEEK-UHFFFAOYSA-N 0.000 description 1
- CVMSVUJJFNGDAR-INIZCTEOSA-N 3-(6-fluoro-5-imidazol-1-yl-1H-benzimidazol-2-yl)-4-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-1H-pyridin-2-one Chemical compound C([C@@H](CO)NC1=C(C(=O)NC=C1)C=1NC2=CC(=C(F)C=C2N=1)N1C=NC=C1)C1=CC=CC=C1 CVMSVUJJFNGDAR-INIZCTEOSA-N 0.000 description 1
- XBNFQLBHGDYKGV-UHFFFAOYSA-N 3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-4-(1-pyridin-2-ylethylamino)-1H-pyridin-2-one Chemical compound C=1C=CC=NC=1C(C)NC=1C=CNC(=O)C=1C(NC1=C2)=NC1=C(C)C=C2N1C=CN=C1 XBNFQLBHGDYKGV-UHFFFAOYSA-N 0.000 description 1
- WLIZTIGQNFVDAC-UHFFFAOYSA-N 3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-4-(1-pyridin-2-ylpropylamino)-1H-pyridin-2-one Chemical compound C=1C=CC=NC=1C(CC)NC=1C=CNC(=O)C=1C(NC1=C2)=NC1=C(C)C=C2N1C=CN=C1 WLIZTIGQNFVDAC-UHFFFAOYSA-N 0.000 description 1
- SZEMOOFCURCGEJ-UHFFFAOYSA-N 3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-4-(2-morpholin-4-ylethylamino)-1H-pyridin-2-one Chemical compound N=1C=2C(C)=CC(N3C=NC=C3)=CC=2NC=1C(C(NC=C1)=O)=C1NCCN1CCOCC1 SZEMOOFCURCGEJ-UHFFFAOYSA-N 0.000 description 1
- KEXOYTAGNDGQQG-UHFFFAOYSA-N 3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-4-(2-pyrrolidin-1-ylethylamino)-1H-pyridin-2-one Chemical compound N=1C=2C(C)=CC(N3C=NC=C3)=CC=2NC=1C(C(NC=C1)=O)=C1NCCN1CCCC1 KEXOYTAGNDGQQG-UHFFFAOYSA-N 0.000 description 1
- KBHXTPPXCFMBIT-UHFFFAOYSA-N 3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-4-(3-pyridin-2-ylpropylamino)-1H-pyridin-2-one Chemical compound N=1C=2C(C)=CC(N3C=NC=C3)=CC=2NC=1C(C(NC=C1)=O)=C1NCCCC1=CC=CC=N1 KBHXTPPXCFMBIT-UHFFFAOYSA-N 0.000 description 1
- WEJHPSFPKRUFTG-UHFFFAOYSA-N 3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-4-(4-pyridin-2-ylbutylamino)-1H-pyridin-2-one Chemical compound Cc1cc(cc2[nH]c(nc12)-c1c(NCCCCc2ccccn2)cc[nH]c1=O)-n1ccnc1 WEJHPSFPKRUFTG-UHFFFAOYSA-N 0.000 description 1
- UPNNKPKJJXEWHO-UHFFFAOYSA-N 3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-4-(isoquinolin-1-ylmethylamino)-1H-pyridin-2-one Chemical compound C=1C=2NC(C=3C(NC=CC=3NCC=3C4=CC=CC=C4C=CN=3)=O)=NC=2C(C)=CC=1N1C=CN=C1 UPNNKPKJJXEWHO-UHFFFAOYSA-N 0.000 description 1
- KZFIAZSPLXQWKG-UHFFFAOYSA-N 3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-4-(isoquinolin-3-ylmethylamino)-1H-pyridin-2-one Chemical compound C=1C=2NC(C=3C(NC=CC=3NCC=3N=CC4=CC=CC=C4C=3)=O)=NC=2C(C)=CC=1N1C=CN=C1 KZFIAZSPLXQWKG-UHFFFAOYSA-N 0.000 description 1
- XNIYZXNPVXQXRD-UHFFFAOYSA-N 3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-4-(pyrazin-2-ylmethylamino)-1H-pyridin-2-one Chemical compound N=1C=2C(C)=CC(N3C=NC=C3)=CC=2NC=1C(C(NC=C1)=O)=C1NCC1=CN=CC=N1 XNIYZXNPVXQXRD-UHFFFAOYSA-N 0.000 description 1
- BJPBNFSCAJCYCV-UHFFFAOYSA-N 3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-4-[(2-phenyl-1-pyridin-2-ylethyl)amino]-1H-pyridin-2-one Chemical compound N=1C=2C(C)=CC(N3C=NC=C3)=CC=2NC=1C(C(NC=C1)=O)=C1NC(C=1N=CC=CC=1)CC1=CC=CC=C1 BJPBNFSCAJCYCV-UHFFFAOYSA-N 0.000 description 1
- LATDLPKZVIEASI-UHFFFAOYSA-N 3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-4-[(2-phenyl-2-pyridin-2-ylethyl)amino]-1H-pyridin-2-one Chemical compound N=1C=2C(C)=CC(N3C=NC=C3)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(C=1N=CC=CC=1)C1=CC=CC=C1 LATDLPKZVIEASI-UHFFFAOYSA-N 0.000 description 1
- DFTFOSFNRXLPGL-UHFFFAOYSA-N 3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-4-[(3,4,5-trimethoxyphenyl)methylamino]-1H-pyridin-2-one Chemical compound COC1=C(OC)C(OC)=CC(CNC2=C(C(=O)NC=C2)C=2NC3=CC(=CC(C)=C3N=2)N2C=NC=C2)=C1 DFTFOSFNRXLPGL-UHFFFAOYSA-N 0.000 description 1
- CQYSUZQPTVXOJF-UHFFFAOYSA-N 3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-4-[(3-methylpyridin-2-yl)methylamino]-1H-pyridin-2-one Chemical compound CC1=CC=CN=C1CNC1=C(C=2NC3=CC(=CC(C)=C3N=2)N2C=NC=C2)C(=O)NC=C1 CQYSUZQPTVXOJF-UHFFFAOYSA-N 0.000 description 1
- CLDWSQBDLXIVHC-UHFFFAOYSA-N 3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-4-[(3-phenyl-1-pyridin-2-ylpropyl)amino]-1H-pyridin-2-one Chemical compound N=1C=2C(C)=CC(N3C=NC=C3)=CC=2NC=1C(C(NC=C1)=O)=C1NC(C=1N=CC=CC=1)CCC1=CC=CC=C1 CLDWSQBDLXIVHC-UHFFFAOYSA-N 0.000 description 1
- CCKUIYBADOLJTC-UHFFFAOYSA-N 3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-4-[(4-methoxypyridin-2-yl)methylamino]-1H-pyridin-2-one Chemical compound COC1=CC=NC(CNC2=C(C(=O)NC=C2)C=2NC3=CC(=CC(C)=C3N=2)N2C=NC=C2)=C1 CCKUIYBADOLJTC-UHFFFAOYSA-N 0.000 description 1
- UTPJJEMXFNOSCX-UHFFFAOYSA-N 3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-4-[(4-methylpyridin-2-yl)methylamino]-1H-pyridin-2-one Chemical compound CC1=CC=NC(CNC2=C(C(=O)NC=C2)C=2NC3=CC(=CC(C)=C3N=2)N2C=NC=C2)=C1 UTPJJEMXFNOSCX-UHFFFAOYSA-N 0.000 description 1
- ZPDUZOSKHKWVLQ-UHFFFAOYSA-N 3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-4-[(4-phenylmethoxypyridin-2-yl)methylamino]-1H-pyridin-2-one Chemical compound N=1C=2C(C)=CC(N3C=NC=C3)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(N=CC=1)=CC=1OCC1=CC=CC=C1 ZPDUZOSKHKWVLQ-UHFFFAOYSA-N 0.000 description 1
- WKHXYINSKMNJSL-UHFFFAOYSA-N 3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-4-[(4-phenylpyridin-2-yl)methylamino]-1H-pyridin-2-one Chemical compound N=1C=2C(C)=CC(N3C=NC=C3)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(N=CC=1)=CC=1C1=CC=CC=C1 WKHXYINSKMNJSL-UHFFFAOYSA-N 0.000 description 1
- CMYJYVMUIGENKS-UHFFFAOYSA-N 3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-4-[(6-methylpyridin-2-yl)methylamino]-1H-pyridin-2-one Chemical compound CC1=CC=CC(CNC2=C(C(=O)NC=C2)C=2NC3=CC(=CC(C)=C3N=2)N2C=NC=C2)=N1 CMYJYVMUIGENKS-UHFFFAOYSA-N 0.000 description 1
- FSURYUKRAFZUIO-UHFFFAOYSA-N 3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-4-[2-(1H-indol-3-yl)ethylamino]-1H-pyridin-2-one Chemical compound C=1C=2NC(C=3C(NC=CC=3NCCC=3C4=CC=CC=C4NC=3)=O)=NC=2C(C)=CC=1N1C=CN=C1 FSURYUKRAFZUIO-UHFFFAOYSA-N 0.000 description 1
- ZQDGPLQDPNZEAJ-UHFFFAOYSA-N 3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-4-[2-(1H-indol-5-yl)ethylamino]-1H-pyridin-2-one Chemical compound C=1C=2NC(C=3C(NC=CC=3NCCC=3C=C4C=CNC4=CC=3)=O)=NC=2C(C)=CC=1N1C=CN=C1 ZQDGPLQDPNZEAJ-UHFFFAOYSA-N 0.000 description 1
- YQTRAGQPMSISGO-UHFFFAOYSA-N 3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-4-[2-(2-methyl-5-nitroimidazol-1-yl)ethylamino]-1H-pyridin-2-one Chemical compound CC1=NC=C([N+]([O-])=O)N1CCNC1=C(C=2NC3=CC(=CC(C)=C3N=2)N2C=NC=C2)C(=O)NC=C1 YQTRAGQPMSISGO-UHFFFAOYSA-N 0.000 description 1
- PPLOJJIFWAOWQT-UHFFFAOYSA-N 3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-4-[2-(3-methylimidazol-4-yl)ethylamino]-1H-pyridin-2-one Chemical compound N=1C=2C(C)=CC(N3C=NC=C3)=CC=2NC=1C(C(NC=C1)=O)=C1NCCC1=CN=CN1C PPLOJJIFWAOWQT-UHFFFAOYSA-N 0.000 description 1
- UYDHVXHRHVCLLU-UHFFFAOYSA-N 3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-4-[2-[(5-nitropyridin-2-yl)amino]ethylamino]-1H-pyridin-2-one Chemical compound N=1C=2C(C)=CC(N3C=NC=C3)=CC=2NC=1C(C(NC=C1)=O)=C1NCCNC1=CC=C([N+]([O-])=O)C=N1 UYDHVXHRHVCLLU-UHFFFAOYSA-N 0.000 description 1
- QMDGYMPZLITHHZ-IBGZPJMESA-N 3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-4-[[(2S)-1-(methylamino)-3-phenylpropan-2-yl]amino]-1H-pyridin-2-one Chemical compound C([C@@H](CNC)NC1=C(C(=O)NC=C1)C=1NC2=CC(=CC(C)=C2N=1)N1C=NC=C1)C1=CC=CC=C1 QMDGYMPZLITHHZ-IBGZPJMESA-N 0.000 description 1
- XVZQTOARPOXMJL-UHFFFAOYSA-N 3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-4-[[3-(trifluoromethyl)pyridin-2-yl]methylamino]-1H-pyridin-2-one Chemical compound N=1C=2C(C)=CC(N3C=NC=C3)=CC=2NC=1C(C(NC=C1)=O)=C1NCC1=NC=CC=C1C(F)(F)F XVZQTOARPOXMJL-UHFFFAOYSA-N 0.000 description 1
- PKKVZEAJMZTRFI-UHFFFAOYSA-N 3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-4-[[4-(3-phenylpropyl)pyridin-2-yl]methylamino]-1H-pyridin-2-one Chemical compound N=1C=2C(C)=CC(N3C=NC=C3)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(N=CC=1)=CC=1CCCC1=CC=CC=C1 PKKVZEAJMZTRFI-UHFFFAOYSA-N 0.000 description 1
- RQNFMRHZPNSFOY-UHFFFAOYSA-N 3-(dimethylamino)-1-(6-imidazol-1-yl-4-methyl-1h-benzimidazol-2-yl)pyridin-2-one Chemical compound O=C1C(N(C)C)=CC=CN1C1=NC2=C(C)C=C(N3C=NC=C3)C=C2N1 RQNFMRHZPNSFOY-UHFFFAOYSA-N 0.000 description 1
- KLAIOABSDQUNSA-WUKNDPDISA-N 3-[(e)-octadec-2-enyl]oxolane-2,5-dione Chemical compound CCCCCCCCCCCCCCC\C=C\CC1CC(=O)OC1=O KLAIOABSDQUNSA-WUKNDPDISA-N 0.000 description 1
- IMHNTEQJZSAALO-UHFFFAOYSA-N 3-[4,6-bis(trifluoromethyl)-1H-benzimidazol-2-yl]-4-(pyridin-2-ylmethylamino)-1H-pyridin-2-one Chemical compound N1C2=CC(C(F)(F)F)=CC(C(F)(F)F)=C2N=C1C(C(NC=C1)=O)=C1NCC1=CC=CC=N1 IMHNTEQJZSAALO-UHFFFAOYSA-N 0.000 description 1
- TUAQYZLOISGVII-UHFFFAOYSA-N 3-[4,6-bis(trifluoromethyl)-1H-benzimidazol-2-yl]-4-[[2-(3-bromo-4-methoxyphenyl)-2-hydroxyethyl]amino]-1H-pyridin-2-one Chemical compound C1=C(Br)C(OC)=CC=C1C(O)CNC1=C(C=2NC3=CC(=CC(=C3N=2)C(F)(F)F)C(F)(F)F)C(=O)NC=C1 TUAQYZLOISGVII-UHFFFAOYSA-N 0.000 description 1
- SXZOMUUOJNIAOM-UHFFFAOYSA-N 3-[4,6-bis(trifluoromethyl)-1H-benzimidazol-2-yl]-4-[[2-(3-bromophenyl)-2-hydroxyethyl]amino]-1H-pyridin-2-one Chemical compound C1=CNC(=O)C(C=2NC3=CC(=CC(=C3N=2)C(F)(F)F)C(F)(F)F)=C1NCC(O)C1=CC=CC(Br)=C1 SXZOMUUOJNIAOM-UHFFFAOYSA-N 0.000 description 1
- UWURXFAXJRQQGO-XMMPIXPASA-N 3-[4-[2-[4-[[(2S)-2-(3-bromo-4-methoxyphenyl)-2-hydroxyethyl]amino]-2-oxo-1H-pyridin-3-yl]-7-methyl-3H-benzimidazol-5-yl]piperazin-1-yl]propanenitrile Chemical compound C1=C(Br)C(OC)=CC=C1[C@H](O)CNC1=C(C=2NC3=CC(=CC(C)=C3N=2)N2CCN(CCC#N)CC2)C(=O)NC=C1 UWURXFAXJRQQGO-XMMPIXPASA-N 0.000 description 1
- BXOLALDWSLHKQC-INIZCTEOSA-N 3-[4-bromo-6-(4,5-dihydro-1H-imidazol-2-yl)-1H-benzimidazol-2-yl]-4-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-1H-pyridin-2-one Chemical compound C([C@@H](CO)NC1=C(C(=O)NC=C1)C=1NC2=CC(=CC(Br)=C2N=1)C=1NCCN=1)C1=CC=CC=C1 BXOLALDWSLHKQC-INIZCTEOSA-N 0.000 description 1
- GMNSGFZTJXXNIG-UHFFFAOYSA-N 3-[4-bromo-6-(trifluoromethyl)-1H-benzimidazol-2-yl]-4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-1H-pyridin-2-one Chemical compound C1=CNC(=O)C(C=2NC3=CC(=CC(Br)=C3N=2)C(F)(F)F)=C1NCC(O)C1=CC=CC(Cl)=C1 GMNSGFZTJXXNIG-UHFFFAOYSA-N 0.000 description 1
- LPRRTSBXIAYEBH-UHFFFAOYSA-N 3-[4-chloro-6-(4,5-dihydro-1H-imidazol-2-yl)-1H-benzimidazol-2-yl]-4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-1H-pyridin-2-one Chemical compound C=1C=CC(Cl)=CC=1C(O)CNC=1C=CNC(=O)C=1C(NC1=C2)=NC1=C(Cl)C=C2C1=NCCN1 LPRRTSBXIAYEBH-UHFFFAOYSA-N 0.000 description 1
- DDTYRYNDMRWQND-UHFFFAOYSA-N 3-[4-chloro-6-(5,5-dimethyl-1,4-dihydroimidazol-2-yl)-1H-benzimidazol-2-yl]-4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-1H-pyridin-2-one Chemical compound N1C(C)(C)CN=C1C1=CC(Cl)=C(N=C(N2)C=3C(NC=CC=3NCC(O)C=3C=C(Cl)C=CC=3)=O)C2=C1 DDTYRYNDMRWQND-UHFFFAOYSA-N 0.000 description 1
- WTVUSEBVKKXYGL-AWEZNQCLSA-N 3-[4-chloro-6-(trifluoromethyl)-1H-benzimidazol-2-yl]-4-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-1H-pyridin-2-one Chemical compound C([C@@H](CO)NC1=C(C(=O)NC=C1)C=1NC2=CC(=CC(Cl)=C2N=1)C(F)(F)F)C1=CC=CC=C1 WTVUSEBVKKXYGL-AWEZNQCLSA-N 0.000 description 1
- BEVAGHHADQTQFV-UHFFFAOYSA-N 3-[6-(1H-benzimidazol-2-yl)-4-methyl-1H-benzimidazol-2-yl]-4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-1H-pyridin-2-one Chemical compound N=1C=2C(C)=CC(C=3NC4=CC=CC=C4N=3)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(Cl)=C1 BEVAGHHADQTQFV-UHFFFAOYSA-N 0.000 description 1
- QAUJLLVZICFFPV-IBGZPJMESA-N 3-[6-(4,5-dihydro-1H-imidazol-2-yl)-4-ethyl-1H-benzimidazol-2-yl]-4-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-1H-pyridin-2-one Chemical compound C([C@@H](CO)NC1=C(C(NC=C1)=O)C=1NC=2C=C(C=C(C=2N=1)CC)C=1NCCN=1)C1=CC=CC=C1 QAUJLLVZICFFPV-IBGZPJMESA-N 0.000 description 1
- DRUPVDFVJAKLKQ-SFHVURJKSA-N 3-[6-(4,5-dihydro-1H-imidazol-2-yl)-4-methyl-1H-benzimidazol-2-yl]-4-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-1H-pyridin-2-one Chemical compound C([C@@H](CO)NC1=C(C(NC=C1)=O)C=1NC=2C=C(C=C(C=2N=1)C)C=1NCCN=1)C1=CC=CC=C1 DRUPVDFVJAKLKQ-SFHVURJKSA-N 0.000 description 1
- VNJDMOYHXMHKQA-KRWDZBQOSA-N 3-[6-(4,5-dihydro-1H-imidazol-2-yl)-4-methyl-1H-benzimidazol-2-yl]-4-[[(2S)-1-hydroxy-3-pyridin-3-ylpropan-2-yl]amino]-1H-pyridin-2-one Chemical compound C([C@@H](CO)NC1=C(C(NC=C1)=O)C=1NC=2C=C(C=C(C=2N=1)C)C=1NCCN=1)C1=CC=CN=C1 VNJDMOYHXMHKQA-KRWDZBQOSA-N 0.000 description 1
- PGDCERUJFGBPAO-KRWDZBQOSA-N 3-[6-(4,5-dihydro-1H-imidazol-2-yl)-4-methyl-1H-benzimidazol-2-yl]-4-[[(2S)-1-hydroxy-3-pyridin-4-ylpropan-2-yl]amino]-1H-pyridin-2-one Chemical compound C([C@@H](CO)NC1=C(C(NC=C1)=O)C=1NC=2C=C(C=C(C=2N=1)C)C=1NCCN=1)C1=CC=NC=C1 PGDCERUJFGBPAO-KRWDZBQOSA-N 0.000 description 1
- SFSOZTCVQOBGNV-HNNXBMFYSA-N 3-[6-(4,5-dihydro-1H-imidazol-2-yl)-4-methyl-1H-benzimidazol-2-yl]-4-[[(2S)-1-hydroxy-3-thiophen-2-ylpropan-2-yl]amino]-1H-pyridin-2-one Chemical compound C([C@@H](CO)NC1=C(C(NC=C1)=O)C=1NC=2C=C(C=C(C=2N=1)C)C=1NCCN=1)C1=CC=CS1 SFSOZTCVQOBGNV-HNNXBMFYSA-N 0.000 description 1
- AMMUERSSUBXTMH-LJQANCHMSA-N 3-[6-(4,5-dihydro-1H-imidazol-2-yl)-4-methyl-1H-benzimidazol-2-yl]-4-[[(2S)-2-hydroxy-2-phenylethyl]amino]-1H-pyridin-2-one Chemical compound C1([C@H](O)CNC2=C(C(NC=C2)=O)C=2NC=3C=C(C=C(C=3N=2)C)C=2NCCN=2)=CC=CC=C1 AMMUERSSUBXTMH-LJQANCHMSA-N 0.000 description 1
- PSNGDGXROKQVFD-UHFFFAOYSA-N 3-[6-(4,5-dihydro-1H-imidazol-2-yl)-4-methyl-1H-benzimidazol-2-yl]-4-[[2-(3-fluorophenyl)-2-hydroxyethyl]amino]-1H-pyridin-2-one Chemical compound N=1C=2C(C)=CC(C=3NCCN=3)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(F)=C1 PSNGDGXROKQVFD-UHFFFAOYSA-N 0.000 description 1
- CMIUKVSIYYJZEJ-QFIPXVFZSA-N 3-[6-(4,5-dihydro-1H-imidazol-2-yl)-4-phenyl-1H-benzimidazol-2-yl]-4-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-1H-pyridin-2-one Chemical compound C([C@@H](CO)NC1=C(C(=O)NC=C1)C=1NC2=CC(=CC(=C2N=1)C=1C=CC=CC=1)C=1NCCN=1)C1=CC=CC=C1 CMIUKVSIYYJZEJ-QFIPXVFZSA-N 0.000 description 1
- TUZKEXPUYPJNDF-UHFFFAOYSA-N 3-[6-(4-acetylpiperazin-1-yl)-4-methyl-1H-benzimidazol-2-yl]-4-[[2-(3-bromophenyl)-2-hydroxyethyl]amino]-1H-pyridin-2-one Chemical compound C1CN(C(=O)C)CCN1C1=CC(C)=C(N=C(N2)C=3C(NC=CC=3NCC(O)C=3C=C(Br)C=CC=3)=O)C2=C1 TUZKEXPUYPJNDF-UHFFFAOYSA-N 0.000 description 1
- QIEKBURWQYYQLT-UHFFFAOYSA-N 3-[6-(4-acetylpiperazin-1-yl)-4-methyl-1H-benzimidazol-2-yl]-4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-1H-pyridin-2-one Chemical compound C1CN(C(=O)C)CCN1C1=CC(C)=C(N=C(N2)C=3C(NC=CC=3NCC(O)C=3C=C(Cl)C=CC=3)=O)C2=C1 QIEKBURWQYYQLT-UHFFFAOYSA-N 0.000 description 1
- ULBGHTQEOQYJDU-UHFFFAOYSA-N 3-[6-(4-aminopiperidin-1-yl)-4-methyl-1H-benzimidazol-2-yl]-4-chloro-1H-pyridin-2-one Chemical compound N=1C=2C(C)=CC(N3CCC(N)CC3)=CC=2NC=1C1=C(Cl)C=CNC1=O ULBGHTQEOQYJDU-UHFFFAOYSA-N 0.000 description 1
- DVSOQVVEQNAVNQ-QHCPKHFHSA-N 3-[6-(4-butylpiperazin-1-yl)-4-methyl-1H-benzimidazol-2-yl]-4-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-1H-pyridin-2-one Chemical compound C1CN(CCCC)CCN1C1=CC(C)=C(N=C(N2)C=3C(NC=CC=3N[C@H](CO)CC=3C=CC=CC=3)=O)C2=C1 DVSOQVVEQNAVNQ-QHCPKHFHSA-N 0.000 description 1
- ITXSEFXQKSSQFX-DEOSSOPVSA-N 3-[6-(4-cyclohexylpiperazin-1-yl)-4-methyl-1H-benzimidazol-2-yl]-4-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-1H-pyridin-2-one Chemical compound C([C@@H](CO)NC1=C(C(NC=C1)=O)C=1NC=2C=C(C=C(C=2N=1)C)N1CCN(CC1)C1CCCCC1)C1=CC=CC=C1 ITXSEFXQKSSQFX-DEOSSOPVSA-N 0.000 description 1
- IUDMQQRTEZRCMZ-IBGZPJMESA-N 3-[6-(5,5-dimethyl-1,4-dihydroimidazol-2-yl)-4-methyl-1H-benzimidazol-2-yl]-4-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-1H-pyridin-2-one Chemical compound C([C@@H](CO)NC1=C(C(NC=C1)=O)C=1NC=2C=C(C=C(C=2N=1)C)C=1NCC(C)(C)N=1)C1=CC=CC=C1 IUDMQQRTEZRCMZ-IBGZPJMESA-N 0.000 description 1
- GISVYEBHXVVYFQ-NRFANRHFSA-N 3-[6-[4-(2-hydroxyethyl)piperazin-1-yl]-4-methyl-1H-benzimidazol-2-yl]-4-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-1H-pyridin-2-one Chemical compound C([C@@H](CO)NC1=C(C(NC=C1)=O)C=1NC=2C=C(C=C(C=2N=1)C)N1CCN(CCO)CC1)C1=CC=CC=C1 GISVYEBHXVVYFQ-NRFANRHFSA-N 0.000 description 1
- VCKPLIALTYHCFK-DEOSSOPVSA-N 3-[6-[4-(benzenesulfonyl)piperazin-1-yl]-4-methyl-1H-benzimidazol-2-yl]-4-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-1H-pyridin-2-one Chemical compound C([C@@H](CO)NC1=C(C(NC=C1)=O)C=1NC=2C=C(C=C(C=2N=1)C)N1CCN(CC1)S(=O)(=O)C=1C=CC=CC=1)C1=CC=CC=C1 VCKPLIALTYHCFK-DEOSSOPVSA-N 0.000 description 1
- HMVQTVDNNHMSBQ-UHFFFAOYSA-N 3-[[3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-2-oxo-1H-pyridin-4-yl]amino]-N-phenylpropanamide Chemical compound N=1C=2C(C)=CC(N3C=NC=C3)=CC=2NC=1C(C(NC=C1)=O)=C1NCCC(=O)NC1=CC=CC=C1 HMVQTVDNNHMSBQ-UHFFFAOYSA-N 0.000 description 1
- SRWILAKSARHZPR-UHFFFAOYSA-N 3-chlorobenzaldehyde Chemical compound ClC1=CC=CC(C=O)=C1 SRWILAKSARHZPR-UHFFFAOYSA-N 0.000 description 1
- 125000006284 3-fluorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C(F)=C1[H])C([H])([H])* 0.000 description 1
- 125000004208 3-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C([H])C(*)=C1[H] 0.000 description 1
- 125000004207 3-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(OC([H])([H])[H])=C1[H] 0.000 description 1
- IHVNKSXTJZNBQA-UHFFFAOYSA-N 3-methyl-4-nitrobenzonitrile Chemical compound CC1=CC(C#N)=CC=C1[N+]([O-])=O IHVNKSXTJZNBQA-UHFFFAOYSA-N 0.000 description 1
- NICYTXJGZRYCEQ-UHFFFAOYSA-N 3h-benzimidazole-5-carbonitrile Chemical compound N#CC1=CC=C2N=CNC2=C1 NICYTXJGZRYCEQ-UHFFFAOYSA-N 0.000 description 1
- 125000000972 4,5-dimethylthiazol-2-yl group Chemical group [H]C([H])([H])C1=C(N=C(*)S1)C([H])([H])[H] 0.000 description 1
- VPGPXYGLELGZEP-UHFFFAOYSA-N 4-(1,2-diphenylethylamino)-3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound N=1C=2C(C)=CC(N3C=NC=C3)=CC=2NC=1C(C(NC=C1)=O)=C1NC(C=1C=CC=CC=1)CC1=CC=CC=C1 VPGPXYGLELGZEP-UHFFFAOYSA-N 0.000 description 1
- HOORANRVQLCKDH-UHFFFAOYSA-N 4-(1-adamantylmethylamino)-3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound Cc1cc(cc2[nH]c(nc12)-c1c(NCC23CC4CC(CC(C4)C2)C3)cc[nH]c1=O)-n1ccnc1 HOORANRVQLCKDH-UHFFFAOYSA-N 0.000 description 1
- YKZWYFYBLBSFLT-UHFFFAOYSA-N 4-(2,3-dihydro-1H-inden-2-ylamino)-3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound C=1C=2NC(C=3C(NC=CC=3NC3CC4=CC=CC=C4C3)=O)=NC=2C(C)=CC=1N1C=CN=C1 YKZWYFYBLBSFLT-UHFFFAOYSA-N 0.000 description 1
- NCVMCGYHZVCLOC-UHFFFAOYSA-N 4-(2,3-dihydroxypropylamino)-3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound N=1C=2C(C)=CC(N3C=NC=C3)=CC=2NC=1C1=C(NCC(O)CO)C=CNC1=O NCVMCGYHZVCLOC-UHFFFAOYSA-N 0.000 description 1
- KHSYQQUFPKGLPY-UHFFFAOYSA-N 4-(3,4-dihydro-2H-quinolin-1-yl)-3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound C=1C=2NC(C=3C(NC=CC=3N3C4=CC=CC=C4CCC3)=O)=NC=2C(C)=CC=1N1C=CN=C1 KHSYQQUFPKGLPY-UHFFFAOYSA-N 0.000 description 1
- YCRISMGUTFLFJD-UHFFFAOYSA-N 4-(pyridin-2-ylmethylamino)-3-(4,5,6-trifluoro-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound N=1C=2C(F)=C(F)C(F)=CC=2NC=1C(C(NC=C1)=O)=C1NCC1=CC=CC=N1 YCRISMGUTFLFJD-UHFFFAOYSA-N 0.000 description 1
- DPXZRRSRJSNENL-UHFFFAOYSA-N 4-[(1-benzylpyrrolidin-3-yl)amino]-3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound N=1C=2C(C)=CC(N3C=NC=C3)=CC=2NC=1C(C(NC=C1)=O)=C1NC(C1)CCN1CC1=CC=CC=C1 DPXZRRSRJSNENL-UHFFFAOYSA-N 0.000 description 1
- ZCBRAIWFTLAUCB-UHFFFAOYSA-N 4-[(2-hydroxy-2-naphthalen-1-ylethyl)amino]-3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound C=1C=2NC(C=3C(NC=CC=3NCC(O)C=3C4=CC=CC=C4C=CC=3)=O)=NC=2C(C)=CC=1N1C=CN=C1 ZCBRAIWFTLAUCB-UHFFFAOYSA-N 0.000 description 1
- XIFIAQFGAPBBRZ-UHFFFAOYSA-N 4-[(3,4-dihydroxyphenyl)methylamino]-3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound N=1C=2C(C)=CC(N3C=NC=C3)=CC=2NC=1C(C(NC=C1)=O)=C1NCC1=CC=C(O)C(O)=C1 XIFIAQFGAPBBRZ-UHFFFAOYSA-N 0.000 description 1
- NEKKEDOYKKWMTM-UHFFFAOYSA-N 4-[(4-chloropyridin-2-yl)methylamino]-3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound N=1C=2C(C)=CC(N3C=NC=C3)=CC=2NC=1C(C(NC=C1)=O)=C1NCC1=CC(Cl)=CC=N1 NEKKEDOYKKWMTM-UHFFFAOYSA-N 0.000 description 1
- YTBYMAHHFRRLKH-UHFFFAOYSA-N 4-[(4-tert-butyl-1-hydroxycyclohexyl)methylamino]-3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound N=1C=2C(C)=CC(N3C=NC=C3)=CC=2NC=1C(C(NC=C1)=O)=C1NCC1(O)CCC(C(C)(C)C)CC1 YTBYMAHHFRRLKH-UHFFFAOYSA-N 0.000 description 1
- AVISGZRUBZQDPJ-UHFFFAOYSA-N 4-[(6-ethoxypyridin-2-yl)methylamino]-3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound CCOC1=CC=CC(CNC2=C(C(=O)NC=C2)C=2NC3=CC(=CC(C)=C3N=2)N2C=NC=C2)=N1 AVISGZRUBZQDPJ-UHFFFAOYSA-N 0.000 description 1
- JACDJWACQIYSEN-UHFFFAOYSA-N 4-[2-(1H-imidazol-5-yl)ethylamino]-3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound N=1C=2C(C)=CC(N3C=NC=C3)=CC=2NC=1C(C(NC=C1)=O)=C1NCCC1=CN=CN1 JACDJWACQIYSEN-UHFFFAOYSA-N 0.000 description 1
- PEMCPTQGODQUPH-UHFFFAOYSA-N 4-[2-(3-chlorophenyl)ethylamino]-3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound N=1C=2C(C)=CC(N3C=NC=C3)=CC=2NC=1C(C(NC=C1)=O)=C1NCCC1=CC=CC(Cl)=C1 PEMCPTQGODQUPH-UHFFFAOYSA-N 0.000 description 1
- PGGXSFKDYLCBEK-UHFFFAOYSA-N 4-[2-(3-chlorophenyl)ethylamino]-3-[6-(4,5-dihydro-1H-imidazol-2-yl)-4-methyl-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound N=1C=2C(C)=CC(C=3NCCN=3)=CC=2NC=1C(C(NC=C1)=O)=C1NCCC1=CC=CC(Cl)=C1 PGGXSFKDYLCBEK-UHFFFAOYSA-N 0.000 description 1
- RIGHMINQKHVRIG-UHFFFAOYSA-N 4-[2-(5-bromo-2-methoxyphenyl)ethylamino]-3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound COC1=CC=C(Br)C=C1CCNC1=C(C=2NC3=CC(=CC(C)=C3N=2)N2C=NC=C2)C(=O)NC=C1 RIGHMINQKHVRIG-UHFFFAOYSA-N 0.000 description 1
- URRCRNSEORCSQV-UHFFFAOYSA-N 4-[2-(5-ethylpyridin-2-yl)ethylamino]-3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound N1=CC(CC)=CC=C1CCNC1=C(C=2NC3=CC(=CC(C)=C3N=2)N2C=NC=C2)C(=O)NC=C1 URRCRNSEORCSQV-UHFFFAOYSA-N 0.000 description 1
- BJNGYYIRBKKUGT-UHFFFAOYSA-N 4-[2-(6-fluoro-1H-indol-2-yl)ethylamino]-3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound C=1C=2NC(C=3C(NC=CC=3NCCC=3NC4=CC(F)=CC=C4C=3)=O)=NC=2C(C)=CC=1N1C=CN=C1 BJNGYYIRBKKUGT-UHFFFAOYSA-N 0.000 description 1
- WNQBYSHSZXGMIY-IBGZPJMESA-N 4-[2-[4-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-2-oxo-1H-pyridin-3-yl]-7-methyl-3H-benzimidazol-5-yl]piperazine-1-carboxylic acid Chemical compound C([C@@H](CO)NC1=C(C(NC=C1)=O)C=1NC=2C=C(C=C(C=2N=1)C)N1CCN(CC1)C(O)=O)C1=CC=CC=C1 WNQBYSHSZXGMIY-IBGZPJMESA-N 0.000 description 1
- IGXUINKQJVVEJJ-UHFFFAOYSA-N 4-[3-(dimethylamino)propylamino]-3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound C1=CNC(=O)C(C=2NC3=CC(=CC(C)=C3N=2)N2C=NC=C2)=C1NCCCN(C)C IGXUINKQJVVEJJ-UHFFFAOYSA-N 0.000 description 1
- QCDSKOUKWJFTKU-NZQKXSOJSA-N 4-[[(1R,2S)-1-hydroxy-2,3-dihydro-1H-inden-2-yl]amino]-3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound Cc1cc(cc2[nH]c(nc12)-c1c(N[C@H]2Cc3ccccc3[C@H]2O)cc[nH]c1=O)-n1ccnc1 QCDSKOUKWJFTKU-NZQKXSOJSA-N 0.000 description 1
- DDVOTDANRIRAON-REWPJTCUSA-N 4-[[(1S,2S)-1,3-dihydroxy-1-phenylpropan-2-yl]amino]-3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound Cc1cc(cc2[nH]c(nc12)-c1c(N[C@@H](CO)[C@@H](O)c2ccccc2)cc[nH]c1=O)-n1ccnc1 DDVOTDANRIRAON-REWPJTCUSA-N 0.000 description 1
- GCHQRFUKBLZIMY-LJQANCHMSA-N 4-[[(2R)-2-hydroxy-2-pyridin-2-ylethyl]amino]-3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound C1([C@H](O)CNC2=C(C(NC=C2)=O)C=2NC=3C=C(C=C(C=3N=2)C)N2C=NC=C2)=CC=CC=N1 GCHQRFUKBLZIMY-LJQANCHMSA-N 0.000 description 1
- WATSTWWMWVSXCZ-HNNXBMFYSA-N 4-[[(2S)-1-(2-chloro-6-fluorophenyl)-3-hydroxypropan-2-yl]amino]-3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound C([C@@H](CO)NC1=C(C(NC=C1)=O)C=1NC=2C=C(C=C(C=2N=1)C)N1C=NC=C1)C1=C(F)C=CC=C1Cl WATSTWWMWVSXCZ-HNNXBMFYSA-N 0.000 description 1
- PLWDMIRRRXMQJQ-IBGZPJMESA-N 4-[[(2S)-1-benzylsulfanyl-3-hydroxypropan-2-yl]amino]-3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound C([C@H](CO)NC1=C(C(NC=C1)=O)C=1NC=2C=C(C=C(C=2N=1)C)N1C=NC=C1)SCC1=CC=CC=C1 PLWDMIRRRXMQJQ-IBGZPJMESA-N 0.000 description 1
- XEJNCVPGVBIYGC-SFHVURJKSA-N 4-[[(2S)-1-cyclohexyl-3-hydroxypropan-2-yl]amino]-3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound C([C@@H](CO)NC1=C(C(NC=C1)=O)C=1NC=2C=C(C=C(C=2N=1)C)N1C=NC=C1)C1CCCCC1 XEJNCVPGVBIYGC-SFHVURJKSA-N 0.000 description 1
- OYLJBZXTOVBQEP-SFHVURJKSA-N 4-[[(2S)-1-hydroxy-3-(1H-indol-3-yl)propan-2-yl]amino]-3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound C=1C=2NC(C=3C(NC=CC=3N[C@H](CO)CC=3C4=CC=CC=C4NC=3)=O)=NC=2C(C)=CC=1N1C=CN=C1 OYLJBZXTOVBQEP-SFHVURJKSA-N 0.000 description 1
- CURCJOHUTQAJFO-INIZCTEOSA-N 4-[[(2S)-1-hydroxy-3-(4-hydroxy-3-iodophenyl)propan-2-yl]amino]-3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound C([C@@H](CO)NC1=C(C(NC=C1)=O)C=1NC=2C=C(C=C(C=2N=1)C)N1C=NC=C1)C1=CC=C(O)C(I)=C1 CURCJOHUTQAJFO-INIZCTEOSA-N 0.000 description 1
- ZIXIMCDPEWBHEX-KRWDZBQOSA-N 4-[[(2S)-1-hydroxy-3-(4-hydroxy-3-methoxyphenyl)propan-2-yl]amino]-3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound C1=C(O)C(OC)=CC(C[C@@H](CO)NC2=C(C(=O)NC=C2)C=2NC3=CC(=CC(C)=C3N=2)N2C=NC=C2)=C1 ZIXIMCDPEWBHEX-KRWDZBQOSA-N 0.000 description 1
- VUNROPKSFLMTOS-SFHVURJKSA-N 4-[[(2S)-1-hydroxy-3-(4-iodophenyl)propan-2-yl]amino]-3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound C([C@@H](CO)NC1=C(C(NC=C1)=O)C=1NC=2C=C(C=C(C=2N=1)C)N1C=NC=C1)C1=CC=C(I)C=C1 VUNROPKSFLMTOS-SFHVURJKSA-N 0.000 description 1
- OAXSESNYEGHIEX-DEOSSOPVSA-N 4-[[(2S)-1-hydroxy-3-(4-phenylmethoxyphenyl)propan-2-yl]amino]-3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound C([C@@H](CO)NC1=C(C(NC=C1)=O)C=1NC=2C=C(C=C(C=2N=1)C)N1C=NC=C1)C(C=C1)=CC=C1OCC1=CC=CC=C1 OAXSESNYEGHIEX-DEOSSOPVSA-N 0.000 description 1
- RVQIUINVAFWZSZ-FQEVSTJZSA-N 4-[[(2S)-1-hydroxy-3-[(3-methylphenyl)methylsulfanyl]propan-2-yl]amino]-3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound CC1=CC=CC(CSC[C@H](CO)NC2=C(C(=O)NC=C2)C=2NC3=CC(=CC(C)=C3N=2)N2C=NC=C2)=C1 RVQIUINVAFWZSZ-FQEVSTJZSA-N 0.000 description 1
- WHQWLCJMLGZPSO-FQEVSTJZSA-N 4-[[(2S)-1-hydroxy-3-[(4-methylphenyl)methylsulfanyl]propan-2-yl]amino]-3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound C1=CC(C)=CC=C1CSC[C@H](CO)NC1=C(C=2NC3=CC(=CC(C)=C3N=2)N2C=NC=C2)C(=O)NC=C1 WHQWLCJMLGZPSO-FQEVSTJZSA-N 0.000 description 1
- HIZBSFNCAKJTMP-INIZCTEOSA-N 4-[[(2S)-1-hydroxy-3-[4-hydroxy-2-(trifluoromethyl)phenyl]propan-2-yl]amino]-3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound C([C@@H](CO)NC1=C(C(NC=C1)=O)C=1NC=2C=C(C=C(C=2N=1)C)N1C=NC=C1)C1=CC=C(O)C=C1C(F)(F)F HIZBSFNCAKJTMP-INIZCTEOSA-N 0.000 description 1
- VDKDKQPMAPALOZ-LBPRGKRZSA-N 4-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-3-(4,5,6-trifluoro-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound OC[C@H](Cc1ccccc1)Nc1cc[nH]c(=O)c1-c1nc2c(F)c(F)c(F)cc2[nH]1 VDKDKQPMAPALOZ-LBPRGKRZSA-N 0.000 description 1
- UDENGOFIXSLHLB-INIZCTEOSA-N 4-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-3-(4-methyl-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound C([C@@H](CO)NC1=C(C(NC=C1)=O)C=1NC=2C=CC=C(C=2N=1)C)C1=CC=CC=C1 UDENGOFIXSLHLB-INIZCTEOSA-N 0.000 description 1
- WUPNGISCXFUMRM-IBGZPJMESA-N 4-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-3-[4-methyl-6-(1-methyl-4,5-dihydroimidazol-2-yl)-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound CN1CCN=C1c1cc(C)c2nc([nH]c2c1)-c1c(N[C@H](CO)Cc2ccccc2)cc[nH]c1=O WUPNGISCXFUMRM-IBGZPJMESA-N 0.000 description 1
- DWXRRSODJNHKQF-FQEVSTJZSA-N 4-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-3-[4-methyl-6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound C1CN(C)CCN1C1=CC(C)=C(N=C(N2)C=3C(NC=CC=3N[C@H](CO)CC=3C=CC=CC=3)=O)C2=C1 DWXRRSODJNHKQF-FQEVSTJZSA-N 0.000 description 1
- LVZUQCAPWQJJQI-FQEVSTJZSA-N 4-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-3-[4-methyl-6-(4-methylsulfonylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound C([C@@H](CO)NC1=C(C(NC=C1)=O)C=1NC=2C=C(C=C(C=2N=1)C)N1CCN(CC1)S(C)(=O)=O)C1=CC=CC=C1 LVZUQCAPWQJJQI-FQEVSTJZSA-N 0.000 description 1
- KQLLMGUBZOIMAP-SFHVURJKSA-N 4-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-3-[6-(1H-imidazol-2-yl)-4-methyl-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound C([C@@H](CO)NC1=C(C(NC=C1)=O)C=1NC=2C=C(C=C(C=2N=1)C)C=1NC=CN=1)C1=CC=CC=C1 KQLLMGUBZOIMAP-SFHVURJKSA-N 0.000 description 1
- OOHPHAMBXHGITE-KRWDZBQOSA-N 4-[[(2S)-1-hydroxy-3-pyridin-3-ylpropan-2-yl]amino]-3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound C([C@@H](CO)NC1=C(C(NC=C1)=O)C=1NC=2C=C(C=C(C=2N=1)C)N1C=NC=C1)C1=CC=CN=C1 OOHPHAMBXHGITE-KRWDZBQOSA-N 0.000 description 1
- FSDYMRXZPHZFJS-OAQYLSRUSA-N 4-[[(2S)-2-(3-bromo-4-methoxyphenyl)-2-hydroxyethyl]amino]-3-(4-methyl-6-morpholin-4-yl-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound C1=C(Br)C(OC)=CC=C1[C@H](O)CNC1=C(C=2NC3=CC(=CC(C)=C3N=2)N2CCOCC2)C(=O)NC=C1 FSDYMRXZPHZFJS-OAQYLSRUSA-N 0.000 description 1
- QQUOABRZUGYNQT-HSZRJFAPSA-N 4-[[(2S)-2-(3-bromo-4-methoxyphenyl)-2-hydroxyethyl]amino]-3-[4-methyl-6-(2-morpholin-4-ylethoxy)-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound C1=C(Br)C(OC)=CC=C1[C@H](O)CNC1=C(C=2NC3=CC(OCCN4CCOCC4)=CC(C)=C3N=2)C(=O)NC=C1 QQUOABRZUGYNQT-HSZRJFAPSA-N 0.000 description 1
- ZPBXYYSGMGJOLO-XMMPIXPASA-N 4-[[(2S)-2-(3-bromo-4-methoxyphenyl)-2-hydroxyethyl]amino]-3-[4-methyl-6-(3-morpholin-4-ylpropoxy)-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound C1=C(Br)C(OC)=CC=C1[C@H](O)CNC1=C(C=2NC3=CC(OCCCN4CCOCC4)=CC(C)=C3N=2)C(=O)NC=C1 ZPBXYYSGMGJOLO-XMMPIXPASA-N 0.000 description 1
- DNTQJDXWGFMNLI-KSFYIVLOSA-N 4-[[(2S)-2-(3-bromo-4-methoxyphenyl)-2-hydroxyethyl]amino]-3-[4-methyl-6-[(2S)-2-methylmorpholin-4-yl]-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound C1=C(Br)C(OC)=CC=C1[C@H](O)CNC1=C(C=2NC3=CC(=CC(C)=C3N=2)N2C[C@H](C)OCC2)C(=O)NC=C1 DNTQJDXWGFMNLI-KSFYIVLOSA-N 0.000 description 1
- JIADGRLHJMOUEK-HSZRJFAPSA-N 4-[[(2S)-2-(3-bromo-4-methoxyphenyl)-2-hydroxyethyl]amino]-3-[6-[4-(2-hydroxyethyl)piperazin-1-yl]-4-methyl-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound C1=C(Br)C(OC)=CC=C1[C@H](O)CNC1=C(C=2NC3=CC(=CC(C)=C3N=2)N2CCN(CCO)CC2)C(=O)NC=C1 JIADGRLHJMOUEK-HSZRJFAPSA-N 0.000 description 1
- IMMXVSIPHLGTTG-XMMPIXPASA-N 4-[[(2S)-2-(3-bromo-4-methoxyphenyl)-2-hydroxyethyl]amino]-3-[6-[4-(3-fluoropropyl)piperazin-1-yl]-4-methyl-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound C1=C(Br)C(OC)=CC=C1[C@H](O)CNC1=C(C=2NC3=CC(=CC(C)=C3N=2)N2CCN(CCCF)CC2)C(=O)NC=C1 IMMXVSIPHLGTTG-XMMPIXPASA-N 0.000 description 1
- LGLHDKFGXZEGKW-XMMPIXPASA-N 4-[[(2S)-2-(3-chloro-4-fluorophenyl)-2-hydroxyethyl]amino]-3-[6-[4-(3-fluoropropyl)piperazin-1-yl]-4-methyl-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound C1([C@H](O)CNC2=C(C(NC=C2)=O)C=2NC=3C=C(C=C(C=3N=2)C)N2CCN(CCCF)CC2)=CC=C(F)C(Cl)=C1 LGLHDKFGXZEGKW-XMMPIXPASA-N 0.000 description 1
- RJOLTVNZKRBSOZ-XMSQKQJNSA-N 4-[[(2S)-2-(3-chloro-4-methoxyphenyl)-2-hydroxyethyl]amino]-3-[6-[(2R)-2-(hydroxymethyl)morpholin-4-yl]-4-methyl-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound C1=C(Cl)C(OC)=CC=C1[C@H](O)CNC1=C(C=2NC3=CC(=CC(C)=C3N=2)N2C[C@H](CO)OCC2)C(=O)NC=C1 RJOLTVNZKRBSOZ-XMSQKQJNSA-N 0.000 description 1
- PKNHVWJAADMUFX-AUSIDOKSSA-N 4-[[(2S)-2-(3-chloro-4-methoxyphenyl)-2-hydroxyethyl]amino]-3-[6-[(2R)-2-(methoxymethyl)morpholin-4-yl]-4-methyl-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound C1CO[C@@H](COC)CN1C1=CC(C)=C(N=C(N2)C=3C(NC=CC=3NC[C@@H](O)C=3C=C(Cl)C(OC)=CC=3)=O)C2=C1 PKNHVWJAADMUFX-AUSIDOKSSA-N 0.000 description 1
- VTMIHYCOXBGSOX-XMMPIXPASA-N 4-[[(2S)-2-(3-chloro-4-methoxyphenyl)-2-hydroxyethyl]amino]-3-[6-[4-(3-fluoropropyl)piperazin-1-yl]-4-methyl-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound C1=C(Cl)C(OC)=CC=C1[C@H](O)CNC1=C(C=2NC3=CC(=CC(C)=C3N=2)N2CCN(CCCF)CC2)C(=O)NC=C1 VTMIHYCOXBGSOX-XMMPIXPASA-N 0.000 description 1
- RGJQBKZCZQAOFW-XMMPIXPASA-N 4-[[(2S)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]-3-[4-methyl-6-(3-morpholin-4-ylpropoxy)-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound C=1C=2NC(C=3C(NC=CC=3NC[C@@H](O)C=3C=C(Cl)C=CC=3)=O)=NC=2C(C)=CC=1OCCCN1CCOCC1 RGJQBKZCZQAOFW-XMMPIXPASA-N 0.000 description 1
- BPAKRUQJYIEQNO-HSZRJFAPSA-N 4-[[(2S)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]-3-[4-methyl-6-[4-(2-methylsulfanylacetyl)piperazin-1-yl]-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound C1CN(C(=O)CSC)CCN1C1=CC(C)=C(N=C(N2)C=3C(NC=CC=3NC[C@@H](O)C=3C=C(Cl)C=CC=3)=O)C2=C1 BPAKRUQJYIEQNO-HSZRJFAPSA-N 0.000 description 1
- ODKOFIIUMZVPOY-HSZRJFAPSA-N 4-[[(2S)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]-3-[4-methyl-6-[4-(2-methylsulfonylacetyl)piperazin-1-yl]-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound C1([C@H](O)CNC2=C(C(NC=C2)=O)C=2NC=3C=C(C=C(C=3N=2)C)N2CCN(CC2)C(=O)CS(C)(=O)=O)=CC=CC(Cl)=C1 ODKOFIIUMZVPOY-HSZRJFAPSA-N 0.000 description 1
- IAOSNXWODOEZQA-XMMPIXPASA-N 4-[[(2S)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]-3-[4-methyl-6-[4-(2-methylsulfonylethyl)piperazin-1-yl]-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound C1([C@H](O)CNC2=C(C(NC=C2)=O)C=2NC=3C=C(C=C(C=3N=2)C)N2CCN(CCS(C)(=O)=O)CC2)=CC=CC(Cl)=C1 IAOSNXWODOEZQA-XMMPIXPASA-N 0.000 description 1
- UIBLHEZWESDKHO-AREMUKBSSA-N 4-[[(2S)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]-3-[4-methyl-6-[4-(2-thiomorpholin-4-ylacetyl)piperazin-1-yl]-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound C1([C@H](O)CNC2=C(C(NC=C2)=O)C=2NC=3C=C(C=C(C=3N=2)C)N2CCN(CC2)C(=O)CN2CCSCC2)=CC=CC(Cl)=C1 UIBLHEZWESDKHO-AREMUKBSSA-N 0.000 description 1
- UHOVHYKNOIFMRB-NFBKMPQASA-N 4-[[(2S)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]-3-[6-[(2R)-2-(methoxymethyl)morpholin-4-yl]-4-methyl-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound C1CO[C@@H](COC)CN1C1=CC(C)=C(N=C(N2)C=3C(NC=CC=3NC[C@@H](O)C=3C=C(Cl)C=CC=3)=O)C2=C1 UHOVHYKNOIFMRB-NFBKMPQASA-N 0.000 description 1
- VQPODECQMREPQU-OAQYLSRUSA-N 4-[[(2S)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]-3-[6-[4-(2,2-difluoroacetyl)piperazin-1-yl]-4-methyl-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound C1([C@H](O)CNC2=C(C(NC=C2)=O)C=2NC=3C=C(C=C(C=3N=2)C)N2CCN(CC2)C(=O)C(F)F)=CC=CC(Cl)=C1 VQPODECQMREPQU-OAQYLSRUSA-N 0.000 description 1
- ODZVOOVRXLCZEN-XMMPIXPASA-N 4-[[(2S)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]-3-[6-[4-(2-hydroxy-2-methylpropyl)piperazin-1-yl]-4-methyl-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound C1([C@H](O)CNC2=C(C(NC=C2)=O)C=2NC=3C=C(C=C(C=3N=2)C)N2CCN(CC(C)(C)O)CC2)=CC=CC(Cl)=C1 ODZVOOVRXLCZEN-XMMPIXPASA-N 0.000 description 1
- DWYUYEUFJJPGLV-MQNHUJCZSA-N 4-[[(2S)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]-3-[6-[4-(3-fluoro-2-hydroxypropyl)piperazin-1-yl]-4-methyl-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound C1([C@H](O)CNC2=C(C(NC=C2)=O)C=2NC=3C=C(C=C(C=3N=2)C)N2CCN(CC(O)CF)CC2)=CC=CC(Cl)=C1 DWYUYEUFJJPGLV-MQNHUJCZSA-N 0.000 description 1
- GGSZBJGKTOHWCQ-AUSIDOKSSA-N 4-[[(2S)-2-(7-bromo-2,3-dihydro-1-benzofuran-5-yl)-2-hydroxyethyl]amino]-3-[6-[(2S)-2-(fluoromethyl)morpholin-4-yl]-4-methyl-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound C=1C=2NC(C=3C(NC=CC=3NC[C@@H](O)C=3C=C(Br)C=4OCCC=4C=3)=O)=NC=2C(C)=CC=1N1CCO[C@H](CF)C1 GGSZBJGKTOHWCQ-AUSIDOKSSA-N 0.000 description 1
- DWMSCQJVBKRKPX-NRFANRHFSA-N 4-[[(2S)-3-[2-(1,3-benzothiazol-2-yl)phenoxy]-2-hydroxypropyl]amino]-3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound C=1C=2NC(C=3C(NC=CC=3NC[C@H](O)COC=3C(=CC=CC=3)C=3SC4=CC=CC=C4N=3)=O)=NC=2C(C)=CC=1N1C=CN=C1 DWMSCQJVBKRKPX-NRFANRHFSA-N 0.000 description 1
- ZJVOZWHMPKCHRF-RPWUZVMVSA-N 4-[[(3S,4R)-3-hydroxy-2,2-dimethyl-3,4-dihydrochromen-4-yl]amino]-3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound Cc1cc(cc2[nH]c(nc12)-c1c(N[C@H]2[C@H](O)C(C)(C)Oc3ccccc23)cc[nH]c1=O)-n1ccnc1 ZJVOZWHMPKCHRF-RPWUZVMVSA-N 0.000 description 1
- MFSFGGSTRBPKGD-UHFFFAOYSA-N 4-[[1-hydroxy-3-(2-hydroxy-3-methylphenyl)propan-2-yl]amino]-3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound CC1=CC=CC(CC(CO)NC2=C(C(=O)NC=C2)C=2NC3=CC(=CC(C)=C3N=2)N2C=NC=C2)=C1O MFSFGGSTRBPKGD-UHFFFAOYSA-N 0.000 description 1
- CDCLBKDUZIWESF-UHFFFAOYSA-N 4-[[2-(3-bromo-4-methoxyphenyl)-2-hydroxyethyl]amino]-3-(4,5,6-trifluoro-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound C1=C(Br)C(OC)=CC=C1C(O)CNC1=C(C=2NC3=CC(F)=C(F)C(F)=C3N=2)C(=O)NC=C1 CDCLBKDUZIWESF-UHFFFAOYSA-N 0.000 description 1
- HOHRDSOQNAPGGU-UHFFFAOYSA-N 4-[[2-(3-bromo-4-methoxyphenyl)-2-hydroxyethyl]amino]-3-(4,6-dibromo-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound C1=C(Br)C(OC)=CC=C1C(O)CNC1=C(C=2NC3=CC(Br)=CC(Br)=C3N=2)C(=O)NC=C1 HOHRDSOQNAPGGU-UHFFFAOYSA-N 0.000 description 1
- MXGWOLTYDLTUFA-UHFFFAOYSA-N 4-[[2-(3-bromo-4-methoxyphenyl)-2-hydroxyethyl]amino]-3-(5,6-dichloro-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound C1=C(Br)C(OC)=CC=C1C(O)CNC1=C(C=2NC3=CC(Cl)=C(Cl)C=C3N=2)C(=O)NC=C1 MXGWOLTYDLTUFA-UHFFFAOYSA-N 0.000 description 1
- DQYDPVLKKLYKLG-UHFFFAOYSA-N 4-[[2-(3-bromo-4-methoxyphenyl)-2-hydroxyethyl]amino]-3-[6-(4,5-dihydro-1H-imidazol-2-yl)-4-methyl-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound C1=C(Br)C(OC)=CC=C1C(O)CNC1=C(C=2NC3=CC(=CC(C)=C3N=2)C=2NCCN=2)C(=O)NC=C1 DQYDPVLKKLYKLG-UHFFFAOYSA-N 0.000 description 1
- PCGBAQQSVZOJMP-UHFFFAOYSA-N 4-[[2-(3-bromophenyl)-2-hydroxyethyl]amino]-3-(4,5,6-trifluoro-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound C1=CNC(=O)C(C=2NC3=CC(F)=C(F)C(F)=C3N=2)=C1NCC(O)C1=CC=CC(Br)=C1 PCGBAQQSVZOJMP-UHFFFAOYSA-N 0.000 description 1
- AHBNNRUAMRUQQQ-UHFFFAOYSA-N 4-[[2-(3-bromophenyl)-2-hydroxyethyl]amino]-3-(4,6-dibromo-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound C1=CNC(=O)C(C=2NC3=CC(Br)=CC(Br)=C3N=2)=C1NCC(O)C1=CC=CC(Br)=C1 AHBNNRUAMRUQQQ-UHFFFAOYSA-N 0.000 description 1
- ILBURSLKFOEBIE-UHFFFAOYSA-N 4-[[2-(3-bromophenyl)-2-hydroxyethyl]amino]-3-(4,6-difluoro-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound C1=CNC(=O)C(C=2NC3=CC(F)=CC(F)=C3N=2)=C1NCC(O)C1=CC=CC(Br)=C1 ILBURSLKFOEBIE-UHFFFAOYSA-N 0.000 description 1
- MCUVOPAFVRGGAU-UHFFFAOYSA-N 4-[[2-(3-bromophenyl)-2-hydroxyethyl]amino]-3-(5,6-dichloro-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound C1=CNC(=O)C(C=2NC3=CC(Cl)=C(Cl)C=C3N=2)=C1NCC(O)C1=CC=CC(Br)=C1 MCUVOPAFVRGGAU-UHFFFAOYSA-N 0.000 description 1
- MPZKKCMOVFYJCP-UHFFFAOYSA-N 4-[[2-(3-bromophenyl)-2-hydroxyethyl]amino]-3-(6-fluoro-5-imidazol-1-yl-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound C=1C=CC(Br)=CC=1C(O)CNC=1C=CNC(=O)C=1C(NC1=C2)=NC1=CC(F)=C2N1C=CN=C1 MPZKKCMOVFYJCP-UHFFFAOYSA-N 0.000 description 1
- BPVUJMFRJMYDOP-UHFFFAOYSA-N 4-[[2-(3-bromophenyl)-2-hydroxyethyl]amino]-3-[4-bromo-6-(trifluoromethyl)-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound C1=CNC(=O)C(C=2NC3=CC(=CC(Br)=C3N=2)C(F)(F)F)=C1NCC(O)C1=CC=CC(Br)=C1 BPVUJMFRJMYDOP-UHFFFAOYSA-N 0.000 description 1
- TXGCRDFEEVFPOE-UHFFFAOYSA-N 4-[[2-(3-chloro-4-hydroxyphenyl)-2-hydroxyethyl]amino]-3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound N=1C=2C(C)=CC(N3C=NC=C3)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(O)C1=CC=C(O)C(Cl)=C1 TXGCRDFEEVFPOE-UHFFFAOYSA-N 0.000 description 1
- XRSLRGIILHIZJH-UHFFFAOYSA-N 4-[[2-(3-chloro-4-methoxyphenyl)-2-hydroxyethyl]amino]-3-(4-methyl-6-piperazin-1-yl-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound C1=C(Cl)C(OC)=CC=C1C(O)CNC1=C(C=2NC3=CC(=CC(C)=C3N=2)N2CCNCC2)C(=O)NC=C1 XRSLRGIILHIZJH-UHFFFAOYSA-N 0.000 description 1
- CKNDTFNZTSXXRK-UHFFFAOYSA-N 4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-3-(4,6-difluoro-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound C1=CNC(=O)C(C=2NC3=CC(F)=CC(F)=C3N=2)=C1NCC(O)C1=CC=CC(Cl)=C1 CKNDTFNZTSXXRK-UHFFFAOYSA-N 0.000 description 1
- STXVWDSLJSMZHR-UHFFFAOYSA-N 4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-3-(4-methyl-6-pyridin-3-yl-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound N=1C=2C(C)=CC(C=3C=NC=CC=3)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(Cl)=C1 STXVWDSLJSMZHR-UHFFFAOYSA-N 0.000 description 1
- XVUBOQPLWAHYNE-UHFFFAOYSA-N 4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-3-[4-methyl-6-(2H-tetrazol-5-yl)-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound N=1C=2C(C)=CC(C=3NN=NN=3)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(Cl)=C1 XVUBOQPLWAHYNE-UHFFFAOYSA-N 0.000 description 1
- UYYCMYGVPNHLTH-UHFFFAOYSA-N 4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-3-[4-methyl-6-(4-propan-2-ylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound C1CN(C(C)C)CCN1C1=CC(C)=C(N=C(N2)C=3C(NC=CC=3NCC(O)C=3C=C(Cl)C=CC=3)=O)C2=C1 UYYCMYGVPNHLTH-UHFFFAOYSA-N 0.000 description 1
- UVLFHQBNNHGKGI-UHFFFAOYSA-N 4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-3-[4-methyl-6-(4-propylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound C1CN(CCC)CCN1C1=CC(C)=C(N=C(N2)C=3C(NC=CC=3NCC(O)C=3C=C(Cl)C=CC=3)=O)C2=C1 UVLFHQBNNHGKGI-UHFFFAOYSA-N 0.000 description 1
- XPVYVCSCSGEOQM-UHFFFAOYSA-N 4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-3-[4-methyl-6-(piperazine-1-carbonyl)-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound N=1C=2C(C)=CC(C(=O)N3CCNCC3)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(Cl)=C1 XPVYVCSCSGEOQM-UHFFFAOYSA-N 0.000 description 1
- UTUYDCDLAWNMDG-UHFFFAOYSA-N 4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-3-[4-methyl-6-(piperidine-1-carbonyl)-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound N=1C=2C(C)=CC(C(=O)N3CCCCC3)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(Cl)=C1 UTUYDCDLAWNMDG-UHFFFAOYSA-N 0.000 description 1
- FTWGPGFTIRWYHI-UHFFFAOYSA-N 4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-3-[6-(1H-imidazol-2-yl)-4-methyl-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound N=1C=2C(C)=CC(C=3NC=CN=3)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(Cl)=C1 FTWGPGFTIRWYHI-UHFFFAOYSA-N 0.000 description 1
- XJXNJXOIOQEMDY-UHFFFAOYSA-N 4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-3-[6-(4,5-dihydro-1,3-thiazol-2-yl)-4-methyl-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound N=1C=2C(C)=CC(C=3SCCN=3)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(Cl)=C1 XJXNJXOIOQEMDY-UHFFFAOYSA-N 0.000 description 1
- YXXMKYGGCDGZMB-UHFFFAOYSA-N 4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-3-[6-(4-cyclobutylpiperazin-1-yl)-4-methyl-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound N=1C=2C(C)=CC(N3CCN(CC3)C3CCC3)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(Cl)=C1 YXXMKYGGCDGZMB-UHFFFAOYSA-N 0.000 description 1
- BRXYAENMEBTBTN-UHFFFAOYSA-N 4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-3-[6-(4-ethylpiperazin-1-yl)-4-methyl-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound C1CN(CC)CCN1C1=CC(C)=C(N=C(N2)C=3C(NC=CC=3NCC(O)C=3C=C(Cl)C=CC=3)=O)C2=C1 BRXYAENMEBTBTN-UHFFFAOYSA-N 0.000 description 1
- GXVPOOFCBXTSCA-UHFFFAOYSA-N 4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-3-[6-(5,5-dimethyl-1,4-dihydroimidazol-2-yl)-4-ethyl-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound N=1C=2C(CC)=CC(C=3NC(C)(C)CN=3)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(Cl)=C1 GXVPOOFCBXTSCA-UHFFFAOYSA-N 0.000 description 1
- HAFMZDWYFKXLON-UHFFFAOYSA-N 4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-3-[6-(hydroxymethyl)-4-methyl-1H-benzimidazol-2-yl]-1H-pyridin-2-one Chemical compound N=1C=2C(C)=CC(CO)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(Cl)=C1 HAFMZDWYFKXLON-UHFFFAOYSA-N 0.000 description 1
- RAFNTNCVCLHNFE-UHFFFAOYSA-N 4-[[2-hydroxy-2-(4-hydroxy-3-methoxyphenyl)ethyl]amino]-3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound C1=C(O)C(OC)=CC(C(O)CNC2=C(C(=O)NC=C2)C=2NC3=CC(=CC(C)=C3N=2)N2C=NC=C2)=C1 RAFNTNCVCLHNFE-UHFFFAOYSA-N 0.000 description 1
- MEGYSGGJERXOPQ-UHFFFAOYSA-N 4-[[6-(3-hydroxypropyl)pyridin-2-yl]methylamino]-3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound N=1C=2C(C)=CC(N3C=NC=C3)=CC=2NC=1C(C(NC=C1)=O)=C1NCC1=CC=CC(CCCO)=N1 MEGYSGGJERXOPQ-UHFFFAOYSA-N 0.000 description 1
- JOYWBZXBRGKVIY-UHFFFAOYSA-N 4-[benzyl(2-hydroxyethyl)amino]-3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound N=1C=2C(C)=CC(N3C=NC=C3)=CC=2NC=1C(C(NC=C1)=O)=C1N(CCO)CC1=CC=CC=C1 JOYWBZXBRGKVIY-UHFFFAOYSA-N 0.000 description 1
- DJVGGCMBSOTOSR-ZCFIWIBFSA-N 4-chloro-6-[(1s)-2-chloro-1-hydroxyethyl]-3h-1,3-benzoxazol-2-one Chemical compound ClC[C@@H](O)C1=CC(Cl)=C2NC(=O)OC2=C1 DJVGGCMBSOTOSR-ZCFIWIBFSA-N 0.000 description 1
- JHFOWEGCZWLHNW-UHFFFAOYSA-N 4-fluoro-2-methyl-1-nitrobenzene Chemical compound CC1=CC(F)=CC=C1[N+]([O-])=O JHFOWEGCZWLHNW-UHFFFAOYSA-N 0.000 description 1
- 125000004176 4-fluorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1F)C([H])([H])* 0.000 description 1
- BDXSWIQVLYXSSU-UHFFFAOYSA-N 4-fluorobutanoic acid Chemical compound OC(=O)CCCF BDXSWIQVLYXSSU-UHFFFAOYSA-N 0.000 description 1
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 description 1
- LJMXTWXGOCCHQO-UHFFFAOYSA-N 4-hydroxy-6-oxo-1H-pyrimidine-5-carbaldehyde Chemical compound OC1=NC=NC(O)=C1C=O LJMXTWXGOCCHQO-UHFFFAOYSA-N 0.000 description 1
- 125000004203 4-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- XEUDPJHDTZGULF-UHFFFAOYSA-N 4-imidazol-1-yl-2-methylaniline Chemical compound C1=C(N)C(C)=CC(N2C=NC=C2)=C1 XEUDPJHDTZGULF-UHFFFAOYSA-N 0.000 description 1
- UBFOGYOZJJDMOL-UHFFFAOYSA-N 4-iodo-3-(4-methyl-6-morpholin-4-yl-1H-benzimidazol-2-yl)-1H-pyridin-2-one Chemical compound N=1C=2C(C)=CC(N3CCOCC3)=CC=2NC=1C1=C(I)C=CNC1=O UBFOGYOZJJDMOL-UHFFFAOYSA-N 0.000 description 1
- HPRVXWPAWSSOMR-UHFFFAOYSA-N 5-(5,6-dihydro-4h-pyrimidin-1-yl)-3-methyl-2-nitroaniline Chemical compound NC1=C([N+]([O-])=O)C(C)=CC(N2C=NCCC2)=C1 HPRVXWPAWSSOMR-UHFFFAOYSA-N 0.000 description 1
- ZLPRWLHUUASVPV-INIZCTEOSA-N 5-bromo-3-[6-(2-bromoimidazol-1-yl)-4-methyl-1H-benzimidazol-2-yl]-4-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-1H-pyridin-2-one Chemical compound C([C@@H](CO)NC1=C(C(NC=C1Br)=O)C=1NC=2C=C(C=C(C=2N=1)C)N1C(=NC=C1)Br)C1=CC=CC=C1 ZLPRWLHUUASVPV-INIZCTEOSA-N 0.000 description 1
- UOFSLKHZOPVGHG-UHFFFAOYSA-N 5-bromo-3-methylbenzene-1,2-diamine Chemical compound CC1=CC(Br)=CC(N)=C1N UOFSLKHZOPVGHG-UHFFFAOYSA-N 0.000 description 1
- PLKVXIMOJPBLCA-FYZOBXCZSA-N 6-[(1s)-2-amino-1-hydroxyethyl]-4-chloro-3h-1,3-benzoxazol-2-one;hydrochloride Chemical compound Cl.NC[C@@H](O)C1=CC(Cl)=C2NC(=O)OC2=C1 PLKVXIMOJPBLCA-FYZOBXCZSA-N 0.000 description 1
- ZSFCIPWQGQXIQO-UHFFFAOYSA-N 6-[[[3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-2-oxo-1H-pyridin-4-yl]amino]methyl]pyridine-3-carbonitrile Chemical compound N=1C=2C(C)=CC(N3C=NC=C3)=CC=2NC=1C(C(NC=C1)=O)=C1NCC1=CC=C(C#N)C=N1 ZSFCIPWQGQXIQO-UHFFFAOYSA-N 0.000 description 1
- RFKKTMYPGJBLAW-UHFFFAOYSA-N 6-bromo-2-(4-iodo-2-methoxypyridin-3-yl)-4-methyl-1h-benzimidazole Chemical compound COC1=NC=CC(I)=C1C1=NC2=C(C)C=C(Br)C=C2N1 RFKKTMYPGJBLAW-UHFFFAOYSA-N 0.000 description 1
- MNIGGBVDMSDBFY-UHFFFAOYSA-N 6-imidazol-1-yl-4-methyl-1H-benzimidazole Chemical compound CC1=CC(=CC2=C1N=CN2)N3C=CN=C3 MNIGGBVDMSDBFY-UHFFFAOYSA-N 0.000 description 1
- WDYVUKGVKRZQNM-UHFFFAOYSA-N 6-phosphonohexylphosphonic acid Chemical compound OP(O)(=O)CCCCCCP(O)(O)=O WDYVUKGVKRZQNM-UHFFFAOYSA-N 0.000 description 1
- STQGQHZAVUOBTE-UHFFFAOYSA-N 7-Cyan-hept-2t-en-4,6-diinsaeure Natural products C1=2C(O)=C3C(=O)C=4C(OC)=CC=CC=4C(=O)C3=C(O)C=2CC(O)(C(C)=O)CC1OC1CC(N)C(O)C(C)O1 STQGQHZAVUOBTE-UHFFFAOYSA-N 0.000 description 1
- OGQJUUDUDBPFTC-HNNXBMFYSA-N 7-bromo-2-[4-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-2-oxo-1H-pyridin-3-yl]-3H-benzimidazole-5-carbonitrile Chemical compound C([C@@H](CO)NC1=C(C(=O)NC=C1)C=1NC2=CC(=CC(Br)=C2N=1)C#N)C1=CC=CC=C1 OGQJUUDUDBPFTC-HNNXBMFYSA-N 0.000 description 1
- VCMAXSVDUZTIHP-HNNXBMFYSA-N 7-bromo-2-[4-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-2-oxo-1H-pyridin-3-yl]-N'-methyl-3H-benzimidazole-5-carboximidamide Chemical compound C\N=C(/N)C1=CC(Br)=C2N=C(NC2=C1)C1=C(N[C@H](CO)CC2=CC=CC=C2)C=CNC1=O VCMAXSVDUZTIHP-HNNXBMFYSA-N 0.000 description 1
- FIPITWKHEBNFHN-QGZVFWFLSA-N 7-bromo-2-[4-[[(2S)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]-2-oxo-1H-pyridin-3-yl]-3H-benzimidazole-5-carbaldehyde Chemical compound C1([C@@H](CNC2=C(C(=O)NC=C2)C=2NC3=CC(C=O)=CC(Br)=C3N=2)O)=CC=CC(Cl)=C1 FIPITWKHEBNFHN-QGZVFWFLSA-N 0.000 description 1
- HMYNJUJZRRBRLB-UHFFFAOYSA-N 7-chloro-1-methyl-2,3-dihydroindole Chemical compound C1=CC(Cl)=C2N(C)CCC2=C1 HMYNJUJZRRBRLB-UHFFFAOYSA-N 0.000 description 1
- GAUXADQEFOBODG-UHFFFAOYSA-N 7-chloro-2-[4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-2-oxo-1H-pyridin-3-yl]-3H-benzimidazole-5-carboxamide Chemical compound N1C2=CC(C(=O)N)=CC(Cl)=C2N=C1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(Cl)=C1 GAUXADQEFOBODG-UHFFFAOYSA-N 0.000 description 1
- BNYBREMGROLTRW-UHFFFAOYSA-N 7-chloro-2-[4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-2-oxo-1H-pyridin-3-yl]-3H-benzimidazole-5-carboxylic acid Chemical compound C1=CNC(=O)C(C=2NC3=CC(=CC(Cl)=C3N=2)C(O)=O)=C1NCC(O)C1=CC=CC(Cl)=C1 BNYBREMGROLTRW-UHFFFAOYSA-N 0.000 description 1
- PFNSRAOGLJNNLD-UHFFFAOYSA-N 7-chloro-5-(2-chloroacetyl)-1,3-dihydroindol-2-one Chemical compound ClC1=CC(C(=O)CCl)=CC2=C1NC(=O)C2 PFNSRAOGLJNNLD-UHFFFAOYSA-N 0.000 description 1
- RUNZJLGYLVIHCI-SFHVURJKSA-N 7-ethyl-2-[4-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-2-oxo-1H-pyridin-3-yl]-N'-methyl-3H-benzimidazole-5-carboximidamide Chemical compound C([C@@H](CO)NC1=C(C(NC=C1)=O)C=1NC=2C=C(C=C(C=2N=1)CC)C(=N)NC)C1=CC=CC=C1 RUNZJLGYLVIHCI-SFHVURJKSA-N 0.000 description 1
- OLLXKFPICSTCGH-UHFFFAOYSA-N 7-methyl-2-[2-oxo-4-(pyridin-2-ylmethylamino)-1H-pyridin-3-yl]-3H-benzimidazole-5-carbonitrile Chemical compound N=1C=2C(C)=CC(C#N)=CC=2NC=1C(C(NC=C1)=O)=C1NCC1=CC=CC=N1 OLLXKFPICSTCGH-UHFFFAOYSA-N 0.000 description 1
- 208000030507 AIDS Diseases 0.000 description 1
- 206010065040 AIDS dementia complex Diseases 0.000 description 1
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- 208000036762 Acute promyelocytic leukaemia Diseases 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 206010003571 Astrocytoma Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- FIPWRIJSWJWJAI-UHFFFAOYSA-N Butyl carbitol 6-propylpiperonyl ether Chemical compound C1=C(CCC)C(COCCOCCOCCCC)=CC2=C1OCO2 FIPWRIJSWJWJAI-UHFFFAOYSA-N 0.000 description 1
- 229910014033 C-OH Inorganic materials 0.000 description 1
- DXVNCWKCOQCJHN-UHFFFAOYSA-N C1=CC=C(C=C1)CCNN2C=CC=CC2=O Chemical compound C1=CC=C(C=C1)CCNN2C=CC=CC2=O DXVNCWKCOQCJHN-UHFFFAOYSA-N 0.000 description 1
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 description 1
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 description 1
- HUGIXRXICQWJCO-UHFFFAOYSA-N C=CCC(CNN1C=CC=CC1=O)(C2=CC=CC=C2)C3=CC=CC=N3 Chemical compound C=CCC(CNN1C=CC=CC1=O)(C2=CC=CC=C2)C3=CC=CC=N3 HUGIXRXICQWJCO-UHFFFAOYSA-N 0.000 description 1
- MXEPQTLMUKLYCH-UHFFFAOYSA-N CC1=CC(=CC2=C1N=C(N2)C3=C(C=CNC3=O)NCC(C4=CC(=CC=C4)SCCl)O)N5CCNCC5 Chemical compound CC1=CC(=CC2=C1N=C(N2)C3=C(C=CNC3=O)NCC(C4=CC(=CC=C4)SCCl)O)N5CCNCC5 MXEPQTLMUKLYCH-UHFFFAOYSA-N 0.000 description 1
- IERWEDCKVOTFAC-UHFFFAOYSA-N CC1=CC(=CC2=C1N=C(N2)C3=C(C=CNC3=O)NCC(C4=CC=CC=C4Br)O)C(=NC)N Chemical compound CC1=CC(=CC2=C1N=C(N2)C3=C(C=CNC3=O)NCC(C4=CC=CC=C4Br)O)C(=NC)N IERWEDCKVOTFAC-UHFFFAOYSA-N 0.000 description 1
- SHVPBTBCSXMRAY-INIZCTEOSA-N CC1=CC(=CC2=C1N=C(N2)C3=C(C=CNC3=O)NC[C@@H](CO)C4=CC(=CC=C4)Cl)C#N Chemical compound CC1=CC(=CC2=C1N=C(N2)C3=C(C=CNC3=O)NC[C@@H](CO)C4=CC(=CC=C4)Cl)C#N SHVPBTBCSXMRAY-INIZCTEOSA-N 0.000 description 1
- ONSQKETWTOYSEK-RUZDIDTESA-N CC1=CC(=CC2=C1N=C(N2)C3=C(C=CNC3=O)NC[C@H](C4=CC=CC=C4)NS(=O)(=O)C5=CC=CC=C5S(=O)(=O)C)N6C=CN=C6 Chemical compound CC1=CC(=CC2=C1N=C(N2)C3=C(C=CNC3=O)NC[C@H](C4=CC=CC=C4)NS(=O)(=O)C5=CC=CC=C5S(=O)(=O)C)N6C=CN=C6 ONSQKETWTOYSEK-RUZDIDTESA-N 0.000 description 1
- 101100439046 Caenorhabditis elegans cdk-2 gene Proteins 0.000 description 1
- 206010058019 Cancer Pain Diseases 0.000 description 1
- CKDWPUIZGOQOOM-UHFFFAOYSA-N Carbamyl chloride Chemical compound NC(Cl)=O CKDWPUIZGOQOOM-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 201000003883 Cystic fibrosis Diseases 0.000 description 1
- 229910014570 C—OH Inorganic materials 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- 235000017274 Diospyros sandwicensis Nutrition 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 201000006107 Familial adenomatous polyposis Diseases 0.000 description 1
- 201000008808 Fibrosarcoma Diseases 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 1
- 208000022072 Gallbladder Neoplasms Diseases 0.000 description 1
- 208000032612 Glial tumor Diseases 0.000 description 1
- 206010018338 Glioma Diseases 0.000 description 1
- BLCLNMBMMGCOAS-URPVMXJPSA-N Goserelin Chemical compound C([C@@H](C(=O)N[C@H](COC(C)(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1[C@@H](CCC1)C(=O)NNC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 BLCLNMBMMGCOAS-URPVMXJPSA-N 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 229910004373 HOAc Inorganic materials 0.000 description 1
- 208000023661 Haematological disease Diseases 0.000 description 1
- 208000017604 Hodgkin disease Diseases 0.000 description 1
- 208000021519 Hodgkin lymphoma Diseases 0.000 description 1
- 208000010747 Hodgkins lymphoma Diseases 0.000 description 1
- 241000701806 Human papillomavirus Species 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- 102000038455 IGF Type 1 Receptor Human genes 0.000 description 1
- 108010031794 IGF Type 1 Receptor Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 description 1
- 208000007766 Kaposi sarcoma Diseases 0.000 description 1
- 206010023347 Keratoacanthoma Diseases 0.000 description 1
- 241000282838 Lama Species 0.000 description 1
- UXBPQRGCVJOTNT-COBSGTNCSA-N Levomethadyl acetate hydrochloride Chemical compound Cl.C=1C=CC=CC=1C(C[C@H](C)N(C)C)([C@@H](OC(C)=O)CC)C1=CC=CC=C1 UXBPQRGCVJOTNT-COBSGTNCSA-N 0.000 description 1
- 229940110339 Long-acting muscarinic antagonist Drugs 0.000 description 1
- 102000036243 Lymphocyte Specific Protein Tyrosine Kinase p56(lck) Human genes 0.000 description 1
- 108010002481 Lymphocyte Specific Protein Tyrosine Kinase p56(lck) Proteins 0.000 description 1
- 239000007993 MOPS buffer Substances 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 201000003793 Myelodysplastic syndrome Diseases 0.000 description 1
- 208000007201 Myocardial reperfusion injury Diseases 0.000 description 1
- MNAYGXUFVCZGOX-IBGZPJMESA-N N'-cyclopropyl-2-[4-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-2-oxo-1H-pyridin-3-yl]-7-methyl-3H-benzimidazole-5-carboximidamide Chemical compound C([C@@H](CO)NC1=C(C(NC=C1)=O)C=1NC=2C=C(C=C(C=2N=1)C)C(=N)NC1CC1)C1=CC=CC=C1 MNAYGXUFVCZGOX-IBGZPJMESA-N 0.000 description 1
- XNWCYGITZGOXDF-SFHVURJKSA-N N'-ethyl-2-[4-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-2-oxo-1H-pyridin-3-yl]-7-methyl-3H-benzimidazole-5-carboximidamide Chemical compound C([C@@H](CO)NC1=C(C(NC=C1)=O)C1=NC2=C(C)C=C(C=C2N1)C(=N)NCC)C1=CC=CC=C1 XNWCYGITZGOXDF-SFHVURJKSA-N 0.000 description 1
- KKRYSASMXUROSL-AREMUKBSSA-N N-[(1S)-2-[[3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-2-oxo-1H-pyridin-4-yl]amino]-1-phenylethyl]benzenesulfonamide Chemical compound N([C@H](CNC1=C(C(NC=C1)=O)C=1NC=2C=C(C=C(C=2N=1)C)N1C=NC=C1)C=1C=CC=CC=1)S(=O)(=O)C1=CC=CC=C1 KKRYSASMXUROSL-AREMUKBSSA-N 0.000 description 1
- YWHHSWMWZMNRTF-JOCHJYFZSA-N N-[(1S)-2-[[3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-2-oxo-1H-pyridin-4-yl]amino]-1-phenylethyl]ethanesulfonamide Chemical compound C([C@@H](NS(=O)(=O)CC)C=1C=CC=CC=1)NC=1C=CNC(=O)C=1C(NC1=C2)=NC1=C(C)C=C2N1C=CN=C1 YWHHSWMWZMNRTF-JOCHJYFZSA-N 0.000 description 1
- QKBUDEHLHMPUOI-UHFFFAOYSA-N N-[1-[2-[4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-2-oxo-1H-pyridin-3-yl]-7-methyl-3H-benzimidazol-5-yl]piperidin-4-yl]acetamide Chemical compound C1CC(NC(=O)C)CCN1C1=CC(C)=C(N=C(N2)C=3C(NC=CC=3NCC(O)C=3C=C(Cl)C=CC=3)=O)C2=C1 QKBUDEHLHMPUOI-UHFFFAOYSA-N 0.000 description 1
- GJYIWCHGKUFIPE-UHFFFAOYSA-N N-[2-[4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-2-oxo-1H-pyridin-3-yl]-7-methyl-3H-benzimidazol-5-yl]acetamide Chemical compound N1C2=CC(NC(=O)C)=CC(C)=C2N=C1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(Cl)=C1 GJYIWCHGKUFIPE-UHFFFAOYSA-N 0.000 description 1
- MQBBUXGZHJORCJ-UHFFFAOYSA-N N-[2-[[3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-2-oxo-1H-pyridin-4-yl]amino]ethyl]acetamide Chemical compound C1=CNC(=O)C(C=2NC3=CC(=CC(C)=C3N=2)N2C=NC=C2)=C1NCCNC(=O)C MQBBUXGZHJORCJ-UHFFFAOYSA-N 0.000 description 1
- GCAMRZPKDHYAEX-UHFFFAOYSA-N N-[2-chloro-4-[1-hydroxy-2-[[3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-2-oxo-1H-pyridin-4-yl]amino]ethyl]phenyl]-2,2-dimethylpropanamide Chemical compound N=1C=2C(C)=CC(N3C=NC=C3)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(O)C1=CC=C(NC(=O)C(C)(C)C)C(Cl)=C1 GCAMRZPKDHYAEX-UHFFFAOYSA-N 0.000 description 1
- MDRORWHOQARRJH-UHFFFAOYSA-N N-[2-chloro-5-[1-hydroxy-2-[[3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-2-oxo-1H-pyridin-4-yl]amino]ethyl]phenyl]methanesulfonamide Chemical compound N=1C=2C(C)=CC(N3C=NC=C3)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(O)C1=CC=C(Cl)C(NS(C)(=O)=O)=C1 MDRORWHOQARRJH-UHFFFAOYSA-N 0.000 description 1
- HJWTWERGJYRSHC-UHFFFAOYSA-N N-[3-[1-hydroxy-2-[[3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-2-oxo-1H-pyridin-4-yl]amino]ethyl]phenyl]-4-methylbenzenesulfonamide Chemical compound C1=CC(C)=CC=C1S(=O)(=O)NC1=CC=CC(C(O)CNC2=C(C(=O)NC=C2)C=2NC3=CC(=CC(C)=C3N=2)N2C=NC=C2)=C1 HJWTWERGJYRSHC-UHFFFAOYSA-N 0.000 description 1
- KGPHAVHYBUPPJS-UHFFFAOYSA-N N-[5-[1-hydroxy-2-[[3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-2-oxo-1H-pyridin-4-yl]amino]ethyl]-2-methoxyphenyl]methanesulfonamide Chemical compound C1=C(NS(C)(=O)=O)C(OC)=CC=C1C(O)CNC1=C(C=2NC3=CC(=CC(C)=C3N=2)N2C=NC=C2)C(=O)NC=C1 KGPHAVHYBUPPJS-UHFFFAOYSA-N 0.000 description 1
- ZDOFPAXWWSBWQC-UHFFFAOYSA-N N-[[6-[[[3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-2-oxo-1H-pyridin-4-yl]amino]methyl]pyridin-2-yl]methyl]formamide Chemical compound N=1C=2C(C)=CC(N3C=NC=C3)=CC=2NC=1C(C(NC=C1)=O)=C1NCC1=CC=CC(CNC=O)=N1 ZDOFPAXWWSBWQC-UHFFFAOYSA-N 0.000 description 1
- 206010029260 Neuroblastoma Diseases 0.000 description 1
- 208000009905 Neurofibromatoses Diseases 0.000 description 1
- 101100030361 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) pph-3 gene Proteins 0.000 description 1
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 206010033128 Ovarian cancer Diseases 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- 108091008606 PDGF receptors Proteins 0.000 description 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 101150003085 Pdcl gene Proteins 0.000 description 1
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 1
- 102000011653 Platelet-Derived Growth Factor Receptors Human genes 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 208000007014 Retinitis pigmentosa Diseases 0.000 description 1
- 108050002653 Retinoblastoma protein Proteins 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 201000010208 Seminoma Diseases 0.000 description 1
- 241000580858 Simian-Human immunodeficiency virus Species 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 206010041067 Small cell lung cancer Diseases 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 208000024770 Thyroid neoplasm Diseases 0.000 description 1
- 206010052779 Transplant rejections Diseases 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 201000006083 Xeroderma Pigmentosum Diseases 0.000 description 1
- REVGZYVUKWXWSK-UHFFFAOYSA-N [2-[4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-2-oxo-1H-pyridin-3-yl]-7-methyl-3H-benzimidazol-5-yl]urea Chemical compound N=1C=2C(C)=CC(NC(N)=O)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(Cl)=C1 REVGZYVUKWXWSK-UHFFFAOYSA-N 0.000 description 1
- 230000001594 aberrant effect Effects 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 125000000641 acridinyl group Chemical group C1(=CC=CC2=NC3=CC=CC=C3C=C12)* 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 150000001263 acyl chlorides Chemical class 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 125000004457 alkyl amino carbonyl group Chemical group 0.000 description 1
- 125000004448 alkyl carbonyl group Chemical group 0.000 description 1
- 230000002152 alkylating effect Effects 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 150000001414 amino alcohols Chemical class 0.000 description 1
- 125000005365 aminothiol group Chemical group 0.000 description 1
- 238000005915 ammonolysis reaction Methods 0.000 description 1
- 206010002026 amyotrophic lateral sclerosis Diseases 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000002491 angiogenic effect Effects 0.000 description 1
- 238000002399 angioplasty Methods 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003217 anti-cancerogenic effect Effects 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 229940076005 apoptosis modulator Drugs 0.000 description 1
- 230000005735 apoptotic response Effects 0.000 description 1
- 239000012223 aqueous fraction Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- VSRXQHXAPYXROS-UHFFFAOYSA-N azanide;cyclobutane-1,1-dicarboxylic acid;platinum(2+) Chemical compound [NH2-].[NH2-].[Pt+2].OC(=O)C1(C(O)=O)CCC1 VSRXQHXAPYXROS-UHFFFAOYSA-N 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 125000002047 benzodioxolyl group Chemical group O1OC(C2=C1C=CC=C2)* 0.000 description 1
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000004619 benzopyranyl group Chemical group O1C(C=CC2=C1C=CC=C2)* 0.000 description 1
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000004935 benzoxazolinyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 description 1
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 1
- IROMZPCBNQNJFR-UHFFFAOYSA-N benzyl N-[2-[[3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-2-oxo-1H-pyridin-4-yl]amino]ethyl]carbamate Chemical compound N=1C=2C(C)=CC(N3C=NC=C3)=CC=2NC=1C(C(NC=C1)=O)=C1NCCNC(=O)OCC1=CC=CC=C1 IROMZPCBNQNJFR-UHFFFAOYSA-N 0.000 description 1
- KCXMKQUNVWSEMD-UHFFFAOYSA-N benzyl chloride Chemical compound ClCC1=CC=CC=C1 KCXMKQUNVWSEMD-UHFFFAOYSA-N 0.000 description 1
- 229940073608 benzyl chloride Drugs 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- SIPUZPBQZHNSDW-UHFFFAOYSA-N bis(2-methylpropyl)aluminum Chemical compound CC(C)C[Al]CC(C)C SIPUZPBQZHNSDW-UHFFFAOYSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000007767 bonding agent Substances 0.000 description 1
- ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 230000005587 bubbling Effects 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- SASIATPWJJLYRR-UHFFFAOYSA-N butanoic acid;hexane Chemical compound CCCCCC.CCCC(O)=O SASIATPWJJLYRR-UHFFFAOYSA-N 0.000 description 1
- 125000004369 butenyl group Chemical group C(=CCC)* 0.000 description 1
- 125000000480 butynyl group Chemical group [*]C#CC([H])([H])C([H])([H])[H] 0.000 description 1
- 239000003560 cancer drug Substances 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 1
- 125000000609 carbazolyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3NC12)* 0.000 description 1
- 125000001589 carboacyl group Chemical group 0.000 description 1
- 229960004562 carboplatin Drugs 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical group 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 238000001516 cell proliferation assay Methods 0.000 description 1
- 108091092328 cellular RNA Proteins 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 201000004559 cerebral degeneration Diseases 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 210000003679 cervix uteri Anatomy 0.000 description 1
- VVIPLSCLYCWUQT-XMMPIXPASA-N chembl1094164 Chemical compound C1([C@H](O)CNC2=C(C(NC=C2)=O)C=2NC=3C=C(C=C(C=3N=2)C)N2CCN(CCC#N)CC2)=CC=CC(Cl)=C1 VVIPLSCLYCWUQT-XMMPIXPASA-N 0.000 description 1
- VUVAXIBXIAPBBM-XMMPIXPASA-N chembl1094458 Chemical compound C1([C@H](O)CNC2=C(C(NC=C2)=O)C=2NC=3C=C(C=C(C=3N=2)C)N2CCN(CCCF)CC2)=CC=CC(Cl)=C1 VUVAXIBXIAPBBM-XMMPIXPASA-N 0.000 description 1
- UIUYQDFIVJOTTH-OAQYLSRUSA-N chembl1097357 Chemical compound C1([C@H](O)CNC2=C(C(NC=C2)=O)C=2NC=3C=C(C=C(C=3N=2)C)N2CCNCC2)=CC=CC(Cl)=C1 UIUYQDFIVJOTTH-OAQYLSRUSA-N 0.000 description 1
- UXGODHMBZZMTNL-HSZRJFAPSA-N chembl1098712 Chemical compound C1CN(C(=O)COC)CCN1C1=CC(C)=C(N=C(N2)C=3C(NC=CC=3NC[C@@H](O)C=3C=C(Cl)C=CC=3)=O)C2=C1 UXGODHMBZZMTNL-HSZRJFAPSA-N 0.000 description 1
- IQSICYGTAPFFKF-UHFFFAOYSA-N chembl230042 Chemical compound N=1C=2C(C)=CC(C=3NCC(C)(C)N=3)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(Cl)=C1 IQSICYGTAPFFKF-UHFFFAOYSA-N 0.000 description 1
- ULETZFIZUULMSQ-QFIPXVFZSA-N chembl230205 Chemical compound C([C@@H](CO)NC1=C(C(NC=C1)=O)C=1NC=2C=C(C=C(C=2N=1)C)C=1C=CC=CC=1)C1=CC=CC=C1 ULETZFIZUULMSQ-QFIPXVFZSA-N 0.000 description 1
- IOGLBSDFFVZJBQ-UHFFFAOYSA-N chembl231002 Chemical compound N=1C=2C(C)=CC(N3C=NC=C3)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(C(F)(F)F)=C1 IOGLBSDFFVZJBQ-UHFFFAOYSA-N 0.000 description 1
- PQCIBFPSJBDHRR-UHFFFAOYSA-N chembl231003 Chemical compound COC1=CC=CC(C(O)CNC2=C(C(=O)NC=C2)C=2NC3=CC(=CC(C)=C3N=2)N2C=NC=C2)=C1 PQCIBFPSJBDHRR-UHFFFAOYSA-N 0.000 description 1
- UNYMWSTWKGIIOC-UHFFFAOYSA-N chembl231110 Chemical compound C1=CC(OC)=CC=C1C(O)CNC1=C(C=2NC3=CC(=CC(C)=C3N=2)N2C=NC=C2)C(=O)NC=C1 UNYMWSTWKGIIOC-UHFFFAOYSA-N 0.000 description 1
- NOTYZJDDBQLRNQ-SFHVURJKSA-N chembl245306 Chemical compound C([C@@H](CO)NC1=C(C(NC=C1)=O)C=1NC=2C=C(C=C(C=2N=1)C)N1C=NC=C1)C1=CC=C(Cl)C=C1 NOTYZJDDBQLRNQ-SFHVURJKSA-N 0.000 description 1
- YMNYMZKUEWAODC-SFHVURJKSA-N chembl245513 Chemical compound C1=CC(OC)=CC=C1C[C@@H](CO)NC1=C(C=2NC3=CC(=CC(C)=C3N=2)N2C=NC=C2)C(=O)NC=C1 YMNYMZKUEWAODC-SFHVURJKSA-N 0.000 description 1
- RTNGMZGXZKCZEF-UHFFFAOYSA-N chembl245567 Chemical compound N=1C=2C(C)=CC(N3C=NC=C3)=CC=2NC=1C(C(NC=C1)=O)=C1NCC1=CC=CS1 RTNGMZGXZKCZEF-UHFFFAOYSA-N 0.000 description 1
- DJXOQVPIGHGJIJ-UHFFFAOYSA-N chembl387611 Chemical compound CN1CCN=C1C1=CC(C)=C(N=C(N2)C=3C(NC=CC=3NCC(O)C=3C=C(Cl)C=CC=3)=O)C2=C1 DJXOQVPIGHGJIJ-UHFFFAOYSA-N 0.000 description 1
- GTKSBZJIGPPPTB-UHFFFAOYSA-N chembl387823 Chemical compound N=1C=2C(C)=CC(N3C=NC=C3)=CC=2NC=1C(C(NC=C1)=O)=C1NCC(O)C1=CC=C(NS(C)(=O)=O)C=C1 GTKSBZJIGPPPTB-UHFFFAOYSA-N 0.000 description 1
- ITUXVMIFNQWGDA-UHFFFAOYSA-N chembl392031 Chemical compound N=1C=2C(C)=CC(N3C=NC=C3)=CC=2NC=1C(C(NC=C1)=O)=C1NCCC1=CC=CC=N1 ITUXVMIFNQWGDA-UHFFFAOYSA-N 0.000 description 1
- KMBRBXVSEQBPJL-UHFFFAOYSA-N chembl393888 Chemical compound N=1C=2C(C)=CC(N3C=NC=C3)=CC=2NC=1C(C(NC=C1)=O)=C1NCC1=CC=CN=C1 KMBRBXVSEQBPJL-UHFFFAOYSA-N 0.000 description 1
- WGPYWDLNUPWWNN-UHFFFAOYSA-N chembl425819 Chemical compound N1C2=CC(C(=N)NC)=CC(C)=C2N=C1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(Cl)=C1 WGPYWDLNUPWWNN-UHFFFAOYSA-N 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 238000012602 chemosensitivity assay Methods 0.000 description 1
- 238000004296 chiral HPLC Methods 0.000 description 1
- JCKYGMPEJWAADB-UHFFFAOYSA-N chlorambucil Chemical compound OC(=O)CCCC1=CC=C(N(CCCl)CCCl)C=C1 JCKYGMPEJWAADB-UHFFFAOYSA-N 0.000 description 1
- 229960004630 chlorambucil Drugs 0.000 description 1
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 1
- 208000029664 classic familial adenomatous polyposis Diseases 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 238000007398 colorimetric assay Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 239000002875 cyclin dependent kinase inhibitor Substances 0.000 description 1
- WDMPXBQEGRZZNA-UHFFFAOYSA-N cyclopentylazanide Chemical compound [NH-]C1CCCC1 WDMPXBQEGRZZNA-UHFFFAOYSA-N 0.000 description 1
- HWDVTQAXQJQROO-UHFFFAOYSA-N cyclopropylazanide Chemical compound [NH-]C1CC1 HWDVTQAXQJQROO-UHFFFAOYSA-N 0.000 description 1
- UWFYSQMTEOIJJG-FDTZYFLXSA-N cyproterone acetate Chemical compound C1=C(Cl)C2=CC(=O)[C@@H]3C[C@@H]3[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 UWFYSQMTEOIJJG-FDTZYFLXSA-N 0.000 description 1
- 229960000978 cyproterone acetate Drugs 0.000 description 1
- STQGQHZAVUOBTE-VGBVRHCVSA-N daunorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(C)=O)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 STQGQHZAVUOBTE-VGBVRHCVSA-N 0.000 description 1
- 229960000975 daunorubicin Drugs 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 125000001664 diethylamino group Chemical group [H]C([H])([H])C([H])([H])N(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000000723 dihydrobenzofuranyl group Chemical group O1C(CC2=C1C=CC=C2)* 0.000 description 1
- 125000004611 dihydroisoindolyl group Chemical group C1(NCC2=CC=CC=C12)* 0.000 description 1
- MKRTXPORKIRPDG-UHFFFAOYSA-N diphenylphosphoryl azide Chemical compound C=1C=CC=CC=1P(=O)(N=[N+]=[N-])C1=CC=CC=C1 MKRTXPORKIRPDG-UHFFFAOYSA-N 0.000 description 1
- PFOJBYJEHUXUMR-UHFFFAOYSA-N ditert-butyl 2-(3,5-difluoro-2-nitrophenyl)propanedioate Chemical compound CC(C)(C)OC(=O)C(C(=O)OC(C)(C)C)C1=CC(F)=CC(F)=C1[N+]([O-])=O PFOJBYJEHUXUMR-UHFFFAOYSA-N 0.000 description 1
- BPKIDOZPXURPKQ-UHFFFAOYSA-N ditert-butyl 2-(3-amino-5-fluoro-2-nitrophenyl)propanedioate Chemical compound CC(C)(C)OC(=O)C(C(=O)OC(C)(C)C)C1=CC(F)=CC(N)=C1[N+]([O-])=O BPKIDOZPXURPKQ-UHFFFAOYSA-N 0.000 description 1
- CLPHAYNBNTVRDI-UHFFFAOYSA-N ditert-butyl propanedioate Chemical compound CC(C)(C)OC(=O)CC(=O)OC(C)(C)C CLPHAYNBNTVRDI-UHFFFAOYSA-N 0.000 description 1
- CNXMDTWQWLGCPE-UHFFFAOYSA-N ditert-butyl-(2-phenylphenyl)phosphane Chemical group CC(C)(C)P(C(C)(C)C)C1=CC=CC=C1C1=CC=CC=C1 CNXMDTWQWLGCPE-UHFFFAOYSA-N 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000009510 drug design Methods 0.000 description 1
- 238000007876 drug discovery Methods 0.000 description 1
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 201000004101 esophageal cancer Diseases 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 125000005678 ethenylene group Chemical group [H]C([*:1])=C([H])[*:2] 0.000 description 1
- XBVPZBSKWUHVSE-LJQANCHMSA-N ethyl 2-[4-[[(2S)-2-hydroxy-2-phenylethyl]amino]-2-oxo-1H-pyridin-3-yl]-7-methyl-3H-benzimidazole-5-carboxylate Chemical compound C1([C@H](O)CNC2=C(C(NC=C2)=O)C2=NC3=C(C)C=C(C=C3N2)C(=O)OCC)=CC=CC=C1 XBVPZBSKWUHVSE-LJQANCHMSA-N 0.000 description 1
- QOUCWXMIGGUZGO-UHFFFAOYSA-N ethyl 2-[4-[[2-(3-bromophenyl)-2-hydroxyethyl]amino]-2-oxo-1H-pyridin-3-yl]-7-methyl-3H-benzimidazole-5-carboxylate Chemical compound N1C2=CC(C(=O)OCC)=CC(C)=C2N=C1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(Br)=C1 QOUCWXMIGGUZGO-UHFFFAOYSA-N 0.000 description 1
- HQUXISPURYCKBF-UHFFFAOYSA-N ethyl 2-[4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-2-oxo-1H-pyridin-3-yl]-3H-benzimidazole-5-carboxylate Chemical compound N1C2=CC(C(=O)OCC)=CC=C2N=C1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(Cl)=C1 HQUXISPURYCKBF-UHFFFAOYSA-N 0.000 description 1
- NAKKIFWSYKSXLM-UHFFFAOYSA-N ethyl 2-[4-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]-2-oxo-1H-pyridin-3-yl]-7-ethyl-3H-benzimidazole-5-carboxylate Chemical compound N1C2=CC(C(=O)OCC)=CC(CC)=C2N=C1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(Cl)=C1 NAKKIFWSYKSXLM-UHFFFAOYSA-N 0.000 description 1
- RCZVUDYCOBPNAC-UHFFFAOYSA-N ethyl 2-[4-[[2-(3-fluorophenyl)-2-hydroxyethyl]amino]-2-oxo-1H-pyridin-3-yl]-7-methyl-3H-benzimidazole-5-carboxylate Chemical compound N1C2=CC(C(=O)OCC)=CC(C)=C2N=C1C(C(NC=C1)=O)=C1NCC(O)C1=CC=CC(F)=C1 RCZVUDYCOBPNAC-UHFFFAOYSA-N 0.000 description 1
- OQVVZKBQDYDKMD-INIZCTEOSA-N ethyl 7-bromo-2-[4-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-2-oxo-1H-pyridin-3-yl]-3H-benzimidazole-5-carboxylate Chemical compound C([C@@H](CO)NC1=C(C(NC=C1)=O)C1=NC2=C(Br)C=C(C=C2N1)C(=O)OCC)C1=CC=CC=C1 OQVVZKBQDYDKMD-INIZCTEOSA-N 0.000 description 1
- DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 210000001650 focal adhesion Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000001640 fractional crystallisation Methods 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 201000010175 gallbladder cancer Diseases 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 229960002913 goserelin Drugs 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004404 heteroalkyl group Chemical group 0.000 description 1
- 125000006038 hexenyl group Chemical group 0.000 description 1
- 125000005980 hexynyl group Chemical group 0.000 description 1
- 150000004050 homopiperazines Chemical class 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 1
- 230000001969 hypertrophic effect Effects 0.000 description 1
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 description 1
- 125000003037 imidazol-2-yl group Chemical group [H]N1C([*])=NC([H])=C1[H] 0.000 description 1
- 125000002140 imidazol-4-yl group Chemical group [H]N1C([H])=NC([*])=C1[H] 0.000 description 1
- 125000002636 imidazolinyl group Chemical group 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 125000003406 indolizinyl group Chemical group C=1(C=CN2C=CC=CC12)* 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 208000037906 ischaemic injury Diseases 0.000 description 1
- 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000000555 isopropenyl group Chemical group [H]\C([H])=C(\*)C([H])([H])[H] 0.000 description 1
- 125000005956 isoquinolyl group Chemical group 0.000 description 1
- 125000001786 isothiazolyl group Chemical group 0.000 description 1
- 125000000842 isoxazolyl group Chemical group 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- UBJFKNSINUCEAL-UHFFFAOYSA-N lithium;2-methylpropane Chemical compound [Li+].C[C-](C)C UBJFKNSINUCEAL-UHFFFAOYSA-N 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000001589 lymphoproliferative effect Effects 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 230000036210 malignancy Effects 0.000 description 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- OKKJLVBELUTLKV-VMNATFBRSA-N methanol-d1 Chemical compound [2H]OC OKKJLVBELUTLKV-VMNATFBRSA-N 0.000 description 1
- OGNIVUOKSZDWLX-HNNXBMFYSA-N methyl (2S)-3-hydroxy-2-[[3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-2-oxo-1H-pyridin-4-yl]amino]propanoate Chemical compound C1=CNC(=O)C(C=2NC3=CC(=CC(C)=C3N=2)N2C=NC=C2)=C1N[C@@H](CO)C(=O)OC OGNIVUOKSZDWLX-HNNXBMFYSA-N 0.000 description 1
- MGJXBDMLVWIYOQ-UHFFFAOYSA-N methylazanide Chemical compound [NH-]C MGJXBDMLVWIYOQ-UHFFFAOYSA-N 0.000 description 1
- DVSDBMFJEQPWNO-UHFFFAOYSA-N methyllithium Chemical compound C[Li] DVSDBMFJEQPWNO-UHFFFAOYSA-N 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 1
- 125000002757 morpholinyl group Chemical group 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 201000006417 multiple sclerosis Diseases 0.000 description 1
- 210000002346 musculoskeletal system Anatomy 0.000 description 1
- 231100000219 mutagenic Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 208000025113 myeloid leukemia Diseases 0.000 description 1
- 230000002071 myeloproliferative effect Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- GKTNLYAAZKKMTQ-UHFFFAOYSA-N n-[bis(dimethylamino)phosphinimyl]-n-methylmethanamine Chemical compound CN(C)P(=N)(N(C)C)N(C)C GKTNLYAAZKKMTQ-UHFFFAOYSA-N 0.000 description 1
- RWIVICVCHVMHMU-UHFFFAOYSA-N n-aminoethylmorpholine Chemical compound NCCN1CCOCC1 RWIVICVCHVMHMU-UHFFFAOYSA-N 0.000 description 1
- VBEGHXKAFSLLGE-UHFFFAOYSA-N n-phenylnitramide Chemical compound [O-][N+](=O)NC1=CC=CC=C1 VBEGHXKAFSLLGE-UHFFFAOYSA-N 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 230000014399 negative regulation of angiogenesis Effects 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 201000004931 neurofibromatosis Diseases 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 229910000069 nitrogen hydride Inorganic materials 0.000 description 1
- LYGJENNIWJXYER-UHFFFAOYSA-N nitromethane Chemical compound C[N+]([O-])=O LYGJENNIWJXYER-UHFFFAOYSA-N 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000007339 nucleophilic aromatic substitution reaction Methods 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 201000008968 osteosarcoma Diseases 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 238000012261 overproduction Methods 0.000 description 1
- 125000001715 oxadiazolyl group Chemical group 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 125000004043 oxo group Chemical group O=* 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 1
- 125000006503 p-nitrobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1[N+]([O-])=O)C([H])([H])* 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 208000008443 pancreatic carcinoma Diseases 0.000 description 1
- 125000002255 pentenyl group Chemical group C(=CCCC)* 0.000 description 1
- 238000010647 peptide synthesis reaction Methods 0.000 description 1
- 210000001428 peripheral nervous system Anatomy 0.000 description 1
- 125000001792 phenanthrenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3C=CC12)* 0.000 description 1
- 125000004934 phenanthridinyl group Chemical group C1(=CC=CC2=NC=C3C=CC=CC3=C12)* 0.000 description 1
- 125000004625 phenanthrolinyl group Chemical group N1=C(C=CC2=CC=C3C=CC=NC3=C12)* 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- MXVIRUOHPRXGTG-UHFFFAOYSA-N phenylboronic acid Chemical compound OB(O)C1=CC=CC=C1.OB(O)C1=CC=CC=C1 MXVIRUOHPRXGTG-UHFFFAOYSA-N 0.000 description 1
- 125000000286 phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000003395 phenylethylamino group Chemical group [H]N(*)C([H])([H])C([H])([H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- RLOWWWKZYUNIDI-UHFFFAOYSA-N phosphinic chloride Chemical compound ClP=O RLOWWWKZYUNIDI-UHFFFAOYSA-N 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- IVXQBCUBSIPQGU-UHFFFAOYSA-N piperazine-1-carboxamide Chemical compound NC(=O)N1CCNCC1 IVXQBCUBSIPQGU-UHFFFAOYSA-N 0.000 description 1
- 229960005235 piperonyl butoxide Drugs 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 1
- 229940080818 propionamide Drugs 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 125000002568 propynyl group Chemical group [*]C#CC([H])([H])[H] 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 208000005069 pulmonary fibrosis Diseases 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 125000002755 pyrazolinyl group Chemical group 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- 125000002098 pyridazinyl group Chemical group 0.000 description 1
- SHNUBALDGXWUJI-UHFFFAOYSA-N pyridin-2-ylmethanol Chemical compound OCC1=CC=CC=N1 SHNUBALDGXWUJI-UHFFFAOYSA-N 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 125000005493 quinolyl group Chemical group 0.000 description 1
- 201000009410 rhabdomyosarcoma Diseases 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 125000003548 sec-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 208000000649 small cell carcinoma Diseases 0.000 description 1
- 208000000587 small cell lung carcinoma Diseases 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 1
- 229940048086 sodium pyrophosphate Drugs 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000008259 solid foam Substances 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- 238000007614 solvation Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 125000005420 sulfonamido group Chemical group S(=O)(=O)(N*)* 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 201000000596 systemic lupus erythematosus Diseases 0.000 description 1
- 208000001608 teratocarcinoma Diseases 0.000 description 1
- DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 1
- KMOAQSZVVBIWOB-UHFFFAOYSA-N tert-butyl N-[2-hydroxy-3-[[3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-2-oxo-1H-pyridin-4-yl]amino]propyl]carbamate Chemical compound N=1C=2C(C)=CC(N3C=NC=C3)=CC=2NC=1C1=C(NCC(O)CNC(=O)OC(C)(C)C)C=CNC1=O KMOAQSZVVBIWOB-UHFFFAOYSA-N 0.000 description 1
- OPHLZZFLFPQWIH-UHFFFAOYSA-N tert-butyl n-[1-[2-(4-iodo-2-methoxypyridin-3-yl)-7-methyl-3h-benzimidazol-5-yl]piperidin-4-yl]carbamate Chemical compound COC1=NC=CC(I)=C1C1=NC2=C(C)C=C(N3CCC(CC3)NC(=O)OC(C)(C)C)C=C2N1 OPHLZZFLFPQWIH-UHFFFAOYSA-N 0.000 description 1
- CKXZPVPIDOJLLM-UHFFFAOYSA-N tert-butyl n-piperidin-4-ylcarbamate Chemical compound CC(C)(C)OC(=O)NC1CCNCC1 CKXZPVPIDOJLLM-UHFFFAOYSA-N 0.000 description 1
- CWXPZXBSDSIRCS-UHFFFAOYSA-N tert-butyl piperazine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCNCC1 CWXPZXBSDSIRCS-UHFFFAOYSA-N 0.000 description 1
- ZGNPLWZYVAFUNZ-UHFFFAOYSA-N tert-butylphosphane Chemical compound CC(C)(C)P ZGNPLWZYVAFUNZ-UHFFFAOYSA-N 0.000 description 1
- 150000005326 tetrahydropyrimidines Chemical class 0.000 description 1
- VXKWYPOMXBVZSJ-UHFFFAOYSA-N tetramethyltin Chemical compound C[Sn](C)(C)C VXKWYPOMXBVZSJ-UHFFFAOYSA-N 0.000 description 1
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 1
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 125000001113 thiadiazolyl group Chemical group 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- 201000002510 thyroid cancer Diseases 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 208000030901 thyroid gland follicular carcinoma Diseases 0.000 description 1
- GZNAASVAJNXPPW-UHFFFAOYSA-M tin(4+) chloride dihydrate Chemical compound O.O.[Cl-].[Sn+4] GZNAASVAJNXPPW-UHFFFAOYSA-M 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000009901 transfer hydrogenation reaction Methods 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 125000003258 trimethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])[*:1] 0.000 description 1
- JBWKIWSBJXDJDT-UHFFFAOYSA-N triphenylmethyl chloride Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(Cl)C1=CC=CC=C1 JBWKIWSBJXDJDT-UHFFFAOYSA-N 0.000 description 1
- BWHDROKFUHTORW-UHFFFAOYSA-N tritert-butylphosphane Chemical compound CC(C)(C)P(C(C)(C)C)C(C)(C)C BWHDROKFUHTORW-UHFFFAOYSA-N 0.000 description 1
- 230000005747 tumor angiogenesis Effects 0.000 description 1
- 150000004917 tyrosine kinase inhibitor derivatives Chemical class 0.000 description 1
- 125000001493 tyrosinyl group Chemical group [H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- 125000002948 undecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229930195735 unsaturated hydrocarbon Natural products 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 230000006459 vascular development Effects 0.000 description 1
- 238000007631 vascular surgery Methods 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 125000001834 xanthenyl group Chemical group C1=CC=CC=2OC3=CC=CC=C3C(C12)* 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27932701P | 2001-03-28 | 2001-03-28 | |
| PCT/US2002/009402 WO2002079192A1 (en) | 2001-03-28 | 2002-03-26 | Novel tyrosine kinase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK12002003A3 true SK12002003A3 (en) | 2004-10-05 |
Family
ID=23068491
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK12002003A SK12002003A3 (en) | 2001-03-28 | 2002-03-26 | Novel tyrosine kinase inhibitors |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP1381598A4 (enExample) |
| JP (1) | JP2004534010A (enExample) |
| KR (1) | KR20030083016A (enExample) |
| CN (1) | CN1514833A (enExample) |
| AR (1) | AR035804A1 (enExample) |
| BG (1) | BG108206A (enExample) |
| BR (1) | BR0208373A (enExample) |
| CA (1) | CA2442428A1 (enExample) |
| CZ (1) | CZ20032615A3 (enExample) |
| EE (1) | EE200300475A (enExample) |
| GE (1) | GEP20053660B (enExample) |
| HR (1) | HRP20030844A2 (enExample) |
| HU (1) | HUP0400323A2 (enExample) |
| IL (1) | IL158041A0 (enExample) |
| IS (1) | IS6968A (enExample) |
| MX (1) | MXPA03008690A (enExample) |
| NO (1) | NO20034308L (enExample) |
| PE (1) | PE20021015A1 (enExample) |
| PL (1) | PL373300A1 (enExample) |
| RU (1) | RU2003131693A (enExample) |
| SK (1) | SK12002003A3 (enExample) |
| UY (1) | UY27234A1 (enExample) |
| WO (1) | WO2002079192A1 (enExample) |
| YU (1) | YU84603A (enExample) |
| ZA (1) | ZA200307466B (enExample) |
Families Citing this family (61)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7081454B2 (en) * | 2001-03-28 | 2006-07-25 | Bristol-Myers Squibb Co. | Tyrosine kinase inhibitors |
| MXPA04008408A (es) | 2002-03-01 | 2004-11-29 | Squibb Bristol Myers Co | Mamiferos no humanos, transgenicos, que expresan receptores de la tirosina cinasa activados constitutivamente. |
| WO2003106452A2 (en) * | 2002-06-12 | 2003-12-24 | Millennium Pharmaceuticals, Inc. | Antagonists of melanin concentrating hormone receptor |
| US7361691B2 (en) * | 2002-12-02 | 2008-04-22 | Arqule, Inc. | Method of treating cancers using β-lapachone or analogs or derivatives thereof |
| EP1581539A4 (en) * | 2003-01-03 | 2007-09-19 | Bristol Myers Squibb Co | NEW TYROSINE KINASE HEMMER |
| WO2004069160A2 (en) * | 2003-01-28 | 2004-08-19 | Smithkline Beecham Corporation | Chemical compounds |
| US7312215B2 (en) | 2003-07-29 | 2007-12-25 | Bristol-Myers Squibb Company | Benzimidazole C-2 heterocycles as kinase inhibitors |
| WO2005020921A2 (en) | 2003-08-29 | 2005-03-10 | Exelixis, Inc. | C-kit modulators and methods of use |
| US20050075358A1 (en) * | 2003-10-06 | 2005-04-07 | Carboni Joan M. | Methods for treating IGF1R-inhibitor induced hyperglycemia |
| US7572914B2 (en) | 2003-12-19 | 2009-08-11 | Takeda Pharmaceutical Company Limited | Kinase inhibitors |
| DE102004010207A1 (de) | 2004-03-02 | 2005-09-15 | Aventis Pharma S.A. | Neue 4-Benzimidazol-2-yl-pyridazin-3-on-Derivate |
| MXPA06011423A (es) | 2004-04-02 | 2007-01-23 | Osi Pharm Inc | Inhibidores de proteina cinasa heterobiciclica sustituida en el anillo 6,6-biciclico. |
| WO2006023931A2 (en) | 2004-08-18 | 2006-03-02 | Takeda San Diego, Inc. | Kinase inhibitors |
| MX2007007330A (es) * | 2004-12-16 | 2007-10-04 | Vertex Pharma | Piridonas de utilidad como inhibidores de quinasas . |
| US7538113B2 (en) | 2005-02-18 | 2009-05-26 | Wyeth | 4-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor |
| US7534796B2 (en) | 2005-02-18 | 2009-05-19 | Wyeth | Imidazo[4,5-b]pyridine antagonists of gonadotropin releasing hormone receptor |
| US7582634B2 (en) | 2005-02-18 | 2009-09-01 | Wyeth | 7-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor |
| US7531542B2 (en) | 2005-05-18 | 2009-05-12 | Wyeth | Benzooxazole and benzothiazole antagonists of gonadotropin releasing hormone receptor |
| US7582636B2 (en) | 2005-05-26 | 2009-09-01 | Wyeth | Piperazinylimidazopyridine and piperazinyltriazolopyridine antagonists of Gonadotropin Releasing Hormone receptor |
| WO2006130657A2 (en) | 2005-05-31 | 2006-12-07 | Bristol-Myers Squibb Company | Stereoselective reduction process for the preparation of pyrrolotriazine compounds |
| US7855289B2 (en) | 2005-08-04 | 2010-12-21 | Sirtris Pharmaceuticals, Inc. | Sirtuin modulating compounds |
| US7345178B2 (en) | 2005-08-04 | 2008-03-18 | Sirtris Pharmaceuticals, Inc. | Sirtuin modulating compounds |
| US8088928B2 (en) | 2005-08-04 | 2012-01-03 | Sirtris Pharmaceuticals, Inc. | Sirtuin modulating compounds |
| US8093401B2 (en) | 2005-08-04 | 2012-01-10 | Sirtris Pharmaceuticals, Inc. | Sirtuin modulating compounds |
| WO2007027729A1 (en) | 2005-08-29 | 2007-03-08 | Vertex Pharmaceuticals Incorporated | 3, 5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-receptor tyrosine kinases |
| AU2006285038A1 (en) * | 2005-08-29 | 2007-03-08 | Vertex Pharmaceuticals Incorporated | 3,5-disubstituted pyrid-2-ones useful as inhibitors of Tec family of non-receptor tyrosine kinases |
| JP5112317B2 (ja) * | 2005-08-29 | 2013-01-09 | バーテックス ファーマシューティカルズ インコーポレイテッド | 非受容体型チロシンキナーゼのｔｅｃファミリーの阻害剤として有用な３，５−二置換ピリド−２−オン |
| WO2007026720A1 (ja) * | 2005-08-31 | 2007-03-08 | Taisho Pharmaceutical Co., Ltd. | 縮環ピラゾール誘導体 |
| US8575164B2 (en) | 2005-12-19 | 2013-11-05 | OSI Pharmaceuticals, LLC | Combination cancer therapy |
| WO2007145203A1 (ja) * | 2006-06-13 | 2007-12-21 | Daiichi Fine Chemical Co., Ltd. | 光学活性２－アミノ－１－（４－フルオロフェニル）エタノール |
| US8063225B2 (en) | 2006-08-14 | 2011-11-22 | Chembridge Corporation | Tricyclic compound derivatives useful in the treatment of neoplastic diseases, inflammatory disorders and immunomodulatory disorders |
| WO2008022747A1 (en) * | 2006-08-21 | 2008-02-28 | F. Hoffmann-La Roche Ag | Tricyclic lactam derivatives, their manufacture and use as pharmaceutical agents |
| WO2008025526A1 (en) * | 2006-08-31 | 2008-03-06 | F. Hoffmann-La Roche Ag | Indole derivatives, their manufacture and use as pharmaceutical agents |
| EP2145021A2 (en) | 2007-05-17 | 2010-01-20 | Bristol-Myers Squibb Company | Biomarkers and methods for determining sensitivity to insulin growth factor-1 receptor modulators |
| TW200916472A (en) | 2007-06-20 | 2009-04-16 | Sirtris Pharmaceuticals Inc | Sirtuin modulating compounds |
| EP2170859A1 (en) * | 2007-06-25 | 2010-04-07 | F. Hoffmann-Roche AG | Benzimidazole amido derivatives as kinase inhibitors |
| EP2065380A1 (en) * | 2007-08-22 | 2009-06-03 | F.Hoffmann-La Roche Ag | Pyridoneamide derivatives as focal adhesion kinase (FAK) inhibitors and their use for the treatment of cancer |
| US7816540B2 (en) * | 2007-12-21 | 2010-10-19 | Hoffmann-La Roche Inc. | Carboxyl- or hydroxyl-substituted benzimidazole derivatives |
| JP5386508B2 (ja) * | 2008-01-22 | 2014-01-15 | ヴァーナリス アールアンドディー リミテッド | インドリル−ピリドン誘導体類 |
| ES2396613T3 (es) | 2008-05-19 | 2013-02-22 | OSI Pharmaceuticals, LLC | Imidazopirazinas e imidazotriazinas sustituidas |
| CN102388054B (zh) | 2008-12-19 | 2015-03-04 | 西特里斯药业公司 | 噻唑并吡啶沉默调节蛋白调节剂的化合物 |
| DE102010001064A1 (de) * | 2009-03-18 | 2010-09-23 | Bayer Schering Pharma Aktiengesellschaft | Substituierte 2-Acetamido-5-Aryl-1,2,4-triazolone und deren Verwendung |
| EP2421837A1 (en) | 2009-04-20 | 2012-02-29 | OSI Pharmaceuticals, LLC | Preparation of c-pyrazine-methylamines |
| EP2435435B1 (en) * | 2009-05-27 | 2014-01-29 | AbbVie Inc. | Pyrimidine inhibitors of kinase activity |
| US20120220594A1 (en) | 2009-10-30 | 2012-08-30 | Bristol-Meyers Squibb Company | Methods for treating cancer in patients having igf-1r inhibitor resistance |
| KR101594002B1 (ko) * | 2010-10-06 | 2016-02-15 | 글락소스미스클라인 엘엘씨 | Ｐｉ３ 키나제 억제제로서의 벤즈이미다졸 유도체 |
| WO2012061169A1 (en) * | 2010-11-01 | 2012-05-10 | Boehringer Ingelheim International Gmbh | Benzimidazole inhibitors of leukotriene production |
| US20140309229A1 (en) | 2011-10-13 | 2014-10-16 | Bristol-Myers Squibb Company | Methods for selecting and treating cancer in patients with igf-1r/ir inhibitors |
| KR102307566B1 (ko) | 2013-06-21 | 2021-10-05 | 제니쓰 에피제네틱스 리미티드 | 신규한 바이사이클릭 브로모도메인 억제제 |
| CN105473581B (zh) * | 2013-06-21 | 2019-04-23 | 齐尼思表观遗传学有限公司 | 作为溴结构域抑制剂的新取代的双环化合物 |
| CA2919948C (en) | 2013-07-31 | 2020-07-21 | Zenith Epigenetics Corp. | Novel quinazolinones as bromodomain inhibitors |
| CN103936719A (zh) * | 2014-05-14 | 2014-07-23 | 中国药科大学 | 苯并咪唑类衍生物制备方法及用途 |
| CN122465832A (zh) | 2014-07-30 | 2026-07-28 | 耶达研究及发展有限公司 | 用于培养多能干细胞的培养基 |
| HK1245246A1 (zh) | 2014-12-01 | 2018-08-24 | 恒翼生物医药科技(上海)有限公司 | 作为溴域抑制剂的取代吡啶酮 |
| WO2016092375A1 (en) | 2014-12-11 | 2016-06-16 | Zenith Epigenetics Corp. | Substituted heterocycles as bromodomain inhibitors |
| CN107406438B (zh) | 2014-12-17 | 2021-05-14 | 恒翼生物医药科技(上海)有限公司 | 溴结构域的抑制剂 |
| EP3283475B1 (en) * | 2015-04-16 | 2019-10-16 | Merck Patent GmbH | 3-(1h-benzimidazol-2-yl)-1h-pyridin-2-one derivatives |
| IL285083B1 (en) | 2019-01-23 | 2026-06-01 | Yeda Res & Dev | Medium for pluripotent stem cells |
| IL297963A (en) | 2020-05-07 | 2023-01-01 | Adorx Therapeutics Ltd | Antagonists of the adenosine a2a receptor |
| CN117069696B (zh) * | 2023-08-17 | 2024-04-26 | 中国药科大学 | 一种双靶点小分子抑制剂及其制备方法和应用 |
| JP7901265B2 (ja) * | 2024-03-22 | 2026-08-05 | ブリストル－マイヤーズ スクイブ カンパニー | 新規ｆａｋ分解化合物およびその使用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6162804A (en) * | 1997-09-26 | 2000-12-19 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
| HK1047582B (zh) * | 1999-06-23 | 2005-03-04 | 萨诺费－阿文蒂斯德国有限公司 | 取代的苯並咪唑 |
| US7081454B2 (en) * | 2001-03-28 | 2006-07-25 | Bristol-Myers Squibb Co. | Tyrosine kinase inhibitors |
-
2002
- 2002-03-26 CA CA002442428A patent/CA2442428A1/en not_active Abandoned
- 2002-03-26 PL PL02373300A patent/PL373300A1/xx not_active Application Discontinuation
- 2002-03-26 YU YU84603A patent/YU84603A/sh unknown
- 2002-03-26 HU HU0400323A patent/HUP0400323A2/hu unknown
- 2002-03-26 WO PCT/US2002/009402 patent/WO2002079192A1/en not_active Ceased
- 2002-03-26 MX MXPA03008690A patent/MXPA03008690A/es unknown
- 2002-03-26 JP JP2002577817A patent/JP2004534010A/ja not_active Withdrawn
- 2002-03-26 EP EP02723631A patent/EP1381598A4/en not_active Withdrawn
- 2002-03-26 SK SK12002003A patent/SK12002003A3/sk not_active Application Discontinuation
- 2002-03-26 RU RU2003131693/04A patent/RU2003131693A/ru not_active Application Discontinuation
- 2002-03-26 CN CNA028105168A patent/CN1514833A/zh active Pending
- 2002-03-26 HR HR20030844A patent/HRP20030844A2/hr not_active Application Discontinuation
- 2002-03-26 EE EEP200300475A patent/EE200300475A/xx unknown
- 2002-03-26 CZ CZ20032615A patent/CZ20032615A3/cs unknown
- 2002-03-26 KR KR10-2003-7012594A patent/KR20030083016A/ko not_active Withdrawn
- 2002-03-26 IL IL15804102A patent/IL158041A0/xx unknown
- 2002-03-26 GE GE5363A patent/GEP20053660B/en unknown
- 2002-03-26 BR BR0208373-6A patent/BR0208373A/pt not_active IP Right Cessation
- 2002-03-27 AR ARP020101167A patent/AR035804A1/es not_active Application Discontinuation
- 2002-03-27 PE PE2002000244A patent/PE20021015A1/es not_active Application Discontinuation
- 2002-03-27 UY UY27234A patent/UY27234A1/es not_active Application Discontinuation
-
2003
- 2003-09-25 ZA ZA200307466A patent/ZA200307466B/en unknown
- 2003-09-26 BG BG108206A patent/BG108206A/bg unknown
- 2003-09-26 NO NO20034308A patent/NO20034308L/no not_active Application Discontinuation
- 2003-09-26 IS IS6968A patent/IS6968A/is unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR0208373A (pt) | 2005-02-22 |
| RU2003131693A (ru) | 2005-05-10 |
| IS6968A (is) | 2003-09-26 |
| EP1381598A1 (en) | 2004-01-21 |
| MXPA03008690A (es) | 2003-12-12 |
| YU84603A (sh) | 2006-03-03 |
| CN1514833A (zh) | 2004-07-21 |
| GEP20053660B (en) | 2005-11-10 |
| HUP0400323A2 (hu) | 2005-11-28 |
| UY27234A1 (es) | 2002-10-31 |
| PL373300A1 (en) | 2005-08-22 |
| NO20034308D0 (no) | 2003-09-26 |
| EE200300475A (et) | 2004-02-16 |
| CA2442428A1 (en) | 2002-10-10 |
| CZ20032615A3 (en) | 2004-03-17 |
| NO20034308L (no) | 2003-11-26 |
| EP1381598A4 (en) | 2008-03-19 |
| HRP20030844A2 (en) | 2005-08-31 |
| BG108206A (bg) | 2004-11-30 |
| KR20030083016A (ko) | 2003-10-23 |
| AR035804A1 (es) | 2004-07-14 |
| WO2002079192A1 (en) | 2002-10-10 |
| ZA200307466B (en) | 2005-01-13 |
| IL158041A0 (en) | 2004-03-28 |
| JP2004534010A (ja) | 2004-11-11 |
| PE20021015A1 (es) | 2002-11-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CZ20032615A3 (en) | Novel tyrosine kinase inhibitors | |
| US20040044203A1 (en) | Novel tyrosine kinase inhibitors | |
| JP5977779B2 (ja) | ２−（２，４，５−置換−アニリノ）ピリミジン化合物 | |
| CA2534921C (en) | Aminotriazole compounds useful as inhibitors of protein kinases | |
| AU2016240033B2 (en) | 1-cyano-pyrrolidine compounds as USP30 inhibitors | |
| TWI902864B (zh) | 新穎二唑系選擇性ｈｄａｃ６抑制劑及其用途 | |
| DE60103935T2 (de) | Imidazol-5-yl-2-anilino-pyrimidine als inhibitoren der zellproliferation | |
| TW496863B (en) | Inhibitors of farnesyl protein transferase | |
| AU2004212421B2 (en) | Heteroaryl substituted pyrolls useful as inhibitors of protein kinases | |
| US7232826B2 (en) | Tyrosine kinase inhibitors | |
| US7189716B2 (en) | Tyrosine kinase inhibitors | |
| CN115605463B (zh) | 用于治疗疾病的受体相互作用蛋白激酶i的抑制剂 | |
| CN112638373A (zh) | 细胞周期蛋白依赖性激酶抑制剂 | |
| CN108699057A (zh) | 5-取代的2-(吗啉-4-基)-1,7-萘啶 | |
| EP1697375A2 (en) | Heterocyclic protein kinase inhibitors and uses thereof | |
| KR20130028732A (ko) | 4―아미노피리미딘 유도체 및 아데노신 ａ2ａ 수용체 안타고니스트로서의 이들의 용도 | |
| PT1569937E (pt) | Indazolilpirrolotriazinas modificadas em c-6 | |
| WO2016041618A1 (en) | Substituted indazoles and related heterocycles | |
| KR20060129040A (ko) | 세포 증식 억제제로서의이미다졸로-5-일-2-아닐리노피리미딘 | |
| CN105814037B (zh) | 作为丙酮酸脱氢酶激酶的抑制剂的n1-(3,3,3-三氟-2-羟基-2-甲基丙酰基)-哌啶衍生物 | |
| ES2402855T3 (es) | Derivados de cianuro de azol-metilideno y su uso como moduladores de proteína cinasas | |
| AU2002254399A1 (en) | Novel tyrosine kinase inhibitors | |
| CA3022793A1 (en) | Aromatic sulfonamide derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC9A | Refused patent application |